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ABSTRACT 
 Osteoarthritis (OA) causes debilitating pain for millions of people, yet OA is 
typically diagnosed late in the disease process after severe damage to the articular 
cartilage has occurred and few treatment options exist. Furthermore, destructive 
techniques are required to measure cartilage biochemical and mechanical properties for 
studying cartilage function and changes during OA. Hence, research and clinical needs 
exist for non-destructive measures of cartilage properties. Various arthroscopic (e.g., 
ultrasound probes) and imaging (e.g., MRI or CT) techniques are available for assessing 
cartilage less destructively. However, arthroscopic methods are limited by patient 
anesthesia/infection risks and cost, and MRI is hindered by high cost, long image 
acquisition times and low resolution. Contrast-enhanced CT (CECT) is a promising 
diagnostic tool for early-stage OA, yet most of its development work utilizes simplified 
and ideal cartilage models, and rarely intact, pre-clinical animal or human models.  
To advance CECT imaging for articular cartilage, this dissertation describes 
further development of a new cationic contrast agent (CA4+) for minimally-invasive 
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assessment of cartilage biochemical and mechanical properties, including 
glycosaminoglycan content, compressive modulus, and coefficient of friction. 
Specifically, CA4+ enhanced CT is compared to these three cartilage properties initially 
using an ideal bovine osteochondral plug model, then the technique is expanded to 
examine human finger joints and both euthanized and live mouse knees. Furthermore, 
CECT attenuations with CA4+ map bovine meniscal GAG content and distribution, 
signifying CECT can evaluate multiple tissues involved in OA. CECT’s sensitivity to 
critical cartilage and meniscal properties demonstrates its applicability as both a non-
destructive research tool as well as a method for diagnosing and monitoring early-stage 
OA. Additionally, CECT enables evaluation of efficacy for a new biolubricant (2M TEG) 
for early-stage OA treatment. In particular, CECT can detect the reduced wear on 
cartilage surfaces for samples tested in 2M TEG compared to samples tested in saline 
(negative control). With its sensitivity to cartilage GAG content, surface roughness, and 
mechanical properties, CA4+ enhanced CT will serve as a valuable tool for subsequent in 
vivo animal and clinical use. 
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CHAPTER 1: Assessing Intact Articular Cartilage Biomechanical Function: Non-
Destructive and Minimally-Invasive Techniques  
 
Introduction 
 Articular cartilage is the glossy, hydrated tissue located at the ends of bones in 
diarthrodial joints, including the knee (Figure 1.1), hip, and hand. Like many biological 
materials, the structure of articular cartilage directly relates to its function. Comprised 
primarily of type-II collagen (10-20%), proteoglycans (PGs, 1-10%), chondrocytes, and 
water (65-85%), cartilage’s composition and architecture serve to distribute load while 
reducing friction and wear during joint articulation [1]. The extracellular matrix (ECM) 
of cartilage confers its resistance to compressive loads and enhanced lubricating abilities 
by providing a porous structure that regulates interstitial-fluid flow. Collagen fibers, 
crucial components of the cartilage ECM, are uniquely oriented in each zone of the 
tissue. Specifically, they are arranged parallel to the articular surface in the superficial 
tangential zone (STZ), more randomly in the middle zone, and perpendicular to the 
subchondral bone in the deep zone. This layered arrangement permits cartilage to resist 
tensile stresses, prevent the expansion of the ECM during compression, and resist shear 
stresses at the articular surface [1-3]. The PGs [4], principally located in the middle and 
deep zones, consist of a protein core with attached glycosaminoglycans (GAGs) that also 
influence the mechanical properties of cartilage. These negatively-charged GAGs repel 
each other and form hydrogen bonds with water, creating a swelling pressure in the ECM 
that contributes to compressive stiffness [1] and lubrication between cartilage surfaces [5-
7]. Chondrocytes, the main cell type in articular cartilage, are responsible for the 
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maintenance and homeostasis of the cartilage ECM and, thus, its biological and 
mechanical function. These cells have different size, shape, orientation, and biosynthetic 
activity in the different zones of articular cartilage [8]. 
 Healthy cartilage maintains a balanced process of synthesis and degradation with 
an intact ECM. However, during osteoarthritis (OA), this balance is disturbed and matrix 
degradation prevails [1]. OA is a multifactorial disease which is typically diagnosed in its 
later stages as patient pain and reduced mobility due to cartilage thinning, lesions, 
osteophytes, and synovial inflammation [9, 10]. Cartilage lesions arise from the loss of 
GAGs and disruption of the collagen network [9]. Although the precise timing of these 
biological events in sequence is being actively investigated, loss of GAG, or the negative 
fixed charge density (FCD), is a key event prior to advanced OA [11-20], along with loss 
or alteration of other biochemical markers, such as denatured collagen or aggrecan. 
Cartilage with reduced GAG content and/or degraded collagen matrix has increased 
tissue pore size, hydraulic permeability, and water content, as well as alteration of the 
organized matrix structure [3, 21-27]. These detrimental biological and physical changes 
lead to reduced mechanical integrity [21, 28, 29] of the cartilage and diminished 
lubrication in the joint, resulting in accelerated wear and further cartilage degradation. 
 Osteoarthritis is a progressive, chronically painful disease that affects millions of 
individuals worldwide. Hence, methods to assess the health of cartilage tissue are useful 
for diagnosing OA, monitoring the disease progression, and evaluating the efficacy of 
potential treatments. As a result, several approaches are available for examining articular 
cartilage, some of which are performed clinically. Arthroscopic assessment is one class of 
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such methods and includes utilization of hand-held probes for indentation testing (Figure 
1.1a), ultrasound (US, Figure 1.1b), and optical coherence tomography (OCT, Figure 
1.1c). Another class of techniques includes performing external imaging, such as 
radiography (Figure 1.1d), magnetic resonance imaging (MRI, Figure 1.1e), or 
computed tomography (CT, Figure 1.1f). These approaches enable probing or visualizing 
various characteristics of articular cartilage, including tissue quantity (e.g., thickness or 
volume) and quality (e.g., biochemical content or mechanical properties). While cartilage 
thickness or volume loss is a common metric for OA severity, early compositional (e.g., 
loss of GAG) and functional (e.g., reduced stiffness) changes predict the onset of OA 
before macroscopic tissue loss is discernable. Hence, techniques to determine the 
biochemical makeup, structure, and mechanical properties of cartilage are crucial for 
early-stage OA diagnosis. Since cartilage is a mechanically stressed tissue, its mechanical 
properties indicate its functionality. These mechanical properties are traditionally 
measured ex vivo using various regimens and mechanical testing systems. However, 
techniques such as the aforementioned arthroscopic probes and imaging modalities 
(Figure 1.1) introduce the opportunity for indirect assessment of cartilage mechanics. In 
this review, background is presented on cartilage mechanical properties and their 
associated standard mechanical testing techniques. Then, the application of arthroscopic 
and imaging techniques for the assessment of cartilage health is explored, with a focus on 
mechanical properties, while highlighting each approach’s advantages, disadvantages, 




Traditional Ex Vivo Measurements of Articular Cartilage Stiffness and Lubricating 
Ability 
Measuring cartilage stiffness (confined, unconfined, and indentation testing) 
 One or more standard tests are able suitable for direct measurement of each 
mechanical property of articular cartilage. Depending on the test, different sample types 
are required, including excised cartilage cylinders (discs) or osteochondral plugs (both of 
which can be harvested from various joint surfaces), intact cartilage surfaces, or intact 
joints. A common metric of cartilage stiffness is the equilibrium aggregate modulus (HA). 
One technique for directly measuring HA is confined compression (Figure 1.2a), which 
involves compressing a cartilage cylinder (disc) while only permitting fluid flow through 
the articular and subchondral surfaces. Another common metric for cartilage stiffness is 
the equilibrium compressive modulus (E), which is measurable with unconfined 
compression (Figure 1.2b). In this setup, fluid may exude from the tissue 
circumferentially during loading. For both confined and unconfined configurations, the 
sample can be compressed in either load or displacement control, and the resulting creep 
or stress-relaxation response, respectively, is measured. If the sample is loaded with a 
stair-step regimen [29], HA (confined) or E (unconfined) are calculated from the linear 
range of the equilibrium stress-strain curve. Alternatively, if the sample is subjected to a 
standard creep/stress-relaxation test, HA or E and hydraulic permeability (κ) are 
determined by fitting the stress-relaxation/creep function to the data and extracting the fit 
parameters [30-33]. Poisson’s ratio (ν) is often measured directly with optical 
measurements, and if any two of the three parameters (HA, E, or ν) are known, the other 
  
5 
is easily computable [33]. These mechanical tests permit examining the effects of various 
internal and external parameters on the mechanical stiffness of articular cartilage, 
including GAG concentration [1, 29, 34] and osmotic pressure [35], overloading [36], 
impact loading [37], solute concentration [38], and osmotic loading [39]. 
 Although performing confined and unconfined compression tests is paramount 
and ubiquitous for studying the interplay between articular cartilage composition, 
external factors, and properties, these tests suffer limitations. First, before either test is 
performed, cartilage discs or osteochondral plugs must be isolated from the desired joint 
surface(s), which is both time-consuming and destructive. Indeed, the exposed, 
circumferential edge created as a result of extraction alters the mechanics and mass 
transfer of fluid and molecules in and out of the cartilage. Additionally, if using cartilage 
discs, the cartilage-bone interface is not preserved. Finally, coring samples is not feasible 
for small joints, such as rat or mouse knees, nor for patients’ joints in the clinic.  
 To address the limitations of confined and unconfined compression, indentation 
testing is also employed to study the stiffness of articular cartilage. Similar to confined or 
unconfined compression, indentation testing (Figure 1.2c) is performed in either load 
[40] or displacement [33] control, and the resulting data is used to compute E, ν, and κ 
[33, 40]. Korhonen et al. [33] compared confined, unconfined and indentation testing on 
the same set of bovine cartilage samples. Based on the slopes of their regressions 
comparing confined and unconfined compression to indentation testing, the authors 
report that indentation modulus results are about 20% greater than those obtained for 
unconfined compression and 15% greater than those obtained for confined compression. 
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However, the correlation strengths of the regressions comparing the testing methods (R
2
 
= 0.83 for unconfined and R
2
 = 0.90 for confined) indicate that the two compression 
techniques are highly correlated with the indentation testing method. Indentation testing 
is also utilized to examine cartilage tissue in different disease/treatment states from 
various non-human and human donors, including the effects of dermatan sulfate exposure 
[41], freeze-thaw cycles [42], and enzymatic degradation [43] on bovine cartilage 
stiffness; ovariectomy on sheep cartilage [44]; aging [45, 46] and sub-fracture impact 
[47] on rabbit cartilage; aging and dietary restriction on the structural integrity of rat 
articular cartilage [48]; type IX collagen deficiency [49] and inactivation of one allele of 
the type II collagen gene [50] on murine cartilage; and surface degeneration [51], probe 
tip geometry [52], and OA on human cartilage samples [53].  
 While macroscopic techniques facilitate assessment of bulk tissue stiffness, the 
surface properties of articular cartilage, including roughness and stiffness, may be studied 
through micro- or nanoindentation techniques, such as atomic force microscopy (AFM). 
Using a nano-scale probe, AFM enables researchers to examine cartilage surface 
properties at multiple regions across the sample surface with indentation depths in the 
range of 10 µm [54]. AFM is able to measure surface roughness for: native [55] and 
superficial-zone-lacking [56] bovine cartilage, the most superficial layer of porcine 
cartilage [57], and canine cartilage after a post-traumatic model of early OA [54]. 
Furthermore, the technique is useful for investigating the surface stiffness of a variety of 
samples, including bovine [58] and canine [54, 59] cartilage; differences between 
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articular cartilage and a gel-microfiber composite [60]; the pericellular matrix of articular 
cartilage from several species [61]; and cartilage in mice lacking lubricin [62]. 
 
Measuring the lubricating ability of cartilage (linear, torsional, and pendulum tests) 
 In conjunction with compressive stiffness, the lubricating ability of articular 
cartilage is essential for its proper function. During joint loading, articular cartilage 
dissipates loads while maintaining a nearly frictionless surface. One method for 
quantifying the lubricating ability of cartilage is to measure the coefficient of friction (µ) 
between the articular surface and an apposed material, such as steel, glass, plastic or 
another cartilage surface. By applying either a static strain or load to a cartilage cylinder 
and then rotating or sliding the sample against the testing surface, friction at the cartilage-
surface interface is easily measurable. Torsional friction tests (Figure 1.2d) typically 
consist of statically compressing the cartilage sample against the testing surface, followed 
by stress-relaxation and then rotation [63]. In this configuration, µ is computed as µ = 
T/(RN); where T = torque, N = normal force, R = radius of sample. Alternatively, linear 
oscillating friction testing (Figure 1.2e) involves either 1) compressing a cartilage sample 
against the test surface to a pre-defined stress or strain and then sliding the sample back 
and forth; or 2) the opposite configuration, namely compressing a test material against a 
cartilage surface and then sliding. The frictional coefficient is then computed as the ratio 
between the normal and frictional (shear) forces. Since µ is a measure of the friction at 
the cartilage-material interface, the sample origin, test material, applied stress and strain 
compressing the two surfaces against each other affect µ. Additionally, other variables 
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impact µ, including rotating/sliding speed and the number of rotations/oscillations. Both 
torsional and linear oscillating regimens enable examining the effects of various 
parameters on cartilage friction, including GAG content [5, 34]; various components of 
synovial fluid, including lubricin [64, 65], hyaluronic acid [64], and surface active 
phospholipids (SAPLs) [64]; glutaraldehyde fixation [66]; interstitial fluid pressure [6]; 
normal stress [67]; and sliding [68] and rotating [63] speeds.  
 While torsional and linear friction regimens enable studying the macroscopic 
frictional interactions of articular cartilage surfaces, recent reports demonstrate that AFM 
allows investigation of articular cartilage lubrication at the micro- and nanoscale. In this 
setup, the AFM probe tip is linearly translated on the cartilage surface, the normal and 
shear loads are recorded, and µ is computed analogously to that for macroscopic linear 
friction tests. AFM enables studying the microscale frictional response of bovine articular 
cartilage [69], the presence of a boundary-lubricant layer in articular cartilage [70], the 
dependence of nanoscale friction and adhesion properties of articular cartilage on contact 
load [71], friction measurements of murine cartilage [72] and murine cartilage lacking 
lubricin [62], microscale surface friction of articular cartilage in early osteoarthritis [73], 
and the interaction of lubricin with type II collagen surfaces [74]. 
 Since AFM evaluates the superficial lubricating ability of articular cartilage in a 
small region and unconfined compressive frictional tests are limited by non-physiologic 
boundary conditions, a method for assessing cartilage lubrication in whole joints is 
warranted. Pendulum testing is an approach to evaluate the frictional properties of 
articulating cartilage surfaces with intact joint capsules. This test obviates the need for 
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coring samples and the loss of the native, cartilage boundary conditions during normal 
joint lubrication. Variations of the original Stanton pendulum are available for different 
joint sizes, but the general approach is that the joint: 1) serves as the pendulum’s fulcrum; 
2) is loaded with a static weight; 3) is articulated to a starting angle and then released; 
and 4) the oscillating and decaying pendulum angle (α) formed by the diaphyses is 
tracked optically or mechanically (Figure 1.2f). With the sinusoidal decay trace of the 
pendulum-joint known, µ is computed by: 1) applying conservation of energy to 
determine the peak velocity of the pendulum arm at the base of each swing; 2) computing 
an acceleration from the slope of the peak velocity vs. time graph; and 3) normalizing the 
acceleration by the gravitational constant [75]. Pendulum testing enables evaluating the 
effect of various conditions on µ for whole-joints, including the influence of the meniscus 
in the natural knee joint [76]; effects of viscous friction parameters in the equine fetlock 
joint [77]; the results of proteolytic disruption [78], deficient anterior cruciate ligaments 
[79], and increasing pendulum mass [80] on guinea pig knees; the outcomes of lubricin 
loss [75] and cyclic loading [81] for murine knees; the effects of experimental 
hemarthrosis [82] and intra-articular administration of high molecular weight hyaluronic 
acid plus phospholipid [83] in rabbit knees; and the influence of expression and 
proteolytic susceptibility of lubricin/superficial zone protein on rat knees with antigen-
induced arthritis [84]. 
 Clearly, these traditional methods facilitate answering many important research 
questions and uncovering important cartilage properties. However, testing regimens 
requiring cored samples are not applicable in vivo. Although less destructive, pendulum 
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testing necessitates removing most of the surrounding extra-capsular tissue, which is not 
possible in either animal models or patients. Therefore, in vivo methods to determine 
cartilage mechanical properties are needed for both research and clinical purposes. 
 
Probing Articular Cartilage Stiffness In Vivo 
Arthroscopic indentation testing (manual, ultrasound, and AFM indentation probes) 
 Although large indentation testing systems are not applicable in vivo, smaller 
devices, particularly arthroscopic instruments, are suited for measuring the mechanical 
stiffness of cartilage inside intact joints. Both arthroscopic indentation and AFM systems 
can determine cartilage stiffness in vivo. The hand-held, arthroscopic, indentation 
instrument (Figure 1.3a- top) by Lyyra et al. [85] is one such example. While holding 
the instrument’s distal end against a material surface, the indenter tip deforms the 
material to a constant depth, and the resulting force can be recorded as a measure of the 
material stiffness (Figure 1.3a- bottom). This device can evaluate elastomeric materials 
and cadaver cartilage [85], enzymatically-degraded cartilage samples [86], and different 
cartilage surfaces in 20 healthy patient knees in vivo [87]. The clinically measured 
indenter forces for each cartilage surface match previously measured equilibrium and 
Aggregate modulus values from cadaveric samples tested ex vivo (Figure 1.3b). 
Furthermore, the device can measure the stiffness of thin cartilage [88], estimate the 
equilibrium modulus of cartilage (when coupled with ultrasound imaging to measure the 
cartilage thickness) [89], examine cartilage lesions of anterior cruciate ligament–deficient 
knees [90], and determine the cartilage health in ex vivo equine metacarpophalangeal 
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joints [91]. The second generation of the arthroscopic indentation instrument is easier to 
insert into the joint, and its stiffness results agree with experimental and numerical 
validation [92] and measures from an ultrasound indentation instrument (to be introduced 
later) [93]. A different handheld indentation probe is designed to test cartilage using 
dynamic indentation [94], but to this author’s knowledge, the device by Lyyra et al. [85] 
– under the product name Artscan 200 – is the only one of this kind to be 
commercialized. The Artscan 200 was available throughout Europe during the early 
2000s, although it ultimately failed clinically.  
 Instead of relying on static, manual pressing of the indenter tip into the cartilage, 
which can be inconsistent, another class of arthroscopic indentation instruments uses 
ultrasound (US) energy to dynamically press the indenter tip into the cartilage once the 
device is properly held against the tissue surface. Although US is an imaging modality 
(see next section), US energy can push an indenter tip into cartilage, and the resulting 
force is a measure of the tissue’s dynamic stiffness. Significant correlations are observed 
between the US modulus from one such device and: hand-held indentation force, 
unconfined compressive static and dynamic moduli, and GAG and collagen contents for 
both ex vivo human [93] and bovine [95] cartilage. The same instrument can measure 
elastomer thickness and dynamic modulus reliably as well as differences in dynamic 
modulus of bovine cartilage before and after various enzymatic degradations [96]. A 
different, pen-sized US indentation system generates results in strong agreement with 
standard, dynamic indentation testing [97], while a third water-jet US indentation probe 
can arthroscopically detect a decrease in femoral groove cartilage stiffness after trypsin 
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digestion of intact porcine knees [98]. A limitation to these devices reported by Lotjonen 
et al. [99] is that US speed decreases significantly in articular cartilage during dynamic 
indentation and is related to the applied strain. The relative error in the acoustically 
determined tissue strain is inversely related to the magnitude of true strain, thus higher 
strains should be used to minimize errors in the measured mechanical parameters. Hence, 
these types of devices require both the application of high tissue strains to reduce errors 
and arthroscopic surgery. 
 By combining the smaller-scale technology for hand-held indentation instruments 
with standard AFM principles, arthroscopic AFM systems enable assessing cartilage 
stiffness at the tissue surface in intact joints. One such AFM device, termed the scanning 
force arthroscope (SFA) [100], stabilizes and positions itself relative to the cartilage 
surface under investigation using eight inflatable balloons. Once positioned, an integrated 
stage, nanoscale probe, and deflection sensor permit measuring the stiffness of a small 
area of cartilage. The SFA can measure the biomechanical properties of ex vivo porcine 
cartilage [101] and detect signs of aging and OA in ex vivo murine and human cartilage 
samples [102]. To this author’s knowledge, the SFA is not used currently in vivo or 
clinically. However, it is likely that adequate and reproducible positioning will be a 
challenge for such devices. More importantly though, these devices only measure the 
surface stiffness of cartilage in discrete regions, not across the entire articulating surface, 
nor in the middle and deeper zones, which are known to degrade during the very early 
stages of OA. Hence, this device may be useful as a quantitative tool for assessing 
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cartilage surface stiffness in conjunction with routine arthroscopic examination, but it is 
not capable of minimally-invasive evaluation of entire joint surfaces. 
 
Arthroscopic alternatives to indentation testing (streaming-potential, ultrasound, optical 
coherence tomography probes) 
 Besides the arthroscopic indentation instruments, other approaches are being 
investigated for probing intact cartilage to determine its stiffness. Dashefsky et al. [103] 
developed a microminiature pressure transducer for analyzing chondromalacia of patella 
cartilage. Another unique approach is electromechanical surface spectroscopy, which 
nondestructively detects cartilage degeneration [104] and can examine the effect of 
applied mechanical displacements [105]. These options possess potential for assessing 
cartilage in intact joints, but still rely on physician-controlled alignment with the cartilage 
surface, which is variable.  
 The Arthro-BST device (Figure 1.4a) is more forgiving with regards to imperfect 
alignment with the cartilage surface. Using an array of microelectrodes located on its 
hemispherical tip (Figure 1.4b) [106], this device measures ion streams released from the 
surface of articular cartilage as a result of gently pressing the probe against the tissue 
(Figure 1.4c). The amplitude, frequency and ionic strength of the emitted ions can be 
spatially resolved into streaming potential maps, which indicate the stiffness and 
biochemical content of both healthy and degenerated articular cartilage [107, 108]. The 
Arthro-BST can examine the effects of refrigeration and freezing on cartilage [109] and 
assess changes immediately post-impact in an equine cartilage injury model [110]. The 
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device’s output (QP, arbitrary units) agrees with the International Cartilage Research 
Society (ICRS) and Mankin scores [106] and moderately correlates with the fibrillar (Ef, 
R
2
 = 0.58, Figure 1.4d) and matrix (Em, R
2
 = 0.48) moduli [111] of ex vivo human knee 
cartilage. The Arthro-BST is currently approved for clinical use in Canada and within the 
European Economic Area. Although this device addresses the alignment shortcoming of 
the aforementioned handheld indentation systems and is easy to operate, it still requires 
an arthroscopic incision to be used clinically. 
 Arthroscopic ultrasound (US) probes are another set of handheld devices that do 
not require exact positioning with respect to the cartilage surface (Figure 1.5a). Unlike 
US indentation instruments, which require high cartilage strains to measure the tissue 
stiffness, US probes require only close proximity to cartilage. Once near the surface, the 
transceiver at the probe’s tip transmits ultrasound waves into the tissue and receives their 
reflections. Based on the delay and amplitude of the reflections, US coefficients are 
computed. Arthroscopic US probes can characterize enzymatically [112, 113] and 
mechanically [114] degraded articular cartilage and monitor cartilage after 
degeneration/repair [115] (Figure 1.5b) and mechanical injury [113]. Three US 
coefficients, specifically integrated reflection coefficient (IRC), apparent integrated 
backscattering (AIB), and ultrasound roughness index (URI), all significantly correlate 
with standard indentation equilibrium and dynamic moduli for healthy and 
spontaneously-repaired equine cartilage (Table 1.1) [116]. However, non-
perpendicularity of the ultrasound beam angle with respect to the cartilage surface 
significantly affects the reflection coefficient (R), IRC and URI for bovine patellae 
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(healthy and PG-degraded) and human tibial plateaus (healthy and OA) [117]. Although 
beam angle significantly affects R, IRC and URI, all three parameters distinguish 
roughened from intact samples, provided the ultrasound beam’s angle of incidence is 
between 0 and 5 degrees. Therefore, the device’s positioning has some flexibility, albeit 
not much. Clinically, arthroscopic US is utilized for simultaneous quantitative assessment 
of articular cartilage and subchondral bone [118] and for extraction of quasi-linear 
viscoelastic parameters for lower limb soft tissues [119]. Although US probes are less 
affected by the exact angle/positioning of the sensor with respect to the articular cartilage 
surface, these devices still require arthroscopic surgery, which is not ideal due to surgery 
costs, time frames, and risk (e.g., anesthetic and infection risks).  
 Another arthroscopic imaging technique for studying articular cartilage is optical 
coherence tomography (OCT). Analogous to US, OCT generates cross-sectional images 
(echographs) at resolutions comparable to histology by transmitting and receiving 
infrared light. Ex vivo, arthroscopic OCT outputs agree with both Safranin-O (a cationic, 
red dye that is attracted to the anionic GAGs in cartilage) stained histology (Figure 1.6) 
and standard indentation testing using healthy and spontaneously-repaired equine 
intercarpal cartilage [116]. Indeed, the OCT coefficients significantly correlate with the 
indentation results (Table 1.1) [116]. Furthermore, the OCT attenuation coefficient also 
relates to human cartilage tensile properties [120]. As for live animal applications, there 
are two reports of in vivo use of arthroscopic OCT [121, 122] to evaluate cartilage 
structure, but neither of these report any mechanical outcomes. Finally, OCT is used 
clinically to examine birefringence differences between arthritic and healthy cartilage 
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[123-126], but these studies do not discuss mechanical properties. Although used 
clinically, OCT is limited as it requires arthroscopic surgery and proper alignment of the 
instrument with the articular surface.   
 In addition to measuring cartilage stiffness or composition, both OCT and US are 
used in conjunction with other techniques to determine cartilage mechanical properties. 
For example, in combination with air-jet indentation [127], the resulting OCT air-jet 
indentation modulus strongly correlates with the modulus obtained through standard 
indentation testing (Figure 1.7a). Similarly, US can measure cartilage deformation for a 
water-jet indentation system and enable computation of cartilage stiffness [127]. In the 
aforementioned study, the water-jet modulus strongly correlates with the air-jet modulus 
(Figure 1.7b) [127]. Furthermore, both OCT and US can measure cartilage thickness 
change during osmotic loading. Osmotic loading is a common research method for 
determining cartilage stiffness without contacting the tissue. Briefly, microscopy is often 
used to measure the displacement of stained cell nuclei following equilibration of 
cartilage samples in both hypertonic and hypotonic saline solution. Image analysis is then 
performed to calculate the 2-dimensional components of swelling-induced Lagrangian 
strain throughout the cartilage [128]. To determine the uniaxial modulus, triphasic model 
predictions for cartilage swelling are matched to experimental measures by least squares 
optimization. Although often paired with microscopy, osmotic loading can potentially be 
performed in vivo, particularly if OCT or US were used to measure the cartilage 
thickness. As evidence of feasibility for such approaches, high-frequency US can 
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measure sample thickness during osmotic loading of intact, ex vivo cartilage samples 
[129, 130].  
 Although US or OCT can measure cartilage stiffness in vivo, these techniques 
require arthroscopic procedures, which not only introduce surgical risk, but also would be 
cumbersome and expensive to perform as routine clinical exams, as a lot of operating 
room time and equipment would be necessary to screen the cartilage health of many 
patients. However, common clinical imaging modalities, including computed tomography 
(CT) or magnetic resonance imaging (MRI), could be clinically feasible techniques for 
assessing cartilage deformation in the presence of osmotic gradients in vivo. Although 
there are currently no published reports of such attempts, CT and MRI are readily 
available in the clinic, do not require invasive procedures, and can easily be performed 
following intra-articular administration of hyper/hypo-osmolar solutions. However, the 
effects of osmotic-loading solutions on chondrocytes, synoviocytes, contrast agent 
diffusion (for CT or MRI) are unclear, as are the implications of the resulting tissue 
deformations on MRI signals. More fundamentally though, osmotic loading only permits 
assessment of cartilage tensile stiffness. Hence, a technique that can minimally-invasively 




Assessing Cartilage Mechanical Properties In Vivo using External Imaging 
Modalities 
Common Clinical Imaging Modalities (Radiography, MRI and CT) 
 As an alternative to expensive, time-consuming, technologically complex and 
invasive arthroscopic procedures (e.g., indentation, ultrasound, or optical coherence 
tomography) to assess articular cartilage biomechanical health, researchers and 
physicians are focusing on prominent clinical imaging modalities, including plain 
radiography (typical x-ray image), magnetic resonance imaging (MRI), and computed 
tomography (CT). These techniques may require intravenously or intra-articularly 
administered contrast agent, but these procedures are considered minimally-invasive 
compared to arthroscopic surgeries, and the imaging itself is rapid, standardized and non-
invasive. The most common imaging modality for assessing late-stage OA and ultimate 
cartilage erosion is plain radiography, likely because of its ubiquity, ease of image 
capture and interpretation, and low cost. However, radiographs cannot visualize soft 
tissues, and thus radiographic criteria are based only on bony changes, including the 
presence of osteophytes, subchondral sclerosis, subchondral cyst formation, joint 
incongruity, mal-alignment and joint space narrowing (a surrogate for cartilage volume 
loss, Figure 1.1d). Although plain radiographs are helpful for confirming late stage OA, 
they cannot directly image cartilage itself, and thus are not useful for the direct 




Magnetic Resonance Imaging (MRI) 
 To overcome plain radiography’s insensitivity to cartilage, MRI is commonly 
used to visualize and measure the biochemical content and mechanical integrity of 
articular cartilage. In brief, MRI uses a strong magnetic field [measured in Tesla (T)] and 
high-frequency radio waves for obtaining images of structures. The magnetic field 
polarizes the protons in an object, and then the radio frequency pulses excite them, 
causing the protons to return to their original orientation at different rates depending on 
their environment, which provides a signal that can be measured with detectors. The four 
most common MRI techniques are T1, T2, T1ρ, and Gadolinium-enhanced T1 (T1Gd), 
although numerous other sequences are now available. T1 is used ex vivo to assess 
cartilage volume [131] and to detect cartilage lesions [132]. With regards to tissue 
composition, T1 relaxation time profiles change between species (Figure 1.8a) [133] and 
with progressive damage [134, 135]. On the other hand, T2 relaxation time is indicative 
of many properties of articular cartilage, including collagen concentration [136, 137], 
fibril orientation [138-141], fibril organization [142, 143] and also of changes in tissue 
water content [144]. There are also reports describing the inverse relationship between T2 
and GAG content [145-147]. Finally, as with T1 values, T2 relaxation time profiles vary 
between species (Figure 1.8a) [133] and can indicate cartilage degeneration (Figure 
1.8b) [95].  
 As for assessing the mechanical properties of articular cartilage, both T1 and T2 
correlate with different stiffness measures of articular cartilage (Tables 1.2 & 1.3) [95, 
133, 145, 148-153]. In this review, linear regressions with a correlation coefficient 
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greater than 0.77 (|r| > 0.77) or with coefficients of variation greater than 0.6 (R
2
 > 0.6) 
are considered strong. Using this criteria, although there are many linear regressions 
comparing bulk (full-thickness) or superficial T1 and T2 relaxation times to equilibrium, 
aggregate, dynamic, and instantaneous moduli, only five correlations (3.9%) out of 128 
(Table 1.3) are strong. Utilizing a 1.5-T General Electric Signa TwinSpeed MRI scanner 
and human patellar cartilage, Lammentausta et al. [152] report four of the strong 
correlations: superficial T2 vs. static modulus (r = -0.86, R
2
 = 0.74), superficial T2 vs. 
dynamic modulus (r = -0.81, R
2
 = 0.66), and bulk T2 vs. static modulus for two patellar 
regions (both r = -0.78, R
2
 = 0.61). Scanning with a 9.4-T Oxford 400 NMR vertical 
magnet, Nissi et al. [133] report the other strong correlation (r = 0.879, R
2
 = 0.77) 
between bulk T2 and dynamic modulus (Edyn) using 12 bovine, patellar cartilage samples. 
The correlations between T2 and dynamic modulus demonstrate the link between T2 and 
collagen content/arrangement. However, out of the 27 reported regressions, there are no 
strong correlations between T1 and stiffness. Hence, the ability of T1 or T2 to accurately 
measure cartilage mechanical properties is questionable. 
 Although measuring cartilage stiffness with T1 or T2 is limited, both techniques 
are frequently performed to assess cartilage health in vivo and clinically. Laurent et al. 
[154] use in vivo T1 and T2 to compute a magnetization transfer rate, which moderately 
correlates (R
2
=0.35) with collagen content (measured post-mortem) in goat knees. 
Another report demonstrates that T2 did not correlate with water concentration, 
hydroxyproline concentration, or any other measures of biochemical content for repair or 
native cartilage tissue after microfracture in a goat model [155]. Clinically, Nishioka et 
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al. [156] show that T2 values from knee osteoarthritis patients significantly correlated 
with GAG content measured directly from osteochondral tibial plateau samples harvested 
during total knee arthroplasty. Although these studies compare MR signal to direct 
measurements of tissue biochemical content, no in vivo T1 or T2 MRI studies have 
directly compared to cartilage mechanical properties. 
 Another MRI relaxation technique is T1ρ, and as with T2, this parameter 
correlates with cartilage PG content ex vivo [147, 157]. Using a 4.7-T research MRI 
scanner, Wheaton et al. [157] examine changes in depth-wise T1ρ between control and 
interleukin-1 (IL-1β)-degraded bovine cartilage samples (Figure 1.9a & b). Importantly, 
these authors demonstrate that T1ρ strongly correlates with HA (Table 1.2, r = 0.91, R
2
 = 
0.83) and the log of permeability [log(κ), r = 0.93, R2 = 0.86] using both control and 
degenerated bovine samples. These results indicate that T1ρ can detect changes in both 
PG content and compressive stiffness of cartilage in a physiologically relevant model of 
cartilage degeneration.  
 Regarding in vivo and clinical utility, Wheaton et al. [158] establish the feasibility 
of in vivo T1ρ to quantitatively measure changes in PG content in pig knees with rapidly 
induced, cytokine-mediated cartilage degeneration. Clinically, Nishioka et al. [156] 
report that T1ρ values obtained from knee OA patients significantly correlated with GAG 
content measured directly from osteochondral tibial plateau samples harvested during 
total knee arthroplasty. Although there are currently no reports of correlations between in 
vivo T1ρ and direct measures of cartilage stiffness, unlike native T1, ex vivo T1ρ 
strongly correlates with cartilage compressive modulus, thereby establishing the 
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feasibility of the technique for in vivo, noninvasive assessment of cartilage stiffness. 
 Although native MRI is frequently used to determine cartilage properties, 
contrast-enhanced MRI yields improved assessment of cartilage biochemical and 
biomechanical health. Predicated on Donnan Equilibrium Theory, delayed Gadolinium-
Enhanced MRI of Cartilage (dGEMRIC) uses gadopentetate (Gd-DTPA
2-
, Figure 1.10a-
1) as a mobile anionic probe that partitions throughout the cartilage ECM in inverse 
proportion to the negative FCD arising from the GAGs. Since T1 relaxation time varies 
indirectly with the concentration of Gd-DTPA
2-
, the mapped T1 relaxation time directly 
indicates the concentration and spatial distribution of GAG throughout the cartilage ECM 
(Figure 1.8a & b). Changes in T1 relaxation time measured by dGEMRIC (T1Gd) 
account for up to 95% of the variability in GAG concentration [159, 160]. Furthermore, 
dGEMRIC can assess cartilage mechanical properties. Several reports describe 
correlations between ex vivo T1Gd or [Gd-DTPA
2-
]- defined as 1/R*(1/T1Gd - 1/T1), 
where R is the relaxivity of Gd-DTPA in cartilage (often considered the same as in saline, 




 at 9.4 T)- and static, dynamic, instantaneous or 
aggregate modulus for bovine [95, 133, 149, 150], porcine [133], and human [133, 151-
153, 161, 162] articular cartilage (Table 1.4). Of the reported 153 correlations between 
T1Gd or [Gd-DTPA
2-
] and various cartilage stiffness measures, 21 (13.7%, Table 1.4) are 
strong (again, defined as R
2
 > 0.6 or |r| > 0.77). However, these strong correlations 
include relationships with equilibrium, dynamic, and instantaneous modulus, 
complicating the understanding of what the imaging technique is actually measuring. 
With such a low and disparate correlation success rate, dGEMRIC appears to unreliably 
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measure cartilage mechanical properties.  
 Nevertheless, many researchers use dGEMRIC in vivo and clinically. However, 
few reports compare in vivo imaging results to direct measures of biochemical content. 
After inducing PG depletion in a goat model by intra-articular papain injection, Laurent 
et al. [163] report a close correlation between the extent of the PG loss (as determined 
biochemically) and T1Gd. Also using a goat model, Watanabe et al. [155] describe 
significant correlations for: R1Gd (defined as 1/T1Gd) vs. [GAG] and DeltaR1 (difference 
between the R1pre and R1Gd) vs. [GAG] in native cartilage, and DeltaR1 vs. [GAG] in 
microfracture-induced repair tissue, but not for R1Gd vs. [GAG]. Clinically, a weak, 
positive relationship (r = 0.49, R
2
 = 0.24) is observed between clinically measured T1Gd 
values and GAG content in synovial fluid from 24 patients imaged 3 weeks after acute 
anterior cruciate ligament (ACL) injury compared to 24 healthy volunteers [164]. 
Examining nine knees from nine patients who underwent autologous chondrocyte 
implantation [165], another study compares MR images at 1.5-T before and after intra-
venous injection of Gd-DTPA
2-
 to GAG content obtained from biopsy. For these patients, 
a strong correlation exists between relative DeltaR1 (DeltaR1 from repaired cartilage 
divided by DeltaR1 of normal cartilage) and relative [GAG] (r = 0.818, R
2
 = 0.67). 
However, no significant correlation is observed between relative R1pre and relative 
[GAG] or between relative R1Gd and relative [GAG] concentration. On the contrary, 
Bashir et al. [160] report a strong correlation between in vivo T1Gd and the ex vivo T1Gd 
results (a surrogate for GAG) obtained after total knee replacement surgery, indicating 
the feasibility to monitor GAG distribution in vivo. Although all these reports compare to 
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GAG content, there are no publications of strong correlations between in vivo T1Gd and 
cartilage stiffness. 
 Most of the MRI techniques presented herein are able to assess cartilage stiffness 
to varying degrees of accuracy, but there are some additional benefits and limitations of 
MRI that should briefly be discussed. Beyond simply examining cartilage, MRI permits 
whole-organ imaging of arthritic joints. Additional advantages of MRI over plain 
radiography include the absence of ionizing radiation and the capacity to generate high 
resolution images of the complete joint: articular cartilage, menisci, subchondral bone, 
subarticular bone marrow, synovium, ligaments, and overlying soft tissues. These 
tomographic images can visualize anatomic cross-sections through the joint without 
morphological distortion, magnification or tissue superposition, thereby allowing 
cartilage defects to be visualized directly, regardless of their location within the joint 
[166]. Other features predictive of OA such as bone marrow lesion volume and synovial 
volume can also be quantified with MRI [167, 168]. Although standard coils enable MR 
imaging of extremity joints, such as the knee, MRI studies of the hip are more limited, 
likely as a consequence of the deep location of the joint, which interferes with the 
efficacy of surface coils and lowers the signal to noise ratio [169]. Additionally, as 
cartilage degenerates, the molecular mobility changes, affecting the relative timing of 
image acquisition for delayed uptake of Gd-DTPA
2-
 after injection. This variability 
complicates standardization of clinical protocols and interferes with longitudinal intra- 
and inter-subject comparisons. Moreover, the use of dGEMRIC in elderly patients and 




2-. While MRI is the current “gold standard” for assessing articular cartilage 
morphology, widespread clinical use is hindered by: 1) high cost; 2) need for high field 
strength magnets to improve spatial resolution; 3) long acquisition times; 4) the 
requirement for specialized coils to improve signal to noise ratio; and 5) the obligation 
for specialized software algorithms to segment articular cartilage and map relaxation 
times. 
 
Computed Tomography (CT) 
 Another tomographic form of medical imaging for examining articular cartilage is 
computed tomography (CT). A CT scanner uses a voltage source (tube) to generate and 
project X-rays through an object(s). A series of detectors are positioned opposite the tube 
to sense the X-rays that successfully transmit through the material. The scanner software 
then generates 3D volumetric images by reconstructing the X-ray attenuation data 
obtained from many rotational increments around the object in several planes throughout 
the object’s length. As with MRI, CT can be performed without the use of contrast agents 
(e.g., native or phase-contrast CT) or following administration of contrast media 
(contrast-enhanced CT (CECT)). Native CT does not enable direct visualization of 
articular cartilage in intact joints nor assessing its biochemical composition or mechanical 
properties, as cartilage is primarily composed of water and hence radiolucent. Thus, 
different phase-contrast or CECT techniques are useful for examining cartilage volume, 
morphology, biochemical makeup and mechanical properties.  
 Several variations of phase-contrast CT are used to assess articular cartilage, 
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including coded-aperture X-ray phase-contrast imaging, analyser-based phase-contrast 
CT, analyzer-based imaging (ABI), and Talbot or Talbot-Lau X-ray interferometry. 
These phase-contrast CT techniques can measure cartilage tissue volume ex vivo for 
different joints of several species, including rat knee [170], mouse knee [171, 172], 
human knee [173-177], and human hand [176, 178]. Additionally, these imaging methods 
enable distinguishing healthy from diseased tissue for both mouse [171, 172, 179] and 
human cartilage [174, 180, 181]. Of note, Lee et al. [179] report a moderate agreement 
between the grading of the phase-contrast CT images and their histopathologic results (r 
= 0.76) in a mouse arthritis model. Compared to healthy cartilage samples (Figure 
1.11a), Coan et al. [174] demonstrate a significantly lower chondrocyte distribution 
homogeneity, less chondrocyte alignment, lower height of tangential, transitional, and 
radial zones and a higher prevalence of superficial cartilage damage for human OA 
samples using ABI-CT (Figure 1.11b). With ABI-CT images, texture analysis facilitates 
detailed characterization of the chondrocyte organization in the cartilage matrix, thus 
enabling accurate classification of cartilage as healthy or osteoarthritic [180, 181]. 
Although several groups are using phase-contrast CT to examine cartilage volume, 
surface features, matrix architecture, and chondrocyte distribution, there are no reports of 
comparing phase-contrast CT results to cartilage mechanical properties. 
 Despite no direct comparisons between phase-contrast CT and cartilage stiffness, 
the imaging technique is being used in vivo and in the clinic. Coan et al. [182] 
demonstrate the feasibility of in vivo ABI to depict joint anatomy and detect OA in a 
guinea pig model. Clinically, Tanaka et al. [183] use Talbot-Lau interferometry to image 
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the joints of human cadavers and healthy volunteers and conclude the technique is 
sufficiently sensitive to cartilage morphology. 
 Although phase-contrast CT can determine cartilage morphology clinically, its 
adoption into standard clinical practice is limited. The technique benefits from improved 
image contrast of soft tissues, while maintaining excellent bone image quality and 
comparable or lower radiation doses with respect to standard absorption-based 
radiography and routinely used clinical imaging techniques [182]. However, phase-
contrast CT is currently hindered by slow scan times and a relatively small field-of-view, 
yet these limitations continue to be addressed with more advanced scanners. 
Nevertheless, without sensitivity to the biochemical composition of the cartilage ECM, 
this technique cannot directly measure the compressive or lubrication properties of 
cartilage tissue, which are critical for the tissue’s health and prevention of cartilage wear 
during OA. 
 An alternative to phase-contrast CT is contrast-enhanced CT (CECT). CECT 
utilizes contrast agent molecules (Figure 1.10a & b) with heavy atoms (e.g., iodine) that 
diffuse into cartilage tissue in proportion to the tissue’s negative FCD. Analogous to 
dGEMRIC (see previous sub-section), the diffusion of CECT contrast agents is governed 
by Donnan Equilibrium Theory. However, unlike clinical dGEMRIC, in which the 
contrast agent is administered intravenously, CECT contrast agents are injected intra-
articularly. Anionic contrast agents (Figure 1.10a) are electrostatically repelled from the 
negative FCD of cartilage, resulting in a low tissue CECT attenuation, which is inversely 
related to tissue GAG content. Hence, several groups report moderate to strong 
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correlations between ex vivo CECT attenuation and GAG content using anionic contrast 
agents in bovine [29, 184-187], equine [188] and human [189, 190] cartilage. However, 
weak correlations are also reported for anionic contrast agents (Figure 1.12a) [191] when 
lower concentrations are used. To develop a contrast medium that is more sensitive to 
cartilage degradation as manifested through GAG loss, researchers are synthesizing 
cationic contrast agents (Figure 1.10b) [192]. One such agent, CA4+, generates CECT 
attenuations that strongly and positively correlate with both the GAG content (Figure 
1.12a) and distribution (Figure 1.12b) of bovine cartilage [34, 185, 191]. 
 Building on the relationship between cartilage mechanical properties and 
biochemical makeup, a few groups are deciphering the relationships between CECT 
attenuation and cartilage mechanical properties. Kokkonen et al. [193] detect a difference 
in anionic Ioxaglate diffusion kinetics and equilibrium partitioning that paralleled a 
difference in both the equilibrium and dynamic moduli between threose treated and un-
treated samples. Other studies report linear correlation coefficients between CECT 
attenuation and various measures of cartilage compressive stiffness (Table 1.5) [29, 34, 
188, 194]. Of the reported 5 correlations between CECT and various cartilage stiffness 
measures, 2 are strong (again, defined as R
2
 > 0.6 or |r| > 0.77). However, the weak 
correlations primarily occurred when low concentrations of anionic contrast agents were 
used. When a high concentration of anionic Ioxaglate or a low concentration of cationic 
CA4+ are used, the correlations between CECT attenuation and equilibrium compressive 
modulus are strong. 
 Contrast-enhanced CT is also used to examine articular cartilage in vivo. The 
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technique can measure differences in rat cartilage volume [195-197] and attenuation 
[195-198] between healthy and arthritic cartilage induced by injection of sodium mono-
iodoacetate. For healthy and arthritic rat cartilage (caused by either surgically induced 
chondral defects (grooves) or an exercise model in which OA develops during strenuous 
running on a treadmill) [196], in vivo CECT attenuation and volume trends are also 
examined. Furthermore, in vivo contrast agent diffusions kinetics are reported for anionic 
contrast agents in rats [195] and for both an anionic and a cationic contrast agent in 
rabbits [199]. Clinically, CT arthrography (CTA) is commonly used to assess cartilage 
thickness, volume and morphology in the hip [200] and knee [201]. Using a higher-
resolution, cone-beam CT, CTA can detect patient cartilage lesions [201] and measure 
cartilage strain during standing [202]. Although some in vivo publications include 
comparisons to histology with varying degrees of agreement, none of the reported in vivo 
or clinical studies compare CECT to either biochemical or biomechanical reference 
measurements. 
 The ability of CECT to confidently predict both the GAG content and key 
mechanical properties (compressive modulus and coefficient of friction) indicates the 
technique is more sensitive than phase-contrast CT for measuring cartilage functional 
changes that occur in early-stage OA. Unlike with MRI; rapid image acquisition, multi-
planar 2D-tomographic and 3D image reconstruction capability, and excellent contrast 
resolution and segmentation of cartilage from bone without the need for specialized 
sequences, make CECT particularly appealing for the assessment of cartilage health. 
Additionally, CECT could be more sensitive than MRI at examining hip cartilage, as it is 
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difficult to achieve the same magnetic field strength in the hip as in the knee, thus 
diminishing the utility of dGEMRIC and other MRI sequences in that joint. Regarding 
radiation concerns, advances in CT technology, such as the aforementioned cone-beam 
CT scanner and helical CT scanners using multi-detector arrays, allow sub-millimeter 
spatial resolution at significant reductions in radiation exposure [203, 204]. Compared to 
a 64-detector row helical CT scanner, imaging with the new 320-detector row helical 
scanner reduces the radiation exposure by 35% [205]. Good CT image quality at radiation 
doses (1.74 mSv) equivalent to a plain radiograph of the pelvis can now be obtained 
using higher (140) kVP and lower (14) mAs with automated tube current modulation 
[206]. Finally, since the subchondral bone is thought to play a role in OA [207-209], 
CECT can evaluate both cartilage and bone tissue, leading to a more thorough monitoring 
and diagnosis of the disease. 
 
Conclusions 
 Many approaches for measuring articular cartilage biomechanical properties are 
available, including traditional ex vivo mechanical testing regimens, arthroscopic 
techniques, and external imaging modalities. Ex vivo mechanical tests will likely 
continue to serve as reference measures for new, less-destructive assessment methods, as 
well as approaches for further understanding the relationships between cartilage structure 
and function. However, a demand exists for clinically applicable techniques to determine 
cartilage health. Most of the arthroscopic techniques presented herein are used clinically, 
including hand-held probes for measuring indentation (both manual and US-driven), 
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electrical streaming potentials (Arthro-BST), US and OCT. Although some of these 
probes are capable of measuring cartilage stiffness quickly in both research and clinical 
settings, these techniques all require arthroscopic surgery, which introduces 
anesthetic/infection risk and substantial cost. Even though arthroscopic surgery is 
routinely practiced and simple, patients must recover afterwards. On the other hand, the 
aforementioned external imaging modalities (MRI and CT) only require at most an 
injection of contrast media, which is less invasive and costly, has fewer risks than a 
surgical procedure, and does not necessitate recovery time. These techniques can measure 
key cartilage mechanical properties, particularly compressive stiffness, and can be 
accomplished relatively quickly both clinically and experimentally. Of the external 
imaging modalities summarized in this review, CECT can measure cartilage function 
rapidly and at high resolution, making it a powerful research and clinical tool. Expanding 
from the promising data presented thus far, this dissertation details the continued 
development of CECT using the cationic contrast agent CA4+ for use in pre-clinical and 
animal models as a method for evaluating the biochemical and biomechanical properties 
of cartilage. Furthermore, CECT is applied to evaluate the GAG of the meniscus (another 
tissue involved in OA) and to evaluate potential efficacy of a new synthetic biolubricant 




Figure 1.1: Basic anatomy of the human knee joint [http://orthoinfo.aaos.org/] and various 
commonly used arthroscopic techniques, including a) indentation testing [87], b) ultrasound (US) 
[118], and c) optical coherence tomography (OCT) [125], as well as different clinical imagining 
modalities, including d) plain radiography, e) delayed Gadolinium-Enhanced Magnetic 
Resonance Imaging of Cartilage (dGEMRIC) [210], f) contrast-enhanced computed tomography 






Figure 1.2: Cross-sectional, 2D schematics of common articular cartilage (either isolated discs of 
tissue or intact joint surfaces) mechanical testing setups for determining the appropriate cartilage 
mechanical properties: a) confined compression, b) unconfined compression, c) torsional friction 





Figure 1.3: a) Schematic of a hand-held arthroscopic indentation instrument developed by Lyyra 
et al. [87] (top), which when pressed against the articular cartilage surface under constant force 
can measure the stiffness of the tissue by pushing an indenter into the tissue to a constant depth 
and recording the resulting force (bottom) [87]. b) Comparison between the stiffness of human 
knee joint cartilage measured by this instrument with previously measured equilibrium (Young’s) 
and aggregate moduli from cadaver specimens. PAM = medial facet of the patella, PAL = lateral 
facet of the patella, FPG = patellar groove of the femur, FCM = medial femoral condyle, FCL = 
lateral femoral condyle, TPM = medial tibial plateau, and TPL = lateral tibial plateau [87]. 
 
 
Figure 1.4: a) Photo of Arthro-BST device with the testing chamber and the camera-positioning 
software [111]; b) schematic of array of microelectrodes placed on the tip of the hemispherical 
Arthro-BST probe [106]; c) photo of Arthro-BST manually compressing the cartilage surface 
[111]; d) negative correlation between the device’s output (electromechanical QP) and fibril 




Figure 1.5: a) Photo of arthroscopic ultrasound (US) probe inside a bovine knee joint [113], and 
b) Left: Safranin-O-stained sections and Right: corresponding high-resolution B-mode US images 
of normal cartilage (i), unrepaired tissue (ii), and tissue repaired by autologous chondrocyte 
transplantation in the knees of three pigs (iii, iv, and v) [115]. In the US images, the white, 
yellow, and green colors represent the echo intensities in decreasing magnitude. US imaging 
reveals some about the structure of porcine cartilage, including the extent and area of lesions and 
distinct abnormalities in the internal tissue structure. 
 
 
Figure 1.6: Example OCT and Safranin-O-stained histology sections (for reference) of a 
spontaneously repaired chondral lesion (lesion diameter 2 mm) compared to intact, equine carpal 
cartilage. As noticeable in the histological sections, the irregular surface and abnormal collagen 
structure of repaired tissue can also be visualized through quantitative OCT imaging by a 
decrease in surface reflection, an increase in cartilage surface roughness, and an increase in 




Figure 1.7: Correlations between the stiffness measured by an OCT-based air-jet indentation 
system and those obtained from a) standard indentation mechanical testing (r = 0.88, p < 0.001) 
and b) a water-jet indentation system (r = 0.83, p < 0.001) for cartilage samples before and after 
degradation with either collagenase or trypsin [127]. 
 
 
Figure 1.8: a) Representative T2, T1 and T1Gd depth-wise, color maps for human (top), bovine 
(middle) and porcine (bottom) cartilage. All color maps are in the same scale (scale bar is 1 mm). 
The color bar on the bottom provides the millisecond-scale for T1, T1Gd, and T2 parameters 
[133]. b) Safranin-O stained cartilage sections (top row) representing different stages of bovine 
cartilage degeneration and quantitative T1Gd and T2 MR images (bottom row) of the same 
samples [95]. For healthy cartilage (left column), the surface is smooth and the Safranin-O 
staining is intense in the histology, and the sample’s T2 image exhibits organized structure. In 
early degeneration (middle column), the cartilage surface is irregular with slightly reduced 
Safranin-O staining in the superficial zone, and the corresponding superficial T2 signal indicates 
a less oriented surface. Cartilage samples with advanced degeneration (right column) show 
clefting to radial zone, severely reduced Safranin-O staining, and a fibrillated surface that can be 




Figure 1.9: a) Example T1ρ maps of control and interleukin-1-degraded bovine patellar cartilage 
specimens after increasing exposure time. Also shown on the T1ρ map of the 0-day specimen is 
the ROI from which the bulk T1ρ data were calculated that were later compared to GAG content, 
aggregate modulus and permeability (Table 1.2) [157]. b) Representative cross-sectional profiles 
of T1ρ map data of samples from 0- (control), 3-, 6-, and 10-day treated groups plotted from the 
superficial to osteochondral surfaces [157]. 
 
 
Figure 1.10: Structures of contrast agents for contrast-enhanced MRI and CT. a) Anionic contrast 
agents, including 1) gadopentetate (Gd-DTPA
2-
, Magnevist, Bayer Pharmaceuticals, Pittsburgh, 
PA, USA) for delayed Gadolinium-Enhanced MRI of Cartilage (dGEMRIC), 2) iothalamate 
(CystoConray II, Mallinckrodt, MO, USA) and 3) ioxaglate (Hexabrix320, Mallinckrodt, MO, 
USA), both for contrast-enhanced CT (CECT). b) Cationic contrast agents [192], including 1) 





Figure 1.11: Analyzer-based imaging CT (ABI-CT) images of a) normal and b) osteoarthritic 
cartilage, both acquired at an analyzer crystal slope position of 50%, at an x-ray energy of 26 




 with corresponding sections from histology. (a-A) 
Radial zone axial slice, (a-B & b-A) Coronal slice, (a-C & b-B) Azan-stained histologic section, 
(a-D & b-C) Magnified ROI indicated by inserted rectangles, and (a-E & b-D) Magnified ROI 
indicated by inserted rectangle [174]. 
 
 
Figure 1.12: a) Linear correlations between CECT attenuation and GAG content for bovine 
cartilage samples using three different contrast agents (Ioxaglate = red circles, Gadopentetate = 
green triangles, CA4+ = blue diamonds) [191]. b) Three dimensional CECT images of the same 
bovine cartilage sample exposed to three different contrast agents (Ioxaglate, Gadopentetate, and 
CA4+). Color bar indicates the CECT attenuation in Hounsfield Units (HU). The distribution of 
the cationic contrast agent (CA4+) reflects the depth-wise inhomogeneous distribution of GAGs 
in articular cartilage, while Ioxaglate and Gadopentetate fail to reflect this distribution at the 




Table 1.1: Spearman’s correlation coefficients between the ultrasound (IRC, URI, AIB) or 
optical coherence tomography (ORC, ORI, OBS) parameters and indentation equilibrium (EE) 
and dynamic (ED) moduli from 88-90 measurement locations of healthy or spontaneously-
repaired cartilage on cuboidal bones (os carpale I, II, III and IV) in the intercarpal joints of seven 
24-month-old horses. IRC= integrated reflection coefficient, URI= ultrasound roughness index 
AIB= apparent integrated backscattering, ORC= optical reflection coefficient, ORI= optical 







Table 1.2: Reported linear correlation coefficients between T1 or T1ρ for various compressive moduli. P = patella, H = humerus, FG = 
femoral grove, LFC = lateral femoral condyle, MFC = medial femoral condyle, MTP = medial tibial plateau, LTP = lateral tibial plateau. # 
= Individual correlations were reported for each joint surface/region indicated plus one correlation for all the surfaces combined, and the 
range of r values obtained are presented in this row to enable the table to be smaller. Green highlighted entries indicate correlation 
coefficients that are strong (R
2







Table 1.3: Reported linear correlation coefficients between T2 for various compressive moduli. P = patella, H = humerus, FG = femoral 
grove, LFC = lateral femoral condyle, MFC = medial femoral condyle, MTP = medial tibial plateau, LTP = lateral tibial plateau, SM = 
superomedial, SL = superolateral, CM = central medial, CL = central lateral, IM = inferomedial, IL = inferolateral, Med = Medial 
surfaces, Lat = Lateral surfaces. # = Individual correlations were reported for each joint surface/region indicated plus one correlation for 
all the surfaces combined, and the range of r values obtained are presented in this row to enable the table to be smaller. Green highlighted 
entries indicate correlation coefficients that are strong (R
2







Table 1.4: Reported linear correlation coefficients between T1Gd or [Gd-DTPA]* for various compressive moduli. P = patella, H = 
humerus, FG = femoral grove, LFC = lateral femoral condyle, MFC = medial femoral condyle, MTP = medial tibial plateau, LTP = lateral 
tibial plateau, SM = superomedial, SL = superolateral, CM = central medial, CL = central lateral, IM = inferomedial, IL = inferolateral, 
Med = Medial surfaces, Lat = Lateral surfaces, Cov = from region under meniscus, Uncov = from region not covered by meniscus, Surg = 
from patients undergoing joint replacement surgery, Cad = from cadavers. # = Individual correlations were reported for each joint 
surface/region indicated plus one correlation for all the surfaces combined, and the range of r values obtained are presented in this row to 
enable the table to be smaller. Green highlighted entries indicate correlation coefficients that are strong (R
2
 > 0.6, |r| > 0.77). *Determined 
as [Gd-DTPA]= 1/R*(1/T1Gd - 1/T1), where R is the relaxivity of Gd-DTPA in cartilage (often considered the same as in saline, with a 












Table 1.5: Reported linear correlation coefficients between CECT using different contrast agents and various compressive moduli (E). 
MTP = medial tibial plateau, P = patella, FG = femoral grove, FC = femoral condyle. *Including healthy and spontaneously repaired 
tissue. Green highlighted entries indicate correlation coefficients that are strong (R
2




CHAPTER 2: Cationic Contrast-Enhanced Computed Tomographic Imaging of Bovine 
Cartilage Correlates with the Compressive Modulus and Coefficient of Friction 
 
Introduction 
 Articular cartilage is the soft, hydrated tissue located at the ends of long bones, 
serving to distribute load while reducing friction and wear during joint articulation. 
Comprised primarily of collagen type II, proteoglycans, chondrocytes, and water, 
articular cartilage’s composition and structure directly affect its mechanical properties 
and function [1]. The extracellular matrix (ECM) of cartilage confers its resistance to 
compressive loads and enhanced lubricating abilities by providing a porous structure that 
regulates and retains water. The proteoglycans[4] and their associated 
glycosaminoglycans (GAGs) repel each other and form non-covalent interactions with 
water, affording a swelling pressure in the ECM that contributes to compressive stiffness 
[1] and lubrication between cartilage surfaces [5-7]. Healthy cartilage maintains a 
balanced process of synthesis and degradation with an intact ECM, however, during 
osteoarthritis (OA), this balance is disturbed and matrix degradation prevails [1]. A 
reduction in GAG concentration and the related decrease in fixed negative charge density 
are key events prior to advanced OA [11-20]. Many studies have established that 
cartilage samples with reduced GAG content and/or degraded collagen matrix have 
increased tissue pore size, hydraulic permeability, and water content as well as alteration 
of the organized matrix structure [3, 21-27]. These biological and physical changes lead 
to reduced mechanical integrity [21, 28, 29] of the cartilage and diminished lubrication in 
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the joint, resulting in accelerated wear and cartilage degradation.  
 Consequently, characterizing and understanding the biomechanical properties of 
cartilage is important from both a basic science and clinical perspective, and various 
mechanical testing regimens have been developed. These approaches typically use either 
excised cartilage disks or osteochondral plugs cored from various joint surfaces. 
Unconfined compressive stress relaxation tests using osteochondral plugs allow facile 
computation of the equilibrium compressive modulus (E) of cartilage by fitting a line to 
the resulting equilibrium stress-strain data [29, 33, 39]. Additionally, torsional friction 
tests consisting of static compression followed by relaxation and then rotation are used 
for evaluating coefficients of friction (µ) of cartilage [63, 64]. Even though both tests are 
non-destructive and allow for subsequent evaluation of the same samples, additional 
minimally-invasive methods to quantify cartilage mechanics are highly desired, 
especially imaging-based techniques that can be used in pre-clinical animal or clinical 
studies.  
 Several quantitative imaging methods are being developed to evaluate 
biochemical changes in cartilage, specifically GAG content changes [210-213]. Most of 
these techniques indirectly determine changes in the GAG content of cartilage tissue 
utilizing an anionic contrast agent probe that partitions in inverse proportion to the GAG 
content of the cartilage matrix. For example, Gadopentetic acid (charge -2) is used for 
delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC) [16, 
152, 159, 160, 214-216] while Ioxaglate [37, 184, 186, 187, 189-191] (charge -1) and 
Iothalamate [29, 185] (charge -1) are used for contrast-enhanced computed tomographic 
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(CECT) imaging of cartilage. dGEMRIC can quantify changes in GAG content in both in 
vitro [152, 159, 160, 216] as well as in vivo [16, 214] models. In this technique, the 
changes in MRI T1 relaxation time in the presence of GdDTPA
2-
 reflect variations in 
both the structure and composition of the cartilage ECM, including GAGs. Similarly for 
CECT, changes in the X-ray attenuation of cartilage in the presence of Ioxaglate or 
Iothalamate can be used to quantify the GAG content of normal as well as degraded 
articular cartilage [29, 37, 184-187, 189-191]. Additionally, CECT attenuation of bovine 
cartilage plugs, obtained using Iothalamate at high concentrations, was correlated to the 
compressive modulus [29], thus providing motivation to further explore this technique for 
the assessment of cartilage tissue mechanical properties.  
 Previously, CECT using a novel cationic contrast agent (CA4+) was reported as a 
sensitive technique for monitoring changes in cartilage GAG content and distribution at 
considerably lower concentrations than anionic contrast agents [185, 191, 192]. Since 
cartilage biomechanical properties are related to GAG content, this author hypothesizes 
that X-ray attenuations obtained from CECT imaging of cartilage using CA4+ will 
correlate with two important articular cartilage biomechanical properties: compressive 
modulus and coefficient of friction. Therefore, the aim of this study was to test this 
hypothesis, and herein, the strong positive correlation between CECT attenuation and 
compressive modulus is described, as well as the strong negative correlation between 






 Twenty-two osteochondral plugs (7mm diameter) were cored from the stifle joints 
of six freshly slaughtered, skeletally mature cows using a diamond-tipped cylindrical 
cutter, irrigated with 0.9% saline at room temperature. Twelve plugs from the femoral 
condyles were used to test for a correlation between CECT attenuation and E (Group 1). 
Five of these plugs were degraded using Chondroitinase ABC (Sigma C3667, St. Louis, 
MO) [0.1 U/mL in 50 mM Tris, 60 mM NaOAc, 0.02% BSA, pH 8.0] at 37 °C for 24 hrs. 
The degraded plugs were then rinsed twice for 4 hrs each in 10 mL of saline at room 
temperature before a final rinse overnight in 10 mL of saline at 4 °C to ensure any 
remaining Chondroitinase ABC was removed. A separate ten plugs were harvested from 
the tibial, femoral, and patellar surfaces (Figure 2.1a) to test for a correlation between 
CECT attenuation and µ (Group 2). All the samples were then frozen at -20 °C in 0.9% 
saline with protease inhibitors, antibiotics, and antimycotics for later use. GIBCO Anti-
Anti stock solution (Invitrogen, Grand Island, NY), 5mM of EDTA (Sigma, St. Louis, 
MO), and benzamidine HCl (Sigma B6506, St. Louis, MO) were included in all the 
solutions that were exposed to the cartilage to prevent nonspecific degradation of the 




Compressive Modulus (E) and Coefficient of Friction (µ) Testing 
 The samples in both groups were evaluated using similar mechanical testing 
procedures. Briefly, a pre-load was applied to establish complete contact between each 
sample’s surface and a polished aluminum platen (Figure 2.1b). While immersed in 
saline, each sample was compressed using a 4-step unconfined stress-relaxation regimen 
consisting of four 5% strain steps at a displacement rate of 0.005 mm/sec (Enduratec 
3230, BOSE, Eden Prairie, MN), each followed by a 45-min relaxation period [29]. For 
Group 1, E was then computed by fitting a linear regression line to the resulting 
equilibrium stress-strain data [29, 33, 39]. The samples in Group 2 were rotated 720 
degrees at 5 degrees/sec (effective velocity of 0.3 mm/sec) [63] immediately following 
the last stress-relaxation period. The compressive force, torque, displacement, and 
rotational data were collected at a sampling rate of 10 Hz. Three torsional coefficients of 
friction (µ) representing the performance of articular cartilage [63] were computed using 
the equation µ = T/(RN), where T is the torque, N is the normal force, and R is radius of 
the sample. Specifically, we calculated: 
 µstatic: the maximum value of µ for the first 10 degrees of rotation.  
 µstatic_eq: computed using the maximum value of T from the first 10 degrees of 
rotation and the normal force as the force at the end of the last relaxation period.  




CA4+ Contrast Agent Solution 
 CA4+ was synthesized as previously reported [192]. The contrast agent solution 
was prepared by dissolving the dry compound in deionized water, balancing the pH to 7.4 
using concentrated 4.0M NaOH and adjusting the osmolality to 400 mOsm/kg using 
sodium chloride to match the in situ osmolality of articular cartilage (350-450 mOsm/kg 
[217]). Similarly to the preparation of saline, protease inhibitors, antibiotics, and 
antimycotics were added before plug immersion. 
 
Contrast-Enhanced CT (CECT) Imaging 
 Following mechanical testing for both groups, the plugs recovered in saline for at 
least 12 hrs at 4 °C prior to exposure to the contrast agent. Each sample was then 
immersed in a 0.9 mL solution of the CA4+ contrast agent at 12 mgI/mL for 24 hrs at 
room temperature. Following immersion, each sample was gently blotted to remove 
excess contrast agent, and the plugs were positioned in a µCT imaging system (µCT40, 
Scanco Medical AG, Brüttisellen, Switzerland) using a custom, airtight holder that 
maintained a humid environment to prevent drying of the cartilage. Sequential transaxial 
µCT images of the cartilage and subchondral bone were acquired at an isotropic voxel 
resolution of 36 µm
3
, 70-kVP tube voltage, 113-µAmp current, and 300-ms integration 
time for all samples. The µCT data were converted to DICOM format using the 
proprietary software from Scanco Medical before being imported for post-processing 
using Analyze™ (BIR, Mayo Clinic, Rochester, MN). The cartilage was segmented from 
the subchondral bone using a semi-automatic, threshold-based algorithm. To perform 
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accurate cartilage segmentation, multiple techniques, such as thresholding and 
component labeling, were utilized. The mean CECT attenuation value for each cartilage 
sample was obtained by averaging the x-ray attenuation over all transaxial µCT images 
corresponding to cartilage tissue and is reported in this study as grayscale intensities in 
Hounsfield Units (HU). 
 
Determine GAG Content 
 Each plug was immersed in saline at 4 °C for 24 hrs to wash out the contrast agent 
before the cartilage was carefully excised from the subchondral bone using a scalpel. 
Care was taken to remove all of the cartilage tissue, including the entire deep zone, and 
the wet mass of the cartilage was obtained. Following lyophilization for 24 hrs, the dry 
weight of each sample was also measured, and the samples were digested in papain (0.5 
mg/mL in a buffer solution of 50 mM sodium phosphate, 5 mM EDTA, 2 mM DTT, pH 
6.8) at 65 °C for 24 hrs. The GAG content of each cartilage sample was determined using 
the 1,9-dimethylmethylene blue (DMMB) colorimetric assay [218]. Briefly, each 
cartilage digestion solution was diluted 40 to 60 times for the assay. To convert from 
absorbance to GAG content, a linear calibration curve was generated using chondroitin-4-
sulfate (Sigma 27042, St. Louis, MO) dissolved in the same buffer as above at 
concentrations ranging from 10-100 µg/mL. Ten microliters of each chondroitin-4-sulfate 
calibration solution and each diluted sample digestion solution were separately combined 
with 100 µL of DMMB dye solution in a 96-well plate. The absorbance of each resulting 
solution at 520 nm was measured in triplicate using a plate reader (Beckman Coulter 
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AD340, Fullerton, CA). The total GAG mass of each sample was calculated using the 
calibration curve and normalized to total mg of GAG per mg wet weight of the cartilage 
for each sample. 
 
Statistics 
 Univariate linear regression analysis (SPSS 17.0, Chicago, IL) was applied to 
evaluate whether the CECT attenuation correlated with the GAG content in both groups. 
Similarly, for Groups 1 and 2, the correlations between E and GAG content, between 
CECT attenuation and E, and between CECT attenuation and each of the three µ values 
were evaluated using univariate linear regression models. The coefficient of 
determination (R
2
) was used to assess the strength of the correlations. Significance level 
was set as two-tailed P-value < 0.05. 
 
Results 
CECT vs. GAG Content (Groups 1 and 2) 
 The CA4+ enhanced CT attenuation and GAG content for the samples tested for 
compressive modulus (Group 1; Figure 2.2a) and those tested for coefficient of friction 
(Group 2; Figure 2.2b) were strongly and significantly correlated with each other: R
2
= 
0.87, p<0.0001 and R
2
= 0.74, p=0.001, respectively. Color maps of samples from Group 
2 with low (Figure 2.2c) and high (Figure 2.2d) GAG content illustrate the differences 
in GAG contents measured with CECT. 
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CECT vs. E (Group 1) 
 Strong positive correlations were observed between E and GAG content as well as 
between CECT attenuation and E: E vs. GAG (R
2
= 0.90, p<0.0001) (Figure 2.3a) and 
CECT vs. E (R
2
= 0.90, p<0.0001) (Figure 2.3b). 
 
CECT vs. µ (Group 2) 
 Additionally, the CA4+ enhanced CT attenuation was negatively correlated with 
the three coefficients of friction, accounting for up to 79% of the variation in µ (Figure 
2.4): CECT vs. µstatic (R
2
=0.71, p=0.002), CECT vs. µstatic_equilibrium  (R
2
=0.79, p<0.001), 
and CECT vs. µkinetic (R
2
=0.69, p=0.003). These correlations were similar to those 
achieved when comparing GAG content to the three coefficients of friction (Figure 2.5), 





evaluate the effect of the cartilage superficial tangential zone (STZ) on the frictional 
properties, we excluded the CECT attenuation of the STZ and correlated the resulting 
CECT attenuation with the coefficients of friction (Figure 2.6). A small percent decrease 
in the R
2
 values (ΔR2) was observed, but the resulting correlations were still statistically 
significant for µstatic (ΔR
2
 = -2.2%, p=0.003 for resulting correlation), µstatic_equilibrium (ΔR
2
 
= -3.5%, p=0.001) and µkinetic (ΔR
2
 = -3.7%, p=0.005). 
 
Discussion 
 The objective of this study was to determine if the biomechanical properties, 
namely equilibrium compressive modulus and coefficient of friction, of bovine articular 
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cartilage can be evaluated using CECT imaging with a cationic contrast agent. As 
mentioned earlier, a decrease in GAG content is an indicator of OA, and GAGs 
contribute to the equilibrium compressive properties of cartilage.  Figures 2.2a&b show 
strong, significant correlations between CECT attenuation and GAG content for all 
samples used in this study, again establishing the well-known link between CECT 
attenuation and GAG content.  Figures 2.2c&d show color maps of representative 
samples with low (2.86%) and high (4.88%) GAG contents. As shown in Figures 
2.3a&b, the equilibrium compressive modulus was strongly and positively correlated 
with GAG content and mean CECT attenuation (R
2
= 0.90 and p<0.0001 for both). The 
CECT attenuation values ranged from 1300 to 2200 HU with GAG contents from 2 to 
7% and E from 0.02 to 0.55 MPa. These findings generally agree with previous results 
[29, 37, 184-187, 189-191] using an anionic contrast agent, except that the correlations 
are inversely related. For example, Bansal et al. [29] reported a negative, linear 
correlation between CECT attenuation and E of bovine osteochondral plugs from the 
patella and femoral groove using Iothalamate [Cysto-Conray II (CCII)]. The specific 
correlations and comparisons are: E vs. GAG: R
2
=0.89 (CCII) vs. R
2
=0.90 (CA4+), and 
CECT vs. E: R
2
=0.93 (CCII) vs. R
2
=0.90 (CA4+). However, the magnitude of the slope 
obtained for the CECT vs. E correlation (slope = 1403) in this study is greater than that 
reported by Bansal et al. [29] (slope = -856), indicating an increased sensitivity to 
changes in compressive modulus compared to the anionic contrast agent. Furthermore, 
the results obtained with CA4+ were achieved with a smaller sample size (n=12 vs. n=30 
for CECT vs. GAG and n=12 vs. n=15 for E vs. GAG and CECT vs. E) and a 
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considerably lower concentration of contrast agent (12 vs. 81 mgI/mL). With CA4+, the 
electrostatic attraction between the contrast agent and the negatively charged GAGs 
results in high contrast agent uptake in cartilage [191], a positive linear correlation 
between CECT attenuation and both GAG content and E, and a steeper slope for the 
correlation between CECT and E.  
 Although there are no reports of the correlation between CECT attenuation and 
cartilage coefficient of friction, previous studies have shown that cartilage GAG content 
affects its frictional properties [5-7]. GAGs contribute to the frictional performance of 
cartilage through both hydrostatic and elastohydrodynamic lubrication [1, 63]. 
Hydrostatic lubrication typically occurs at the onset of loading and for a prolonged period 
thereafter, during which the cartilage interstitial fluid becomes pressurized and supports 
most of the load transmitted across the contact interface. On the other hand, 
elastohydrodynamic lubrication occurs as the cartilage ECM is further compressed during 
motion, during which the cartilage interstitial fluid becomes increasingly pressurized and 
more of the fluid is exuded at the tissue interface. When the interstitial water is 
pressurized, the frictional load of the collagen-proteoglycan matrix is considerably 
reduced, resulting in a lower µ. Since GAGs bind water in cartilage, contributing to the 
interstitial fluid pressure, the GAG content of cartilage affects frictional performance, and 
this was confirmed by Basalo et al. [7], who showed that the depletion of GAGs from 
cartilage results in increased µ. Additionally, the same group also demonstrated that 
removal of the superficial tangential layer of cartilage did not increase µ [56], indicating 
that the frictional response of cartilage is not limited to a surface phenomenon, rather it is 
  
55 
also affected by the GAG content deeper in the tissue.  
 As shown in Figures 2.4 & 2.5, both the CECT attenuation and GAG content 
were strongly and significantly correlated with the three torsional coefficients of friction. 
The µstatic values ranged from 0.05 to 0.4, µstatic_equilibrium values ranged from 0.1 to 0.35, 
and µkinetic values ranged from 0.05 to 0.2, with GAG contents from 1 to 5% and CECT 
attenuation from 1000 to 2000 HU. The discrepancy in correlation strengths for the 




=0.49, respectively) may 
reflect that frictional properties are influenced by more than GAG. Other factors, such as 
permeability, could affect both the diffusion of the contrast agent into the cartilage tissue 
and elastohydrodynamic lubrication. Thus, GAG content may not be the only contributor 
influencing cartilage frictional performance, especially as the tissue is continually 
deformed during the µkinetic testing. Since structural changes are associated with GAG 
loss in cartilage during OA, future studies are planned to investigate the effect of 
permeability and collagen content on cartilage biomechanical properties using CECT.  
Next, the effect of excluding the superficial-tangential zone (STZ) of cartilage on the 
three correlations between CECT attenuation and frictional coefficients was investigated. 
This was predicated on the Krishnan et al. report that demonstrated that removal of the 
superficial layer did not increase µ [56], indicating that the frictional response of cartilage 
is not limited to a surface phenomenon, rather it is also affected by the GAG content 
deeper in the tissue. Since this was demonstrated by performing frictional tests, removing 
the STZ layer with a microtome, and re-testing, which required altering the tissue, this 
author sought to examine if a similar result could be obtained nondestructively by 
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removing the STZ layer via image processing. The 10% of the CECT image slices closest 
to the articular surface were excluded, and the regression analyses were repeated. The 
effect of removing the STZ voxels was minimal (Figure 2.6), affording a small percent 
decrease in the R
2
 values (ΔR2), but the resulting correlations were still significant for 
µstatic (ΔR
2
 = -2.2%, p=0.003 for resulting correlation), µstatic_equilibrium (ΔR
2
 = -3.5%, 
p=0.001) and µkinetic (ΔR
2
 = -3.7%, p=0.005). This result corroborates the fact that 
frictional properties are not purely a surface phenomenon. Although current clinical CT 
scanners do not have sufficient resolution to examine only the STZ layer of cartilage, the 
scanners do have enough resolution to examine the cartilage tissue as a whole, which as 
shown in this ex vivo setting is sufficient for correlating cartilage frictional performance 
to CECT attenuation. 
 The slight discrepancy in correlation strength between the two CECT vs. GAG 
correlations (Figures 2.2a&b) is likely due to the way the samples were selected and 
prepared. For comparing CECT attenuation to compressive modulus (Group 1), the 
samples were selected from the same surface from multiple knees and then five of them 
were degraded using Chondroitinase ABC to selectively cleave GAG. This procedure 
was selected to enable comparison to previous studies comparing CECT attenuation and 
GAG content to compressive modulus. Degrading the samples to obtain a more 
continuous range of GAG content rather than selecting intact tissue samples is likely to 
improve the correlation strength for the CECT vs. GAG data for Group 1. The samples 
used to compare CECT attenuation to µ (Group 2) were selected from different surfaces 
in multiple knees to generate a sample set with varying GAG content without enzymatic 
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degradation. This approach for obtaining a series of samples with different GAG contents 
was chosen, as opposed to using Chondroitinase ABC, to minimize any possible surface 
alterations that could be introduced with degradation via Chondroitinase ABC, as it has 
been shown that the degradation process begins at the articular surface and progresses 
deeper into the tissue [29].  
 In this study, the samples were compressed against an aluminum platen, which 
does not represent the in vivo conditions whereby two opposing cartilage surfaces are 
loaded against each other. However, previous studies have demonstrated reliable 
compressive modulus measurements using unconfined compression [33, 39] and 
frictional testing [7, 56, 57, 67, 219-222] against non-biological surfaces (e.g., metal or 
glass). These results are also similar to those reported when two cartilage surfaces are 
tested against each other [29, 63]. The frictional samples were subjected to a 4-step 
compression before torsional loading to measure the coefficient of friction. This loading 
regimen allows sufficient time for the interstitial fluid to depressurize, which could affect 
the frictional performance of the samples. However, the samples supported loads typical 
of what is observed at the end of a shorter compression regimen [223], indicating that the 
interstitial fluid is likely still pressurized at the end of the 45-min dwell after the 4
th
 step. 
Additionally, the normal force increased during the rotations as the tissue was further 
deformed, indicating a further pressurization of the interstitial fluid [67]. All the samples 
were also mechanically tested in saline, which is not the native environment of cartilage. 
Synovial fluid contains various biomacromolecules that function as boundary lubricants 
that affect the frictional performance of cartilage [224, 225]. Since the goal was to isolate 
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the effects of hydrostatic and elastohydrodynamic lubrication, which are linked with 
GAG content [5-7], saline was used to prevent confounding the results from the presence 
of these lubricants. However, future studies are now positioned to look at the effects of 
lubricants on µ, E, and GAG degradation. 
 In osteoarthritis, cartilage progressively breaks down, resulting in a loss of 
proteoglycans, increased hydration, and fibrillation of the extracellular matrix [27]. As a 
result of these compositional alterations, the biomechanical performance of osteoarthritic 
cartilage reduces affecting the functionality of the tissue. Since CECT attenuation has 
been shown to correlate with GAG content [29, 37, 184-187, 189-191], compressive 
modulus [29] (and shown here), and now, for the first time, with frictional performance, 
CECT is a valuable tool for determining not only the GAG content of the cartilage tissue, 
but also its overall mechanical integrity. Additionally, a recent study demonstrated that 
CA4+ remains in the knee cartilage of an in vivo rabbit model for up to 2 hrs and is 
eliminated from the cartilage and joint space within 24 hrs; thus indicating CA4+ may be 
suitable for evaluating cartilage in animal OA models [199]. Since the subchondral bone 
is thought to play a role in OA [207-209], CECT can evaluate both cartilage and bone 
tissue, leading to a more thorough monitoring and diagnosis of the disease. Future studies 
using healthy and osteoarthritic human cartilage tissue are planned to validate these 
findings and further challenge this cationic CECT imaging technique for the assessment 




Figure 2.1: a) Photos showing locations where osteochondral plugs were harvested from bovine 
patellae, femoral grooves, and femoral condyles. Plugs were randomly selected after freezing. b) 
Schematic of mechanical testing setup. A- Frame of machine, B- Plug fixture with set screws to 
anchor plug by its subchondral bone, C- 7mm diameter osteochondral plug, D- physiologic saline, 
E- aluminum platen, F- Torque Cell, G- Load Cell, H- Actuator. Each osteochondral plug from 
both groups was subjected to a 4-step compression against the aluminum platen while immersed 
in saline. Plugs from Group 2 were also subjected to a 720°
 
rotation following the 45-min 






Figure 2.2: Correlations between CECT Attenuation (HU) and GAG content (mg/mg) of 
cartilage samples for a) CECT vs. E samples (Group 1, unfilled data points indicate degraded 
samples) and b) CECT vs. µ samples (Group 2). Both correlations were strong (coefficients of 
variation greater than or equal to 0.74) and statistically significant (p≤0.001). Color maps of 
representative, non-degraded samples with c) low (2.86%) and d) high (4.88%) GAG contents. 
 
 
Figure 2.3: Correlations between a) Equilibrium Compressive Modulus (E) (MPa) and GAG 
content and b) CECT attenuation (HU) and Equilibrium Compressive Modulus (E) (MPa) for 
Group 1 (unfilled data points indicate degraded samples). Both correlations were strong 





Figure 2.4: Correlations between CECT attenuation (HU) and three different experimentally-
determined coefficients of friction (µ): a) µstatic, b) µstatic_eq, c) µkinetic for Group 2. 
 
 
Figure 2.5: Correlations between GAG content of each sample and three different 





Figure 2.6: Correlations between CECT attenuation (HU) excluding the STZ of each sample and 
three different experimentally-determined coefficients of friction (µ): a) µstatic, b) µstatic_eq, c) 









 The menisci are crescent-shaped fibrocartilaginous tissues located in most 
vertebrates’ knee joints. The meniscus stabilizes the knee joint, absorbs shocks, protects 
the articular cartilage from excessive stress, and is principally composed of water (70-
75%), collagens (20-25%), and proteoglycans (1-2%) [1, 226, 227]. Meniscal collagen- 
principally Type I [226]- forms bundles that resist tensile and shear forces arising during 
locomotion [1, 228], while the internal proteoglycans and their associated 
glycosaminoglycan (GAG) side chains bond to water. All of these components contribute 
to its compressive strength [1, 226, 228]. Similar to articular cartilage degeneration, 
meniscus degeneration is associated with osteoarthritis (OA), and the menisci are often 
damaged during knee OA, first resulting in GAG depletion and, finally, in irreversible 
collagen damage [229]. Thus, a number of groups are investigating new repair strategies 
(e.g., tissue engineered constructs) [228, 230, 231]. 
 A nondestructive imaging technique for examining meniscal biochemical 
composition and structure is important from a basic science, pre-clinical, and clinical 
perspective. Various imaging modalities are used to evaluate the meniscus, including 
MRI and CT [232, 233]. Clinically, MRI is the standard for examining meniscus 
morphology, including detection of lesions and evaluation of treatment post-operatively 
using both native [232, 234, 235] and contrast-enhanced MRI [236-238]. However, no 
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studies have reported the correlations between meniscal GAG content and MRI signal. 
 Unlike MRI, CT has the advantages of 1) being more widely available, 2) being 
relatively inexpensive, 3) having higher resolution, 4) not requiring specialized pulse 
sequences, 5) being able to image patients with metal implants, and 6) being more 
comfortable for patients due to fast acquisition times and minimal enclosure. Although 
CT imaging uses ionizing radiation, newer CT scanners can maintain high resolution with 
lower radiation doses [205] for imaging the knee. Clinically, CT arthrography is used to 
diagnose meniscal tears [232, 233]. There are no in vivo or ex vivo reports of correlations 
between CT attenuation and meniscal GAG content. However, CECT can measure 
changes in the GAG content of cartilage utilizing contrast agents [239] that partition in 
proportion to the GAG content of the cartilage matrix. For example, changes in the X-ray 
attenuation of cartilage in the presence of Ioxaglate or Iothalamate can be used to 
quantify the GAG content of normal as well as degraded articular cartilage [29, 37, 184, 
191]. Recently, studies have reported a new, cationic contrast agent (CA4+) for CECT 
imaging of cartilage [34, 185, 192, 199] and the soft callus of fractures [240]. Ioxaglate 
and CA4+ have the same number of iodine atoms per molecule (6), similar molecular 
weights and sizes, while Ioxaglate has one formal negative charge, and CA4+ has four 
formal positive charges. CECT using CA4+ is a more sensitive technique for monitoring 
changes in cartilage GAG content and can be accomplished at low concentrations.   
 Since GAGs are also an important component of the meniscus, the focus of this 
study is to determine if CECT can image bovine menisci. This author hypothesizes that: 
1) a lower concentration of CA4+ than Ioxaglate can be used to depict GAG distribution; 
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and 2) the CECT attenuation following immersion in CA4+ or Ioxaglate will correlate 
with GAG content. Herein, the diffusion-in characteristics of Ioxaglate and CA4+ into ex 
vivo bovine menisci are described, as well as the distribution of both contrast agents 
within the tissue and the correlation between CECT attenuation and GAG content. 
 
Methods 
Material/Specimen Preparation and Study Design 
 Eight medial and five lateral menisci were carefully excised from skeletally-
mature cow knees and sectioned into three regions: anterior, central, and posterior [227, 
228, 241] (Figure 3.1a). Each region served as one sample, and all samples were frozen 
at -20 °C in gauze soaked with 0.9% saline containing protease inhibitors and antibiotic-
antimycotic for later use. Anti-Anti solution (1x Gibco® Antibiotic-Antimycotic, Life 
Technologies, Carlsbad, CA), 5mM of EDTA (Sigma, St. Louis, MO) and benzamidine 
HCl (Sigma B6506, St. Louis, MO) were included in all the solutions that were exposed 
to the menisci samples to prevent degradation during the studies. Prior to all studies, the 
menisci were thawed for 4 hrs at 25 °C before the cut-exposed sides of each region were 
sealed with cyanoacrylate glue to prevent contrast agent diffusion through the non-native, 
cut surfaces. 
 CA4+ was synthesized as previously reported [192]. The CA4+ solutions were 
prepared by dissolving the dry compound in deionized water to the desired concentration 
and balancing the pH to 7.4 using concentrated 4.0M NaOH.  The Ioxaglate 
(Hexabrix320, Mallinckrodt, St. Louis, MO) solutions were prepared by diluting native 
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Ioxaglate to the desired concentration using deionized water. All solutions were adjusted 
to 400 mOsm/kg using sodium chloride to match the in situ osmolality of the meniscus 
(350-450 mOsm/kg [217]). Ioxaglate and CA4+ have the same number of iodine atoms 
per molecule (6), similar molecular weights and sizes (molecular weight and estimated 
length and width for Ioxaglate is 1,268.87 g/mol with a length of 26 Å and width of 13 Å; 
for CA4+, it is 1,354.03 g/mol with length of 29 Å and width of 18 Å), while Ioxaglate 
has one formal negative charge, and CA4+ has four formal positive charges. 
 Three studies were performed: 1) a diffusion-in study to determine the immersion 
time required for both Ioxaglate and CA4+ to reach steady-state within the different 
anatomic regions of the meniscus; 2) a concentration optimization study with additional 
regions to qualitatively determine the optimal concentration of CA4+ and Ioxaglate to 
depict the GAG distribution in bovine menisci; and 3) a final study to compare the CECT 
attenuations of two groups of samples after immersion to steady-state in Ioxaglate and 
CA4+ with GAG content. The samples used in each study are summarized in Table 3.1. 
 
Contrast Enhanced Computed Tomography (CECT) Imaging 
 For the diffusion-in study, two posterior, one central, and one anterior samples 
(see Table 3.1) were immersed in 30 mL solutions of CA4+ at 12 mgI/mL, while one 
posterior, one central and two anterior samples were immersed in 30 mL solutions of 
Ioxaglate at 60 mgI/mL. Both sets of meniscal samples were imaged using CECT at 
various time points up to 95 hr. The time required for the contrast agent to reach 
equilibrium within the different regions was determined as the time at which the change 
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in CECT attenuation was less than 0.25%/hr, corresponding to a 1000-fold decrease from 
the original rate of change. The diffusion-in CECT attenuation vs. time data were then 
fitted with an exponential of the form CECT_attenuation = a*exp(-b*time)+c  
(MATLAB 2011a, MATLAB, Natick, MA), and a tau value (1/b) was computed that 
represented the time at which 63.2% of the equilibrium attenuation was reached [184]. 
Once the steady-state immersion time was determined for both agents, five more samples 
(see Table 3.1) were immersed to equilibrium in 30 mL of five concentrations (12, 24, 
48, 60, and 80 mgI/mL) of Ioxaglate. Simultaneously, three regions neighboring the 
samples used for Ioxaglate (see Table 3.1) were immersed in 30 mL of three 
concentrations of CA4+ (6, 12, and 24 mgI/mL) to enable direct qualitative comparisons 
between the distributions of both contrast agents within the meniscus at various 
concentrations.  
 From the results of the first and second studies, we determined that immersing 
samples to equilibrium in CA4+ at 12 mgI/mL generated CECT color maps that 
qualitatively best reflected the GAG distribution in the bovine meniscus as determined by 
Safranin-O stained histological slices (described below), while samples immersed in 
Ioxaglate at 60 mgI/mL reflected the GAG distribution. Thus, for the final study, six 
more samples (Table 3.1) were each immersed to equilibrium in 30 mL of CA4+ at 12 
mgI/mL to provide additional samples for examining the correlation between CA4+ 
CECT attenuation and GAG content. To compare the Ioxaglate CECT attenuation vs. 
GAG content, nine regions (Table 3.1) were each immersed to equilibrium in 30 mL of 
Ioxaglate at 60 mgI/mL and CECT scanned.  
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 For all studies, each sample was gently blotted following contrast agent 
immersion, and the meniscus region was positioned in a µCT imaging system (µCT40, 
Scanco Medical AG, Brüttisellen, Switzerland) using a custom airtight holder that 
maintained a humid environment to prevent drying of the tissue. Sequential coronal µCT 
images of the center of each meniscus section were acquired at an isotropic voxel 
resolution of 36 µm
3
, 70 kVp tube voltage, 113 µAmp current and 300 ms integration 
time. The µCT image data were converted into DICOM format and imported for post-
processing using Analyze (BIR, Mayo Clinic, Rochester, MN). The imaging zone of the 
meniscus was segmented from the surrounding air and the holder using a semi-automatic 
threshold based algorithm. The mean CECT attenuation (in Hounsfield Units, HU) for 
each imaging zone was obtained by averaging the attenuation values over all pixels 
contained within the zone. A central slice of each imaging zone from Studies 1 and 2 was 
examined qualitatively using a color map to determine if the contrast agent distribution 
illustrated the GAG distribution, using Safranin-O stained sections as a reference. The 
color maps from Study 1 were also used to evaluate if the diffusion of the contrast agent 
occurred predominately through a particular surface(s). Following CECT, the imaged 
zone of each meniscus was excised from the surrounding tissue (Figure 3.1b) and 
immersed in saline for 24 hr to wash out the contrast agent. 
 
Histological and Biochemical Assessment of GAG 
 Four meniscus regions neighboring those used in Study 2 were analyzed using 
Safranin-O histological staining to determine the natural distribution of GAGs in the 
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regions. In brief, the four regions were fixed in paraformaldehyde, embedded in paraffin 
and sectioned. The radial sections were then stained with Safranin-O to determine the 
natural distribution of GAGs in the regions.  
The excised meniscus imaging zones from Studies 1 and 3 were cut into three 
subregions (inner, middle, outer) [228] (Figure 3.1c), and their GAG contents were 
determined using the DMMB assay as follows. The subregions were lyophilized for 24 
hr, and the dry weight of each sample was measured. After digestion in papain (0.5 
mg/mL in 50 mM sodium phosphate, 5 mM EDTA, 2 mM DTT, pH 6.8) at 65 °C for 24 
hr, the GAG content of each meniscus subregion was determined using the 1,9-
dimethylmethylene blue (DMMB) colorimetric assay [218]. Briefly, each meniscus 
digestion solution was diluted ten to sixty times for the assay. A linear calibration curve 
was generated using chondroitin-4-sulfate (Sigma C4384, St. Louis, MO) to convert from 
absorbance to GAG content. After adding 10 µL of solution to 100 µL of dye, the 
absorbance of the standard curve and diluted digestion solutions at 520 nm was measured 
in triplicate using a plate reader (Beckman Coulter AD340, Fullerton, CA). The total 
GAG mass of each sample was calculated using the calibration curve and normalized to 
total mg of GAG per mg wet weight of the meniscus subregion. The weighted-average 
GAG content for each imaging zone was then calculated.  
 
Statistical Analysis 
 Since multiple samples were extracted from each knee, a multivariate linear 
regression was first applied to examine if knee origin and GAG content were strong 
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predictors of CECT attenuation.  Since knee origin was not a strong predictor, univariate 
linear regression (SPSS 17.0, Chicago, IL) was applied to evaluate whether the CECT 
attenuation correlated with the entire GAG content of the samples. Additionally, one-way 
ANOVA was used to test for significant differences in GAG content by region and by 
subregion. Significance level was set as two-tailed P-value < 0.05. 
 
Results 
Diffusion of Ioxaglate and CA4+ into Bovine Menisci Regions 
 The CECT attenuation rapidly increased during the first ten hours of immersion 
for both Ioxaglate and CA4+, with the rate of increase eventually decreasing to 
<0.25%/hr after 95 hr (Figure 3.2a). Fitting an exponential curve to the data 
(CECT_attenuation = a*exp(-b*time)+c) resulted in a tau value (1/b) of 20.6 ± 3.98 hr 
[mean ± SD] for CA4+ and 25.9 ± 3.71 hr for Ioxaglate, representing the mean time at 
which 63.2% of the final attenuation was reached. Since CECT attenuation is a measure 
of contrast agent concentration, representative color maps from the same imaging slice of 
a medial, anterior region over the course of the diffusion-in study (Figure 3.2b) indicated 
that the diffusion of CA4+ (as well as Ioxaglate; not shown) occurred preferentially 
through the proximal and secondarily through the distal surface, with minimal diffusion 




Comparison of Ioxaglate and CA4+ Distributions in the Meniscus 
 After immersion of a sample in Ioxaglate at 12 mgI/mL for 95 hr, the contrast 
agent was uniformly distributed throughout the tissue cross-section, as determined by the 
CECT attenuation (Figure 3.3a). Repeating the procedure at 24 mgI/mL, the contrast 
concentrated in the inner and outer subregions of the tissue (Figure 3.3b). Increasing the 
Ioxaglate concentrations to 48, 60 (Figures 3.3c&d, respectively) and 80 mgI/mL (not 
shown) afforded even greater concentrations in the inner and outer subregions. The 
CECT images obtained with Ioxaglate at higher concentrations only vaguely reflected the 
inverse of the GAG distribution observed with neighboring Safranin-O stained 
histological sections (one of the four neighboring histological sections is shown in Figure 
3.3h). Following immersion of a sample in CA4+ at 6 mgI/mL for 95 hr, a greater CECT 
attenuation was observed in the inner subregion and the proximal and distal portions of 
the middle subregion, albeit the CECT attenuation in these subregions was not substantial 
compared to the outer subregion (Figure 3.3e). The CECT attenuation was the greatest in 
the inner and middle subregions for a sample immersed in CA4+ at 12 mgI/mL (Figure 
3.3f). The same distribution pattern was observed for a sample immersed in CA4+ at 24 
mgI/mL, although the CECT attenuation was much greater in the inner subregion and the 
proximal and distal portions of the middle subregion (Figure 3.3g). Safranin-O stained 
histological slices from neighboring regions to these regions depicted that the GAG 
content of bovine menisci was highly concentrated in the inner subregion, followed by 
the middle subregion (example slice shown in Figure 3.3h). Additionally, the DMMB 
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assay indicated that the GAG concentration in the inner and middle subregions was 
greater than in the outer subregion for all meniscus regions (Figure 3.3i). 
 
CECT Attenuation vs. GAG Content 
 Following immersion in Ioxaglate at 60 mgI/mL, the CECT attenuation was 
moderately and negatively correlated with the GAG content of the meniscus regions (R
2
 
= 0.51, p=0.03) (Figure 3.4a). After exposure to CA4+ at 12 mgI/mL, the CECT 
attenuation was strongly and positively correlated with the GAG content of the meniscus 
regions, accounting for 89% of the variation in GAG content (p<0.001), (Figure 3.4b). 
 
Discussion 
 This study investigated whether CECT imaging can quantify the GAG content 
and distribution in ex vivo bovine meniscus samples. As mentioned earlier, an imaging 
method for evaluating meniscus biochemical composition, analogous to those for 
articular cartilage, could enable early diagnosis of knee OA and provide opportunities to 
monitor disease progression. Figure 3.2a shows the diffusion-in kinetics of the cationic 
contrast agent CA4+ and the anionic agent Ioxaglate into four bovine meniscus regions 
each. The CECT attenuation reached 971 HU for CA4+ and 2248 HU for Ioxaglate 
following 95 hr of diffusion, reflecting the difference in initial concentration used for 
each agent (CA4+: 12 mgI/mL and Ioxaglate 60 mgI/mL). Tau values of 20.6 ± 3.98 hr 
[mean ± SD] for CA4+ and 25.9 ± 3.71 hr for Ioxaglate represent the time at which 
63.2% of the final attenuation was reached. Although there are no prior reports of 
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contrast agent diffusion kinetics into ex vivo meniscus, CT contrast agents reach 
equilibrium within 24 hr in articular cartilage specimens [37, 184, 185]. Tau values for 
such agents diffusing into cartilage range from 1.08 - 4.49 hr [184, 185]. The slower 
diffusion-in for meniscus reported herein is likely due to the larger size and lower 
permeability of the bovine meniscal samples compared to the articular cartilage samples. 
This is supported by a report that the meniscus is about 1/6 as permeable as cartilage 
[226], and that the volume of the meniscus samples is about thirty times larger than 7-mm 
diameter cartilage plugs. The lower permeability is likely related to the heavily linked 
collagen fibers around the surface of the meniscus [242].  
 The contrast agents diffused preferentially through the proximal and secondarily 
through the distal surface, with minimal diffusion through the medial surface (Figure 
3.2b). This is likely due to the anisotropic arrangement of collagen fibers throughout the 
meniscus, with the tightest bundles located in the outer subregions [1, 242]. Following 
intra-articular injection, the contrast agent would be exposed to the proximal and distal 
surfaces of the meniscus, thus permitting the agent to diffuse into the meniscal tissue. 
While a 95-hr exposure period is not feasible clinically, human menisci are about 1/3 the 
size of bovine menisci, which should reduce the diffusion time, but this will need to be 
confirmed. Additionally, asking a patient to walk (as is done clinically for dGEMRIC 
[237, 238]) may accelerate the contrast agent uptake via mechanical convection.  
 Next, the effect of contrast agent charge and concentration on equilibrium 
partitioning within the meniscus was evaluated. Color maps from CECT images of 
various meniscus regions immersed in five concentrations of Ioxaglate, ranging from 12 
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to 80 mgI/mL (Figures 3.3a-d), did not adequately reflect the inverse of the natural GAG 
distribution of bovine meniscus as determined by histology and the DMMB assay 
(Figures 3.3h&i). At 12 mgI/mL (Figure 3.3a), the contrast agent distribution was 
essentially homogeneous throughout the meniscus [mean CECT attenuation by 
subregion: Inner (I): 633 HU, Middle (M): 601 HU, Outer (O): 649 HU]. Higher 
concentrations showed up to 43% increased signal in both the outer and inner subregions 
compared to the middle subregion (Figures 3.3b-d), despite the high GAG concentration 
in the inner subregion (Figures 3.3h&i). It is known that Ioxaglate diffuses poorly into 
the middle and deep zones in articular cartilage, where the majority of the GAGs are 
concentrated [37, 185, 191, 192], with only partial penetration into the deeper cartilage at 
concentrations as high as 80 mgI/mL [29]. The penetration of Ioxaglate into the GAG-
concentrated inner subregion of the meniscus (e.g., mean CECT attenuations for 
Ioxaglate at 60 mgI/mL: I: 2236 HU, M: 1928 HU, O: 2479 HU) is likely due to the 
lower concentration of GAG in this subregion (2-3%, Figure 3.3i) compared to the 
greater concentration of GAG in the deeper cartilage tissue (4-6%) [29]. After immersion 
in the cationic contrast agent CA4+ at 6 mgI/mL (Figure 3.3e), the CA4+ was essentially 
homogeneously distributed throughout the meniscus (mean CECT attenuations: I: 725 
HU, M: 616 HU, O: 406 HU). However, immersions in concentrations of 12 and 24 
mgI/mL (similar to those used with articular cartilage [34, 185, 191]) clearly reflected the 
Safranin-O-stained GAG distribution in the meniscus (Figure 3.3h), with higher CECT 
attenuation in the middle and inner subregions than the outer subregion (12 mgI/mL: I: 
1692 HU, M: 1123 HU, O: 661 HU and 24 mgI/mL: I: 2318 HU, M: 1648 HU, O: 1054 
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HU) (Figures 3.3f&g).  
 The imaging signal differences we observed between the subregions with CA4+ 
differ from other reports. With dGEMRIC, Krishnan et al. showed no difference in inner, 
middle, and outer subregions for T1Gd following intravenous Gd-DPTA
2-
 injection [238]. 
Li et al. also found no difference in T1Gd amongst the subregions. These results may be 
due to the limited vascularization of meniscus and the much lower GAG content in 
meniscus compared to cartilage [237]. The GAG content of the subregions reported 
herein (Figure 3.3i) agree with the findings of Ionescu et al. for bovine meniscus [228] 
and the pattern for sheep and rabbit [241].  
 The moderate, negative correlation between the Ioxaglate enhanced CECT 
attenuation and the GAG content of the meniscus regions (R
2
 = 0.51, p=0.03, Figure 
3.4a), and the strong, positive correlation between the CA4+ enhanced CT attenuation 
and the GAG content of the meniscus regions (R
2
 = 0.89, p<0.001, Figure 3.4b) agree 
with the relationships reported for these contrast agents in articular cartilage [29, 34, 184, 
185, 191]. In this study with CA4+ at 12 mgI/mL, CECT attenuations ranged from 850 to 
1300 HU with GAG from 0.8 to 2.5%, while CECT attenuations ranged from 2100 to 
2600 HU with GAG from 0.7 to 1.7% for Ioxaglate at 60 mgI/mL. The Ioxaglate CECT 
attenuation range is similar to that obtained with Ioxaglate at 80 mgI/mL in cartilage 
(1600-3000 HU for 0-5% GAG range) [29], and the CA4+ attenuation range is similar to 
that with CA4+ at 12 mgI/mL for cartilage (1000-2000 HU for 1.4-2.9% GAG range) 
[34]. The slopes of -32045 for Ioxaglate and 24543 for CA4+ relating CECT attenuation 
to GAG content of bovine meniscus are also comparable to those reported for cartilage 
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(Ioxaglate: slope = 30132 at 80 mgI/mL [29], CA4+ slope = 19936 at 12 mgI/mL [34]), 
indicating a similar sensitivity to meniscal GAG content.  However, the CECT 
attenuation using CA4+ at a lower concentration accounted for more of the variability in 
GAG content than did the CECT attenuation following Ioxaglate exposure (89% vs. 
51%). Thus, CECT with CA4+ can quantify the GAG content in both articular cartilage 
and meniscus, illustrating the potential for low-dose intra-articular injections of CA4+ to 
assess knee soft-tissue GAG content.  
 In this study, extracted regions from intact menisci were used to provide a wide 
range of GAG contents and to enable more reproducible imaging. These regions are not 
representative of the native geometry of the meniscus in the knee. However, the cross-
sectional geometry was maintained, and the cut ends were sealed to ensure diffusion 
through only native surfaces. These menisci were frozen and thawed twice, which could 
increase their permeability and the diffusion rate of the contrast agents into the samples. 
Even though this study demonstrates proof of principle, a 95-hr exposure time is not 
clinically feasible. In vivo, the diffusion of the contrast agents may be accelerated by 
mechanical convection (e.g., a patient walking) and body temperature, which may 
decrease the time required to reach equilibrium in tissue. 
 In OA, both cartilage and meniscus progressively degrade, resulting in a loss of 
GAGs, increased hydration, and fibrillation of the extracellular matrix. These alterations 
affect tissue function; hence, a diagnostic capable of monitoring biochemical changes 
within the tissues could enable earlier detection of OA before severe damage occurs. 
Since CECT attenuation correlates with GAG content of cartilage and now, for the first 
  
77 
time, with GAG content in meniscus, CECT may permit quantitative GAG analysis of 
two critical, soft tissues involved in OA. Importantly, since subchondral bone attenuates 
X-rays and is also affected by OA [207], CECT enables simultaneous evaluation of both 
soft tissues and bone, providing the possibility for  comprehensive monitoring and 





Table 3.1: Origin of meniscus samples (regions) for each study, where X denotes samples used 
for given study, A denotes sample shown in Figure 3.3a, B denotes Figure 3.3b, C denotes Figure 
3.3c, D denotes Figure 3.3d, E denotes Figure 3.3e, F denotes Figure 3.3f, G denotes Figure 3.3g, 
H denotes Figure 3.3h, J denotes sample immersed in Iox at 80 mgI/mL (not shown in Figure 




Figure 3.1: Preparation of the bovine menisci for CECT imaging and biochemical analysis. a) 
Schematic displaying how anterior (A), central (C) and posterior (P) regions were harvested from 
bovine menisci for all three studies. b) Location of CECT imaged zone in all regions that was 
also excised for DMMB assay to determine GAG content. c) Excised CECT imaged zones from 
samples in the diffusion-in and fixed-immersion time studies were further divided into inner, 





Figure 3.2: a) Diffusion-in results for CA4+ and Ioxaglate contrast agents in anterior, central, 
and posterior regions of bovine meniscus. The curves are for visualization purposes only. The rate 
of change in CECT attenuation decreased to less than 0.25%/hr after 95 hr compared to >200%/hr 
initially, indicating that a relative equilibrium was reached. *The mean CECT attenuation was 
significantly greater for the Ioxaglate samples than for those immersed in CA4+ for all time 
points after 1 hr (p<0.01). b) CECT color maps of a cross-sectional slice from an anterior region 
immersed in CA4+ showing progressing contrast enhancement over 95 hr of diffusion. 
 
Figure 3.3: CECT color maps of cross-sectional slices from bovine menisci following 95 hr 
immersions in Ioxaglate (Iox) at a) 12 mgI/mL, b) 24 mgI/mL, c) 48 mgI/mL, d) 60 mgI/mL, and 
in CA4+ at e) 6 mgI/mL, f) 12 mgI/mL, and g) 24 mgI/mL. h) Representative histological cross-
sectional slice from a bovine meniscus stained with Safranin-O to indicate GAG distribution. i) 
GAG contents in the inner, middle and outer subregions of anterior, central and posterior menisci 
samples (n=3 per region). *GAG content lower than posterior inner subregion (p<0.05). **GAG 




Figure 3.4: Correlations between CECT Attenuation (HU) and GAG content (mg/mg) of menisci 




CHAPTER 4: Contrast-Enhanced CT Characterizes the Biochemical and Biomechanical 
Properties of Human Metacarpophalangeal Joint Cartilage: Development of a New 
Osteoarthritis Research Model 
 
Introduction 
 Articular cartilage functional properties (e.g., compressive stiffness and 
lubricating ability) are routinely studied using excised cartilage discs or osteochondral 
plugs (Chapter 1) [1, 29, 33, 34, 63, 68]. Osteochondral plugs are also commonly 
employed for ex vivo imaging studies (Chapter 1), including delayed Gadolinium-
Enhanced MRI of Cartilage (dGEMRIC) [133, 152, 159, 160] and contrast-enhanced 
computed tomography (CECT) [29, 34, 186, 187, 189]. While cartilage discs and plugs 
have advantageous geometries for high-resolution imaging and mechanical testing, they 
do not recapitulate the native boundary conditions for the cartilage and subchondral bone 
as exist in the joint. Specifically, the exposed, circumferential edge created during 
extraction alters the mechanics and mass transfer of fluid and molecules in and out of the 
cartilage. Additionally, when using cartilage discs, the cartilage-bone interface has been 
sacrificed and may not be analyzed during imaging or mechanical testing. Therefore, a 
more ideal research model for studying cartilage and osteoarthritis (OA) is warranted. 
 The human metacarpophalangeal joint (MCPJ) has small, intact, hemispherical, 
nearly axi-symmetric cartilage surfaces that are ideal for high resolution imaging and 
mechanical testing. Furthermore, OA occurs in human fingers [243-246], including the 
MCPJ [243-246], which obviates the need for artificial cartilage degradation that is often 
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performed in ex vivo studies [29, 34]. Indeed, epidemiologic studies of hand OA have 
shown that OA prevalence can be quite high in MCPJs (7%-78%, depending on 
population) [245-247], is associated with heavy labor [248], and may be linked to the fact 
that forces generated during gripping are higher in the MCPJ than distal joints [249]. 
Additionally, maximal grip [250-252] and pinch [252] strength inversely correlate with 
MCPJ OA development. Hence, the human MCPJ offers cartilage surfaces with ideal 
geometries for testing and a natural range of tissue health. 
 Currently, the most common method for diagnosing OA in the fingers is plain 
radiography and clinical symptomatology. However, plain radiography cannot directly 
visualize cartilage tissue, so this technique and patient pain only indicate late OA after 
significant cartilage deterioration has occurred. Thus, additional imaging modalities are 
being developed to clinically assess MCPJs for patients with OA and rheumatoid arthritis 
(RA), including ultrasound (US) for measuring cartilage thickness [253, 254] and 
abnormalities [255-257]; and CT [258-262], MRI [258, 260] and US [257, 260, 261, 263, 
264] for measuring bone abnormalities and erosions. However, none of these approaches 
are sensitive to the glycosaminoglycan (GAG) content of articular cartilage. A reduction 
in GAG content is a hallmark of early OA; hence these imaging techniques are not viable 
as early-stage OA diagnostics. Therefore, imaging methods that quantify cartilage GAG 
loss during the early phases of OA are of significant interest. 
 Both dGEMRIC relaxation times [159, 160] and CECT attenuations [29, 34, 184, 
194] strongly correlate with GAG content, making these imaging techniques candidates 
for early OA diagnosis. A few publications showcase dGEMRIC for clinical examination 
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of MCPJ cartilage [265-267], while there are two reports of conventional MRI and MRI 
arthrography to examine MCPJ structures ex vivo [268, 269]. However, none of these 
MCPJ studies directly compare to cartilage GAG content or mechanical properties. To 
develop MCPJ cartilage surfaces as a new model for cartilage research, imaging results 
need to agree with these standard reference measures, as demonstrated for the 
osteochondral plug model [29, 34]. Using a novel, cationic nanoparticle contrast agent, 
one report demonstrates the ability of CECT to indicate GAG distribution in MCPJs 
[270]. However, no previous reports directly correlate imaging data with cartilage GAG 
content or compressive stiffness. Herein, the utility of the MCPJ as a new model for 
imaging and mechanical studies is demonstrated by exploring relationships between 





 metacarpophalangeal joint (MCPJ) was dissected from 12 human cadaver 
hands (12 donors with no reported hand OA or RA, 50% male, mean age: 66.8 yrs, age 
range: 47-80 yrs) and frozen at -20 °C in 0.9% saline with protease inhibitors, antibiotics, 
and antimycotics for later use. GIBCO Anti-Anti stock solution (Invitrogen, Grand 
Island, NY), 5mM of EDTA (Sigma, St. Louis, MO), and benzamidine HCl (Sigma 
B6506, St. Louis, MO) were included in all solutions that were exposed to the cartilage to 
prevent degradation of the cartilage during the study. Each intact joint was thawed, all 
surrounding soft tissue was removed, the joints were disarticulated, and the cartilage 
surfaces were rinsed 3x in saline to remove any remaining synovial fluid. To facilitate 
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easier gripping during imaging and mechanical testing, the metacarpal diaphyses were 
embedded in polymethylmethacrylate (PMMA) bone cement (Harry J. Bosworth 
Company, Skokie, IL). 
 
Indentation Compressive Modulus (E) Testing 
 Once embedded in PMMA, the metacarpal samples were individually positioned 
in a µCT imaging system (µCT40, Scanco Medical AG, Brüttisellen, Switzerland) using 
a custom, airtight holder that maintained a humid environment to prevent drying of the 
cartilage. Sequential transaxial µCT images of the cartilage and subchondral bone were 
acquired at an isotropic voxel resolution of 36 µm, 70-kVp tube voltage, 113-µAmp 
current, and 300-ms integration time for all samples. The baseline µCT data were 
converted to DICOM format using the proprietary software from Scanco Medical before 
being imported for post-processing using Analyze™ (AnalyzeDirect, Overland Park, 
KS). The mean cartilage thickness was then determined using the Line Profile module in 
Analyze.   
 The samples were then evaluated using a standard indentation testing procedure 
[271]. Briefly, the metacarpal diaphysis was secured in a fixture and positioned such that 
the central, apex of the hemispherical cartilage surface was aligned perpendicular to a 1-
mm diameter, plane-ended, stainless-steel indenter tip. After submerging the cartilage in 
saline, a 1N pre-load was applied. Each sample was then compressed using a 4-step 
indentation stress-relaxation regimen consisting of four 5% strain steps at a displacement 
rate of 2.5% strain/sec (Enduratec 3230, BOSE, Eden Prairie, MN), each followed by a 
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300-sec relaxation period. The compressive modulus (E) was then computed by fitting a 
linear regression line to the resulting equilibrium stress-strain data. 
 
Contrast Agent Solutions Preparation 
 Ioxaglate at 80 mgI/mL was prepared by diluting native Ioxaglate (Hexabrix320, 
Mallinckrodt, St. Louis, MO) with deionized water. CA4+ was synthesized as previously 
reported [192], and the CA4+ contrast agent solution was prepared at 12 mgI/mL by 
dissolving the dry compound in deionized water and balancing the pH to 7.4 using 
concentrated 4.0M NaOH. Both the Ioxaglate and CA4+ solutions were adjusted to 400 
mOsm/kg using sodium chloride to match the in situ osmolality of articular cartilage 
(350-450 mOsm/kg [217]). Similarly to the preparation of saline, protease inhibitors, 
antibiotics, and antimycotics were added to contrast solutions before sample immersion. 
 
Contrast-Enhanced CT (CECT) Imaging 
 Following mechanical testing, the samples recovered in saline for at least 12 hrs at 
4 °C prior to exposure to contrast agent. The cartilage of each metacarpal was then 
immersed in 6 mL of Ioxaglate solution for 24 hrs at room temperature. Each sample was 
then gently blotted to remove excess contrast agent and scanned again using the same 
µCT scanner and settings. After scanning, each sample was rinsed in 40-mL of saline 
overnight at room temperature on a rocker table, and the baseline imaging, sample 
immersion, CECT scanning, and desorbing process was repeated with the CA4+ contrast 
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agent. The contrast-enhanced CT (CECT) data were converted to DICOM format, 
imported into Analyze, and the cartilage was segmented from the subchondral bone using 
a region-growing algorithm in the ROI module. The mean CECT attenuation value for 
each sample was obtained by averaging the X-ray attenuation over all transaxial µCT 
slices corresponding to cartilage tissue and is reported as grayscale intensities in 
Hounsfield Units (HU). To negate the effect of biologic variation, the CECT attenuation 
using Ioxaglate as the contrast agent was normalized by the baseline (non-enhanced) CT 
attenuation, while for CA4+, the attenuation values were normalized by their saline 
washout values post-Ioxaglate desorption. 
 
Determination of Glycosaminoglycan (GAG) Content and Distribution 
 After desorbing the CA4+ contrast agent, the cartilage surfaces were carefully cut 
in half through the mid-sagittal plane using a diamond-tipped saw blade (Isomet, Buehler, 
Lake Bluff, IL). The cartilage from the radial surface was excised from the subchondral 
bone using a scalpel, and the wet mass of the cartilage was measured. Following 
lyophilization for 24 hrs, the dry weight of each sample was obtained, and the samples 
were then digested in papain (1 mg/mL in a buffer solution of 50 mM sodium phosphate, 
5 mM EDTA, 2 mM DTT, pH 6.8) at 65 °C for 24 hrs. The GAG content of each 
metacarpal was determined using the 1,9-dimethylmethylene blue (DMMB) colorimetric 
assay [218]. Briefly, each cartilage digestion solution was diluted 10 to 60 times for the 
assay. To convert from absorbance to GAG content, a linear calibration curve was 
generated using chondroitin-4-sulfate (Sigma 27042, St. Louis, MO) dissolved in the 
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same buffer as above at concentrations ranging from 10-100 µg/mL. Ten microliters of 
each chondroitin-4-sulfate calibration solution and each diluted sample digestion solution 
were separately combined with 100 µL of DMMB dye solution in triplicate in a 96-well 
plate. The absorbance of each resulting solution at 520 nm was measured using a plate 
reader (Beckman Coulter AD340, Fullerton, CA). The total GAG mass of each sample 
was calculated using the calibration curve and normalized by the wet mass of the 
cartilage. 
 The ulnar side was then placed in a decalcifier/fixative solution (Formical-4, 
Decal Chemical Corporation, Tallman, NY) for at least 72 hours before being processed 
for histological sectioning. Briefly, all samples were simultaneously immersed in the 
following sequence on an automatic tissue processor: 80% EtOH (1hr 30 min), 95% 
EtOH (1hr 30 min), 95% EtOH (1hr 30 min), 100% EtOH (1hr), 100% EtOH (1hr), 
100% EtOH (1hr), Xylene (1hr 30 min), Xylene with vacuum (1hr  30 min), Paraffin with 
vacuum (2 hrs), and Paraffin (2 hrs). Samples were then removed and embedded in 
Tissue Prep 2 paraffin at 60 °C, sectioned sagittally with a rotary microtome at 5 micron 
thickness, and baked at 60 °C for 25-30 minutes. The first 5-µm section, corresponding to 
the site of indentation testing, was then stained for GAG with 0.1% Safranin-O (S-2255, 
Sigma, St. Louis, MO) with 0.02% Fast Green (F7258-25G, Sigma, St. Louis, MO) 
following a standard procedure from www.ichworld.com. This staining protocol 
consisted of deparaffinizing and hydrating the slides in water, staining with Weigert’s 
Hematoxylin working solution (10 min), washing in running water (10 min), staining 
with Fast Green solution (5 min), quickly rinsing in 1% acetic acid solution (not >15 sec), 
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staining with 0.1% Safranin O solution (5 min), dehydrating and clearing with 95% 
EtOH, 100% EtOH and Xylene (2 changes each, ~1 min each), and mounting with 
permount.  
 Photomicrographs of each stained section were captured at 5x magnification 
(Axio Imager 2, Zeiss Microscopy, Thornwood, NY) and analyzed to determine the mean 
Ip value (an optical density measure for GAG content from Safranin-O stained histology 
sections [128]) for each section. Briefly, regions corresponding to background and the 
entire cartilage layer were extracted from the whole image using Analyze’s ROI and 
Image Calculator modules. For both the background and cartilage regions, these isolated 
color images were separated into the red (R), green (G), and blue (B) channels using a 
custom code (MATLAB 2010a); and the average of the G and B components was 
subtracted from the R component. The resulting normalized values for the background 
regions were then subtracted from the cartilage regions, and only positive results 
(ignoring any cartilage values less than the background) were averaged to compute the 
mean Ip value for the entire cartilage region. 
 
Statistics 
 Univariate linear regression analysis (SPSS 17.0, Chicago, IL) was applied to 
examine relationships between E, CECT attenuations, GAG content, and mean Ip values. 
The coefficient of determination (R
2
) was used to assess the strength of the correlations, 





CECT vs. GAG Content and Distribution 
 The CA4+ enhanced CT attenuation strongly and significantly correlated with 
both GAG content (Figure 4.1a, R
2
 = 0.86, p<0.05) and mean Ip value (Figure 4.1b, R
2
 
= 0.70, p<0.05). However, for Ioxaglate, the CECT attenuation and GAG content were 
weakly and not significantly correlated (Figure 4.1a, R
2
 = 0.12, p>0.05), and the 
correlation between Ioxaglate CECT attenuation and mean Ip value was also not strong 
or significant (Figure 4.1b, R
2
 = 0.13, p>0.05). Using the red color in Safranin-O stained 
histological sections as a reference for GAG distribution, the color maps generated from 
CA4+ enhanced CT scans reflected the GAG distribution in both samples with high GAG 
content (Figure 4.2a) and samples with low GAG content (Figure 4.2b) more than did 
color maps created from Ioxaglate scans (Figures 4.2a &b). 
 
CECT and GAG vs. E 
 Strong positive correlations were observed between E and GAG content as well as 
between E and axial rigidity: E vs. GAG (Figure 4.3a, R
2
= 0.80, p<0.05) and E vs. axial 
rigidity (Figure 4.3b, R
2
= 0.84, p<0.05). Additionally, the CA4+ enhanced CT 
attenuation was strongly and positively correlated with E, accounting for 88% of the 
variation in E (Figure 4.3c). On the other hand, CECT attenuations following immersion 







 Cartilage disc and osteochondral plug models for cartilage research are limited by 
their non-native boundary conditions. However, the human metacarpophalangeal joint 
(MCPJ) provides intact cartilage surfaces suitable for mechanical testing and imaging. 
Provided strong relationships exist between imaging, mechanical and biochemical data 
for its cartilage surfaces, the MCPJ could serve as a more ideal OA research model. 
Figures 4.1a & b show strong, significant correlations between CA4+ enhanced CT 
attenuation and both GAG content and mean Ip value (a measure of red pixel density 
from Safranin-O stained histological sections that is indicative of GAG) for the 
metacarpal cartilage samples used in this study, which agrees with what has been 
previously reported for bovine cartilage. Specifically, Lakin et al. [34] (Chapter 2) report 
positive and significant correlations between CECT and GAG using bovine cartilage with 
coefficients of variation of 0.74 for native tissue and 0.87 for healthy and GAG-depleted 
tissue. Additionally, this study’s correlations agree with those published with CA4+ at 8 
and 27 mgI/mL [185, 191]. However, the correlations between CECT attenuation and 
GAG content for Ioxaglate herein were weak and not significant. Bansal et al. [191] 
report similarly weak correlations using bovine cartilage, but this experiment used a 
lower concentration of Ioxaglate (16 mgI/mL). However, stronger correlations are 
reported when using the same low concentration for healthy and degraded bovine [186, 
187] and native human [189] cartilage, and when using Ioxaglate at 320 mgI/mL for 
healthy bovine cartilage [184] and at 96 mgI/mL for human cartilage [190]. The 
differences in correlation strengths reported herein for Ioxaglate and those reported 
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previously could be due to ECM differences between MCPJ and knee cartilage.  
 Regarding GAG distribution, the CA4+ distributions shown for the metacarpal 
samples with the highest (Figure 4.2a) and lowest (Figure 4.2b) GAG content 
qualitatively agree with Safranin-O stained histological sections from the same regions. 
However, anionic Ioxaglate did not partition with the expected inverse distribution of 
GAG content for either the high (Figure 4.2a) or low (Figure 4.2b) GAG samples. 
Instead, Ioxaglate appeared to distribute uniformly throughout both samples, although 
more contrast agent penetrated the low-GAG sample as predicted. These color maps 
agree with previously reported contrast agent distribution patterns for CA4+ [34, 185, 
191] and for Ioxaglate [184, 186, 187, 189, 191]. Additionally, the Safranin-O stain 
distribution in the histological sections agrees with previous reports for human cartilage 
[106, 272]. Hence, CECT with CA4+ is a useful methodology to measure not only bulk 
GAG content, but also GAG distribution within cartilage tissue. 
 As shown in Figures 4.3a-c, the indentation, equilibrium compressive modulus 
(E) was strongly and positively correlated with GAG content, axial rigidity, and mean 




 = 0.84, and R
2
 = 0.88, respectively; all 
p<0.05), while Ioxaglate CECT attenuation did not strongly correlate with E (R
2
 = 0.24, 
p>0.05). The strong correlations between E and GAG content agree with previous results 
[29, 34], and since axial rigidity equals GAG content multiplied by cartilage thickness, 
this strong correlation is expected. For CECT attenuation vs. E, the results for Ioxaglate 
do not agree with the findings of Bansal et al. [29], who report a strong, negative 
correlation between CECT attenuation and E using bovine knee osteochondral plugs and 
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Iothalamate (Iot). Comparing that study to this one, the specific correlation comparisons 
are: R
2
=0.93 (Iot) vs. R
2
=0.24 (Iox). The Iothalamate study used a slightly larger sample 
size (n=15 vs. n=12), yet the GAG and E ranges from that study are comparable to those 
found here. However, these samples were not artificially GAG-depleted, so it is possible 
that GAG degradation with Chondroitinase-ABC affects other aspects of the cartilage 
ECM, resulting in altered uptake of Iothalamate. On the other hand, the correlations 
reported herein between CA4+ enhanced CT attenuation and E agree with a previous 
correlation using bovine cartilage [34] (Chapter 2). The specific correlation comparisons 
(n=12 for both studies) are: R
2
=0.90 (bovine) vs. R
2
=0.88 (human MCPJ). With CA4+, 
the electrostatic attraction between the contrast agent and the negatively charged GAGs 
results in high contrast agent uptake in human cartilage and positive linear correlations 
between CECT attenuation and both GAG content and E. 
 Since the CA4+ enhanced CT attenuation, compressive modulus, and GAG 
content were all strongly related in this study, the MCPJ is appropriate for a new model 
to study OA. Furthermore, unlike with bovine cartilage, which often requires GAG-
depletion to mimic the natural GAG loss during OA, human MCPJs from donors of 
various ages provide a sample set with naturally-occurring GAG content, which reflects 
the physiologic spectrum of OA in a clinically relevant human joint. As demonstrated, 
human MCPJs are suitable for high-resolution imaging and mechanical testing without 
altering the native boundary conditions for the cartilage and subchondral bone. For larger 
animal or human joints, it is difficult to perform high resolution imaging on the cartilage 
surfaces, as the surfaces are often larger than the scanners’ field of view. Indentation 
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testing is possible for larger intact surfaces, but the more common practice is to core 
osteochondral plugs from the joint surfaces for easier mechanical testing (Chapter 1), 
contrast agent immersion, and high resolution scanning. Finally, the human MCPJ model 
facilitates the investigation of both cartilage and bone simultaneously without risking 
disruptions of the cartilage-bone interface during sample extraction. Since OA is a whole 
joint disease [273], this model is appropriate for examining the interrelations between 
cartilage and bone properties as OA develops, particularly with the use of CECT. 
 Compared to indentation testing and histology, CECT has several substantial 
advantages. Indentation testing must be performed at multiple locations on a sample’s 
surface to generate a compressive stiffness map, which requires many hours. 
Furthermore, the sample thickness at each testing site must be measured to compute a 
compressive modulus, and this is often accomplished with a destructive, needle-puncture 
technique [50]. Following contrast agent immersion, one CECT scan (~20-30 min) yields 
the related information rapidly and non-destructively. There are also some considerable 
challenges and pitfalls associated with using histology, including: 1) irreversible sample 
damage due to machine or personnel processing glitches; 2) loss of data due to incorrect 
sectioning orientation, sample tears during sectioning, or tissue folding or dislodging 
during mounting; and 3) repeat staining cannot be performed on tissue sections. For 
CECT, the sample does not need to be processed or sectioned, reducing the risk of 
sample damage and data loss, and contrast agents can be washed out of samples, enabling 
repeat scanning with different contrast agents (as performed in this study) and 
concentrations. If quantitative measures (e.g., optical density [128]) are desired from 
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histological sections, this data is drastically affected by debris on the slides and day-to-
day variability in microscope lighting and staining batches (even with the same settings 
or recipes). Therefore, if re-staining is necessary, it must be performed on all samples, 
and microscope imaging of all slides for a given study must be performed without 
interruption. On the other hand, provided samples are immersed in the same contrast 
agents for the same duration, samples can be CECT scanned at the same settings on 
subsequent days with no ill effects. Additionally, the 2D sections obtained from histology 
cannot easily be viewed in a different orientation, while CECT enables 3D 
reconstructions and virtual sectioning in real-time through one to three planes 
simultaneously (Figure 4.4). In summary, the CECT attenuations that quantitatively and 
qualitatively agreed with GAG content and distribution as well as compressive modulus 
in Figures 4.1-4.3 can easily be viewed in any arbitrary plane or as a whole 3D structure, 
including for healthy (Figure 4.4a) and early-stage OA (Figure 4.4b) samples. 
 The MCPJ was chosen, as the metacarpal cartilage surface resembles a simple 3D 
geometric shape, namely a hemisphere, which enabled appropriate indentation testing, as 
adequate tissue surrounded the testing site [274], while other joint surfaces (e.g., PIP and 
DIP) did not have appropriate surface shapes. Future studies could examine the properties 
explored herein and new properties (e.g., collagen content) of MCPJs from different 
fingers to determine if differences exist between commonly used and less used digits or 
between dominant and non-dominant hands. Furthermore, the data generated herein 
facilitates future whole-joint imaging studies, in which relationships between cartilage 
and the surrounding synovium could be examined. 
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 Osteoarthritis is a whole joint disease that affects cartilage, bone, and other intra-
capsular soft tissues. During OA, cartilage progressively breaks down while reactionary 
changes also occur in the underlying bone tissue. Since CECT correlates with cartilage 
GAG content [29, 34, 184-187, 189-191] (shown here) and compressive modulus [29, 34] 
(also shown here) and can measure bone properties, CECT is a valuable tool for 
simultaneously assessing two of the most crucially affected tissues in OA. Additionally, 
the technique is more rapid, reproducible, easier to use, and non-destructive compared to 
common mechanical testing and histological methods for evaluating cartilage health. The 
strong correlations between CECT attenuation, compressive stiffness, and GAG content 
demonstrated herein establish the human metacarpophalangeal joint as a new model for 
OA research, which coupled with CECT, enables further investigations into the 






Figure 4.1: Correlations between CECT Attenuation (HU) and: a) GAG content (mg GAG/mg 
cartilage) and b) mean Ip value (a measure of red pixel density from Safranin-O stained 
histological sections that is indicative of GAG) for human metacarpal cartilage samples. Unfilled 
data points indicate the Ioxaglate CECT attenuations, while filled data points represent the CA4+ 
attenuations. Both correlations for CA4+ were strong (coefficients of variation greater than or 
equal to 0.70) and statistically significant (p<0.05), while the correlations for Ioxaglate were not 






Figure 4.2: Representative color maps from a central, sagittal, CECT slice for the metacarpal 
sample with a) the highest GAG content and b) the lowest GAG content, as well as the 
corresponding Safranin-O stained histological section. Color scale bar indicates corresponding 
CECT attenuation in Hounsfield Units (HU) for all CECT color maps. The distribution of the 
CA4+ contrast agent (top row in a & b) more clearly matches the distribution of the Safranin-O 
stain than does that of Ioxaglate (bottom row in a & b) for both samples. For easier comparison 
with the corresponding histological sections, the middle column displays a magnified image of 





Figure 4.3: Correlations between indentation equilibrium modulus (E) and: a) GAG content and 
b) axial rigidity, and c) between mean CECT attenuation and E. Unfilled data points indicate the 
Ioxaglate CECT attenuations, while filled data points represent the CA4+ attenuations. GAG 
content and axial rigidity (GAG * thickness) were both strong, significant predictors of E (R
2
 ≥ 
0.80, p<0.05). CA4+ CECT attenuation also strongly and significantly correlated with E (R
2
 = 
0.88, p < 0.05), while Ioxaglate CECT attenuation did not (R
2
 = 0.24, p>0.05). 
 
 
Figure 4.4: Representative three-dimensional (3D) CECT color maps from CA4+ enhanced CT 
scans of the metacarpal sample with a) the highest GAG content and b) the lowest GAG content. 
The same 3D color maps were generated for Ioxaglate but are not shown, as they do not 
accurately represent the cartilage GAG content (as demonstrated in Figure 4.2). Unlike histology, 
which only permits 2D sectioning in one plane and is both time-consuming and destructive, 
CECT enables rapid, facile, non-destructive, 3D color maps indicative of cartilage GAG content 




CHAPTER 5: Assessing the Biochemical and Biomechanical Properties of Mouse Tibial 
Plateau Cartilage using Cationic Contrast-Enhanced CT 
 
Introduction 
 Osteoarthritis (OA) is a common, non-inflammatory disease that alters synovial 
joint structure and function. Articular cartilage provides a smooth, nearly frictionless 
surface that distributes applied loads to articulating joint surfaces. Unfortunately, this 
tissue breaks down as OA progresses, resulting in eventual cartilage erosion and bone-on-
bone contact leading to patient pain. The mouse has become an essential animal model to 
study cartilage degeneration mechanisms in OA. In this model, the disease can be 
induced via genetic knockouts (e.g., collagen IX [49, 275, 276], osteopontin [277], 
ADAMTS4 [278], or ADAMTS5 [279] deficiencies), surgery (e.g., anterior cruciate 
ligament transection (ACLt) [280] or destabilization of the medial meniscus (DMM) 
[280-282]), or the disease can spontaneously develop in some murine strains (e.g, 
STR/ort) [283-285]. Additionally, the mouse model is common for assessing various 
treatment options in development for OA, including intra-articular hyaluron injections 
[286] and administration of pharmacologic therapeutics [287].  
 During the early stages of OA, cartilage glycosaminoglycan (GAG) content 
decreases. Hence, GAG concentration is an important indicator of cartilage tissue health 
and is routinely studied in OA research. A reduction in GAG prohibits cartilage from 
maintaining a substantial interstitial fluid pressure, which diminishes its compressive 
stiffness and lubricating ability while distributing more of the tissue’s internal load to the 
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collagen matrix, resulting in eventual tissue damage. A common method to assess GAG 
content in mouse models is Safranin-O staining of histological sections [49, 288], 
because the cationic dye is attracted to the anionic GAGs in cartilage. However, since 
cartilage mechanical integrity and lubricating ability are important functional measures, 
these properties are also frequently examined for mouse models using ex vivo indentation 
testing [40, 49, 50] and pendulum friction testing [75, 81, 289]. Although the techniques 
are common; histology, indentation testing, and pendulum testing of mouse articular 
cartilage are challenging and limited, because they are time-consuming, require advanced 
skill, and cannot quickly provide a 3D map of the biochemical or mechanical properties 
of the cartilage (histology requires 2D sectioning, indentation tests specific sites, and 
pendulum testing assesses whole-joint performance, not individual cartilage surfaces). 
Additionally, both histology and indentation are destructive and cannot be performed on 
intact joints or used to monitor disease progression or treatment efficacy in a given 
animal. To generate more global measures of murine joint pathology, whole joint and 
mixed modality imaging [279, 282, 285], fluorescence-assisted carbohydrate 
electrophoresis (FACE) [279], and phase-contrast computed tomography (CT) [172] are 
utilized to examine cartilage. However, these imaging techniques primarily assess 
morphological features of cartilage (e.g., thickness and volume). Thus, a facile, non-
destructive technique that can determine the biochemical and mechanical properties of 
mouse articular cartilage is of significant interest. 
 Predicated on Donnan Equilibrium Theory, delayed Gadolinium-Enhanced MRI 
of Cartilage (dGEMRIC) and contrast-enhanced CT (CECT) use anionic contrast agents 
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that partition throughout the cartilage extracellular matrix (ECM) in inverse proportion to 
the negative fixed charge density (FCD) arising from the GAGs (Chapter_1) [159, 160, 
185, 191], and the resulting image data strongly correlate with cartilage GAG content 
[29, 159, 160] and compressive stiffness [29, 153]. A new cationic, iodinated contrast 
agent (CA4+) [192] partitions throughout cartilage in direct proportion to GAG content 
[185, 191], and the resulting CECT attenuations strongly correlate with bovine cartilage 
GAG content [34, 185, 191] (Chapter_2), equilibrium compressive modulus (E) [34] 
(Chapter 2) and torsional coefficient of friction (µ) [34] (Chapter 2) using osteochondral 
plugs. The aim of this study was to demonstrate the feasibility of using high-resolution 
CECT with CA4+ to measure the GAG content and mechanical properties (E and µ) of 
murine articular cartilage. Herein, the utility of CA4+ enhanced CT as a simple, non-
destructive technique for assessing ex vivo murine cartilage GAG content, compressive 




 The skin and other soft tissues were carefully removed from the hind limbs of 
seven, euthanized, 16 week-old, female C57BL/6 mice, leaving the knee capsules intact 
(n = 13). Three of the knees were set aside for the diffusion-in experiment, while the 
other knees randomly received a 20-µL intra-articular injection of either Chondroitinase 
ABC (to deplete GAG as occurs during OA; C3667, Sigma, St. Louis, MO) at 0.1 U/mL 
(n=3) or 0.5 U/mL (n=3) or saline (control, n=4). The injected limbs were flexed and 
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extended 30 times and then stored at 37 °C for 4 hrs. To facilitate easier gripping during 
imaging and mechanical testing, both the proximal femur and the distal tibia of all knees 
were embedded in polymethylmethacrylate (PMMA) bone cement.  
 The cationic contrast agent CA4+ was synthesized as previously reported [192], 
and a CA4+ contrast agent solution was prepared at 12 mgI/mL by dissolving the dry 
compound in deionized water, balancing the pH to 7.4 using concentrated 4.0M NaOH, 
and adjusting the osmolality to 400 mOsm/kg using sodium chloride to match the in situ 
osmolality of articular cartilage (350-450 mOsm/kg [217]). GIBCO Anti-Anti stock 
solution (Invitrogen, Grand Island, NY), 5mM of EDTA (Sigma, St. Louis, MO), and 
benzamidine HCl (Sigma B6506, St. Louis, MO) were included in all the contrast agent 
and saline solutions that were exposed to the cartilage to prevent nonspecific degradation 
of the cartilage during the study. 
 
Contrast Agent Diffusion-In Experiment 
 The three non-injected knees were disarticulated, all the surrounding soft tissue 
was removed, and the tibias were rinsed three times in excess saline to remove any 
residual synovial fluid. The tibial plateau surfaces were then each immersed in 1-mL of 
CA4+ solution at room temperature. The samples were removed from the contrast agent 
for CT scanning after being immersed for the following total times: 0, 5, 10, 20, 30, 45, 
60, and 90 min. When removed from the solution, the samples were gently blotted dry 
and individually positioned in a µCT imaging system (µCT40, Scanco Medical AG, 
Brüttisellen, Switzerland) using a custom, airtight holder that maintained a humid 
  
103 
environment to prevent drying of the cartilage. Sequential transaxial µCT images of the 
cartilage and subchondral bone were acquired at an isotropic voxel resolution of 6 µm, 
70-kVp tube voltage, 113-µAmp current, and 300-ms integration time for all samples. 
These diffusion-in µCT data were converted to DICOM format using the proprietary 
software from Scanco Medical before being imported for post-processing using 
Analyze™ (AnalyzeDirect, Overland Park, KS). For each time point, the cartilage was 
segmented from the subchondral bone using a region-growing algorithm in the Volume 
Edit module, and the mean contrast-enhanced CT (CECT) attenuation value for the 
medial and lateral surfaces combined was obtained by averaging the X-ray attenuation 
over all transaxial µCT slices corresponding to cartilage tissue. The attenuation values for 
each time point were then normalized by the 0-min time point (baseline/non-enhanced) 
attenuation. 
 
Pendulum Coefficient of Friction (µ) Testing 
 For the ten knees that were injected, their femurs and tibias were then gripped in a 
modified Stanton pendulum apparatus [81] with a 50-mg pendulum arm. The pendulum 
arm was offset to 15 degrees, released, and allowed to freely oscillate until coming to 
rest. Each knee was tested three times, and the pendulum arm motion was recorded with 
high-speed video. The video was analyzed to calculate a coefficient of friction (µ) for 
each knee joint using conservation of energy [75] and a custom MATLAB code 




Indentation Compressive Modulus (E) Testing 
 After pendulum testing, the knee joints were disarticulated, all the surrounding 
soft tissue was removed, and the tibias were rinsed three times in excess saline to desorb 
any residual enzyme. The tibial samples were then individually positioned in a µCT 
imaging system (µCT50, Scanco Medical AG, Brüttisellen, Switzerland) using another 
custom, airtight holder that maintained a humid environment. The samples were scanned 
at an isotropic voxel resolution of 2 µm, 70-kVp tube voltage, 114-µAmp current, 500-
ms integration time, and 3x frame averaging. These baseline µCT data were converted to 
DICOM format as previously described and imported for post-processing in Analyze. 
The mean cartilage thickness of the both the medial and lateral cartilage surfaces was 
then determined using the Line Profile module in Analyze.  
 Both the medial and lateral surfaces of each sample were then evaluated using a 
standard indentation testing procedure [271]. Briefly, the tibial diaphysis was secured in a 
fixture and positioned such that the central, weight-bearing region of the cartilage surface 
was aligned perpendicular to a 0.3-mm diameter, plane-ended, glass indenter tip. After 
submerging the cartilage in saline, a 3mN pre-load was applied. Each sample was then 
compressed using a 4-step indentation stress-relaxation regimen consisting of four 5% 
strain steps at a displacement rate of 60 µm/min (Zwick Z005, Zwick/Roell GmbH, 
Kennesaw, GA), each followed by a 200-sec relaxation period. The compressive modulus 
(E) was then computed by fitting a linear regression line to the resulting equilibrium 
stress-strain data. When positioning the lateral surface of one sample, the cartilage was 
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accidently overloaded, so that surface has been excluded from subsequent analyses, as its 
modulus and imaging results could have been compromised. 
 
Contrast-Enhanced CT (CECT) Imaging 
 Following mechanical testing, the samples recovered in saline for at least 1 hr at 
room temperature before being immersed in 0.25 mL of CA4+ solution for 2 hrs at room 
temperature. Each sample was then gently blotted to remove excess contrast agent and 
scanned again using the same µCT50 scanner and settings. After scanning, each sample 
was rinsed in 1 mL of saline at 4° C overnight and then frozen. The CECT data were also 
converted to DICOM format, imported into Analyze, and the cartilage was segmented 
from the subchondral bone using a region-growing algorithm in the Volume Edit module. 
The mean CECT attenuation value for each cartilage surface was obtained and is reported 
as grayscale intensities in Hounsfield Units (HU). 
 
Determination of Glycosaminoglycan (GAG) Content 
 Pilot studies indicated that excising mouse tibial plateau cartilage from the 
subchondral bone was not reliable, thus preventing the use of the 1,9-dimethylmethylene 
blue (DMMB) assay to directly measure GAG content for these samples. Hence, to 
quantify GAG content, an optical density technique was applied to Safranin-O stained 
histological sections of the samples. To convert from the red intensity measured from the 
histology sections to GAG content as would be determined via the DMMB assay, a 
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standard curve was generated using bovine articular cartilage in a manner similar to 
previous approaches [128, 290]. Briefly, 6 neighboring pairs of osteochondral plugs were 
harvested from the lateral condyles of 4 bovine knees. One plug from each pair was 
cryostatically sectioned transversely into 100-µm thick layers, and the GAG content of 
each layer was directly measured using the DMMB assay as described below. The other 
plugs from each pair were embedded in paraffin and sectioned sagittally to generate full-
thickness sections across the diameter of the tissue. Each section was then stained with 
Safranin-O, imaged on a microscope, and the red pixel intensity (expressed as Ip value) 
was determined for 100-µm thick layers in each image (all further described below). A 
standard curve between Ip value and GAG content was generated by applying linear 
regression to relate the Safranin-O-obtained Ip values to the DMMB-determined GAG 
contents for each layer. This standard curve was then used to convert from Ip value to 
GAG content for the mouse tibial cartilage samples. 
 For the bovine samples designated for the DMMB assay, the cartilage was 
excised from the subchondral bone using a scalpel, and the wet mass of the cartilage was 
measured. Following lyophilization for 24 hrs, the dry weight of each sample was also 
obtained, and the samples were digested in papain (1 mg/mL in a buffer solution of 50 
mM sodium phosphate, 5 mM EDTA, 2 mM DTT, pH 6.8) at 65 °C for 24 hrs. The GAG 
content of each cartilage sample was determined using the DMMB colorimetric assay 
[218]. Briefly, each cartilage digestion solution was diluted 1 to 10 times for the assay. 
To convert from absorbance to GAG content, a linear calibration curve was generated 
using chondroitin-4-sulfate (27042, Sigma, St. Louis, MO) dissolved in the same buffer 
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as above at concentrations ranging from 10-100 µg/mL. Ten microliters of each 
chondroitin-4-sulfate calibration solution and each diluted sample digestion solution were 
separately combined with 100 µL of DMMB dye solution in a 96-well plate. The 
absorbance of each resulting solution at 520 nm was measured in triplicate using a plate 
reader (AD340, Beckman Coulter, Fullerton, CA). The total GAG mass of each sample 
was calculated using the calibration curve and normalized by the wet mass of the 
cartilage for each layer. 
 The other six bovine samples and all the mechanically tested mouse tibial samples 
were placed in decalcifier/fixative solutions (Formical-4, Decal Chemical Corporation, 
Tallman, NY for the bovine samples and Decalcifier I, Leica Biosystems, Buffalo Grove, 
IL for the murine samples) for at least 72 hours before being processed for histological 
sectioning. Briefly, each sample was immersed in the following sequence on an 
automatic tissue processor: 80% EtOH (1hr 30 min), 95% EtOH (1hr 30 min), 95% EtOH 
(1hr 30 min), 100% EtOH (1hr), 100% EtOH (1hr), 100% EtOH (1hr), Xylene (1hr  30 
min), Xylene with vacuum (1hr  30 min), Paraffin with vacuum (2 hrs), and Paraffin (2 
hrs). The samples were then removed and embedded in Tissue Prep 2 paraffin at 60 °C, 
sectioned sagittally with a rotary microtome at 5 micron thickness, and baked at 60 °C for 
25-30 minutes. Sagittal sections across the width of all surfaces were then stained with 
0.1% Safranin-O with 0.02% Fast Green following a standard procedure from 
www.ichworld.com. This process consisted of deparaffinizing and hydrating the slides in 
water, staining with Weigert’s Hematoxylin working solution (10 min), washing in 
running water (10 min), staining with Fast Green solution (5 min), quickly rinsing in 1% 
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acetic acid solution (not >15 sec), staining with 0.1% Safranin O solution (5 min), 
dehydrating and clearing with 95% EtOH, 100% EtOH and Xylene (2 changes each, ~1 
min each), and mounting with permount. Photomicrographs of each bovine and murine 
section were captured at 5x or 10x magnification, respectively (Axio Imager 2, Zeiss 
Microscopy, Thornwood, NY).  
 The photomicrographs were then analyzed to determine the mean Ip value for 
each murine section and bovine layer [128]. Briefly, a background region and either the 
100-µm thick cartilage layers (for bovine) or the entire cartilage region (for murine) were 
extracted from the whole image using Analyze’s ROI and Image Calculator modules. For 
both the background and cartilage regions, these isolated color images were separated 
into the red (R), green (G), and blue (B) channels using a custom code (MATLAB 
2010a); and the average of the G and B components was subtracted from the R 
component. The resulting normalized values for the background regions were then 
subtracted from the cartilage regions, and only positive results (ignoring any cartilage 
values less than the background) were averaged to compute the mean Ip value for the 
entire cartilage region. The global mean Ip value for a given bovine layer or murine 
cartilage surface was then computed by averaging all the mean Ip values obtained for all 
sections across the width of the sample. 
 
Statistics 
 Univariate linear regression analysis (SPSS 17.0, Chicago, IL) was applied to 
examine relationships between E, µ, CECT attenuations, and GAG content. The 
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coefficient of determination (R
2
) was used to assess the strength of the correlations, and 
significance was set as two-tailed P-value < 0.05. 
 
Results 
CA4+ Diffusion into Mouse Tibial Plateau Cartilage 
 The cationic contrast agent CA4+ rapidly diffused into the mouse tibial plateau 
cartilage tissue and reached a plateau after approximately 20 min (Figure 5.1), indicating 
that an equilibrium had been achieved. After fitting the data for each sample with an 
equation of the form CECT Attenuation = a*e
-b(time)
 + c, tau values (calculated as 1/b) 
were computed for each sample, and the mean tau value was found to be 6.17 ± 0.19 min 
(mean ± SD). 
 
Quantifying Cartilage GAG Content from Safranin-O Stained Histological Sections 
 Using 42 depth-wise layers obtained from six neighboring bovine cartilage plug 
pairs, a standard curve correlating mean Ip Value (a measure of the red intensity from 
Safranin-O stained histology sections) to GAG content determined via the DMMB assay 
was developed (Figure 5.2). Since the correlation was strong (R
2
 = 0.93) and statistically 
significant (p < 0.05), the red content from Safranin-O stained histology sections reflects 
the GAG content of the cartilage tissue. Therefore, this standard curve was used to 




Relationships between CECT Attenuation, GAG Content, and Compressive Modulus  
 The CA4+ enhanced CT attenuation was strongly and significantly correlated 
with GAG content (determined via Safranin-O staining) for both the medial and lateral 
(Figure 5.3a) samples, with coefficients of variation greater than or equal to 0.64. 
Additionally, strong, positive correlations were observed between compressive modulus 
(E) and GAG content for both the medial and lateral surfaces (Figure 5.3b, R
2≥0.63, 
p<0.05). Accounting for up to 78% of the variation in E, the CECT attenuation was also 
strongly and positively correlated with E for both surfaces (Figure 5.3c). 
 
Relationships between CECT Attenuation, GAG Content, and Coefficient of Friction  
 As shown in Figure 5.4a, pendulum coefficient of friction (µ) was moderately 
and negatively correlated with GAG content (R
2
=0.59, p<0.05). On the other hand, 
CECT attenuation was strongly and negatively correlated with µ (Figure 5.4b), with µ 
accounting for 69% of the variation in CECT attenuation. 
 
Discussion 
 In this study, contrast-enhanced CT (CECT) was compared to murine tibial 
plateau cartilage glycosaminoglycan (GAG) content, indentation compressive modulus 
(E) and pendulum coefficient of friction (µ). As previously described, cartilage GAG 
content directly affects its mechanical properties and decreases during OA; hence a 
technique that is sensitive to changes in GAG content for cartilage would be beneficial. 
Performing CECT with a contrast agent that is sensitive to changes in GAG content is a 
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tool for nondestructively assessing murine cartilage GAG content and mechanical 
properties. Figure 5.1a displays the diffusion-in kinetics of the cationic contrast agent 
CA4+ into the cartilage of three murine tibial plateaus. The CECT attenuation reached a 
mean value of 1206 ± 174 HU [mean ± SD] after 90 min of diffusion with a 
corresponding mean tau value of 6.17 ± 0.19 min, representing the time at which 63.2% 
of the final attenuation was reached. Although there are no prior reports of CA4+ 
diffusion into murine cartilage, Ioxaglate (an anionic CT contrast agent) reaches 
equilibrium within 30 min in mouse femoral [291] and tibial [292] articular cartilage 
specimens. Longer equilibration periods appear necessary for phosphotungstic acid [293]; 
however, this report did not examine time points in the early stages of diffusion, so 
equilibrium was likely reached prior to 24 hrs. The mean tau value obtained for CA4+ 
agrees with that reported for Ioxaglate for murine femoral cartilage (6.7 min) [291]. Both 
the tau value and equilibrium immersion time for CA4+ are much less than previously 
reported for this contrast agent when diffused into bovine cartilage tissue [185], likely 
due to the smaller volume and thickness of the murine samples compared to the bovine 
samples.  
 The strong, positive correlation obtained between mean Ip Value (a measure of 
the red intensity from Safranin-O stained histology sections) and GAG content 
determined via the DMMB assay (Figure 5.2) demonstrates that quantifying the red 
content from Safranin-O stained histology sections reflects the GAG content of the 
cartilage tissue. This finding agrees with previous reports using a similar procedure for 
bovine [290] and human [128, 294] cartilage. This relationship is essential for effectively 
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quantifying GAG content of small rodent cartilage, as performing the DMMB assay 
directly on such samples is unreliable due to the difficulty of removing the cartilage 
tissue without also excising subchondral bone fragments or surrounding soft tissue 
pieces.  
 The strong, significant correlations between CA4+ enhanced CT attenuation and 
GAG content for both the medial and lateral cartilage surfaces used in this study (Figure 
5.3a) agree with previously reports for bovine and human cartilage. Specifically, using 
the same CA4+ concentration, Lakin et al. [34] (Chapter 2) report positive and significant 
correlations between CECT and GAG using bovine cartilage with coefficients of 
variation of 0.74 for native tissue and 0.87 for healthy and GAG-depleted tissue. For 
human metacarpal cartilage, the coefficient of variation was 0.86 (Chapter 4). 
Additionally, this study’s correlations agree with those published with CA4+ at 8 
mgI/mL [185] and 27 mgI/mL [191]. The GAG contents reported herein are lower than 
those previously reported for bovine (Chapter 2) [29, 34, 185, 191] and human (Chapter 
4) cartilage, which could be due to differences in the cartilage ECM between species.  
 As shown in Figures 5.3b-c, the indentation equilibrium compressive modulus 
(E) was strongly and positively correlated with GAG content and mean CECT attenuation 
for the medial (R
2
= 0.78 for both) and lateral (R
2
 = 0.63 for both) tibial plateau (TP) 
surfaces (all p<0.05). The strong correlations between E and GAG content and CECT and 
E both agree with previous results using bovine femoral condyle (FC, Chapter 2) [29, 34] 
and human metacarpal (MC, Chapter 4) cartilage. The specific correlation comparisons 







=0.63 (murine medial and lateral TP, respectively), and CECT vs. E: 
R
2
=0.90 (bovine FC) vs. R
2




=0.63 (murine medial 
and lateral TP, respectively). With CA4+, the electrostatic attraction between the contrast 
agent and the negatively charged GAGs again results in high contrast agent uptake in 
mouse cartilage and positive linear correlations between CECT attenuation and both 
GAG content and E. Interestingly, the relationship between CECT and GAG appears 
consistent between the two surfaces, while the relationships between E and both GAG 
and CECT have different slopes. The similar slopes for CECT vs. GAG are likely a result 
of CA4+ equilibrium partitioning being primarily influenced by GAG alone, while E is 
known to vary between cartilage surfaces [1].  
 In addition to affecting the compressive stiffness of cartilage, GAG content is also 
known to influence cartilage coefficient of friction (µ) [5-7, 34] (Chapters 1 & 2). GAGs 
contribute to the frictional performance of cartilage through both hydrostatic and 
elastohydrodynamic lubrication [1, 63] irrespective of the superficial tangential layer of 
cartilage [56]. Most reports examining the relationships between µ and GAG utilized 
excised cartilage discs or osteochondral plugs. As a result of sample extraction, these 
sample types have an exposed, circumferential edge that alters the mechanics and mass 
transfer of fluid and molecules in and out of the cartilage. Additionally, if using cartilage 
discs, the cartilage-bone interface is not preserved during testing. To overcome these 
limitations and preserve the native boundary conditions for the cartilage and subchondral 
bone, this study performed friction testing using a modified pendulum apparatus, which 
has been previously applied to study rodent joints [75, 81, 289]. This approach also 
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enables loading the cartilage surfaces in a physiologically relevant manner (cartilage-on-
cartilage) with appropriate force and displacement trajectories. Although other joint 
tissues (e.g., ligaments and joint capsule) can affect the whole-joint frictional properties 
using the pendulum setup, by controlling for mouse age, strain, gender, and weight, and 
artificially degrading the cartilage GAG content using Chondroitinase ABC, the frictional 
results reported herein are driven by differences in cartilage tissue GAG. 
 As a result of this relationship, Figures 5.4a & b, show the strong, negative 
correlations between pendulum coefficient of friction (µ) and both GAG content and 
CECT attenuation. These relationships agree with those reported using bovine cartilage 
plugs with three torsional coefficients of friction [34] (Chapter 2). Specifically, for the 
bovine cartilage samples, the coefficient of variation ranged between 0.49 to 0.78 for 
GAG vs. µ and between 0.69 and 0.79 for CECT vs. µ, while the R
2
 values obtained in 
this study were 0.59 for GAG vs. µ and 0.69 for CECT vs. µ. However, in this study, the 
µ values ranged from 0.00025 to 0.00075, which is 2-3 orders of magnitude lower than 
those reported for the bovine samples (range: 0.05 to 0.4). The discrepancy in the ranges 
is likely due the fact that coefficients of friction are highly dependent on testing 
conditions [68]. Although different than the values reported for the bovine study, the 
coefficients of friction are not significantly different than those reported by Jay et al. [75] 
(range: 0.0005 to 0.003), in which a 20-mg pendulum arm was used (compared to the 50-
mg pendulum arm in this study). Of note, this study is the first report of a significant 
correlation between CECT attenuation and pendulum coefficient of friction, further 
demonstrating the power of CECT as a useful tool for assessing cartilage biochemical 
  
115 
and biomechanical properties. 
 Compared to pendulum testing, indentation, and histology, CECT has several 
substantial advantages. To generate a compressive stiffness map of a sample using 
indentation testing, the sample must be positioned and tested for each discreet location on 
its surface, which can require many hours. Additionally, to compute a compressive 
modulus, the sample thickness at each testing site must be measured. This is commonly 
performed with needle-puncture [50], which is a destructive technique. Regarding, 
pendulum testing, this technique is less destructive than indentation testing, however it is 
unlikely applicable in vivo, as the surrounding muscle tissue would influence the joint 
articulation. Additionally, performing the pendulum testing reliably requires developing 
an apparatus and properly gripping both the femur and tibia such that the natural axis of 
pivot for the knee is properly maintained during artificial articulation. Learning to 
properly position the joints in the tester is not trivial and requires several pilot studies. On 
the other hand, one CECT scan (~2 hrs at the high resolutions used in this study) 
following contrast agent immersion to equilibrium yields the same stiffness and friction 
information non-destructively and more quickly. For histology, there are some 
considerable challenges and pitfalls associated with using this technique to obtain 
information about cartilage biochemical content. These include: 1) machine or personnel 
processing glitches that can cause irreversible sample damage; 2) accidently sectioning 
samples in the incorrect orientation (also irreversible); 3) the tissue can tear during 
sectioning or fold or wash off during mounting, both resulting in loss of data; and 4) once 
stained, a different staining cannot be performed (in CECT, contrast agents can be 
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washed out of samples so the samples can be subsequently immersed in a different 
agent). If quantitative measures (e.g., optical density) are desired from histological 
sections, debris on the slides can affect optical measurements, and day-to-day variability 
in microscope lighting and staining batches (even with the same settings or recipes) 
necessitate that all tissue sections be stained in the same batch and imaged in an 
uninterrupted sequence. Such constraints can be problematic if re-staining is required or 
if equipment or computer glitches interrupt staining or imaging. On the contrary, one 
rapid, facile CECT scan post-contrast immersion generates related information more 
quickly, non-destructively, and without the risk of sample damage/loss. Additionally, 
histology only permits 2D sections to be obtained from samples, which cannot easily be 
viewed from a different orientation. CECT enables the same 2D views (Figure 5.5a & b) 
in any desired plane and 3D reconstructions of samples, which can be visually sectioned 
in real-time in one to three planes simultaneously (Figure 5.5c-f). Therefore, the same 
information that quantitatively agreed with GAG content, compressive modulus, and 
coefficient of friction in Figures 5.3-5.4 can easily be viewed in any arbitrary plane or as 
a whole 3D structure.  
 The tibial plateau was chosen for imaging and testing, as its cartilage surfaces are 
thicker than the opposing femoral surfaces and resemble simpler 3D geometric shapes, 
namely a convex, yet relatively flat dome. The tibial plateau cartilage geometry enabled 
appropriate indentation testing, as adequate tissue surrounded the testing site [274], while 
the femoral cartilage surfaces did not have appropriate surface shapes or thicknesses. 
Since only one mouse species was examined in this study, and the cartilage GAG 
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contents were artificially degraded, future studies should examine the relationships 
reported herein using knees from different mouse strains, including some with OA (e.g., 
surgical instability or knockout models). However, it is unclear if the correlations 
involving pendulum coefficient of friction will be strong and significant using true 
arthritic mouse cartilage, as other joint structures (e.g., ligaments and joint capsule) will 
also be affected during OA, and these tissues influence joint articulation. Future studies 
could examine the feasibility of injecting contrast agents intra-articularly and performing 
intact joint CECT scans of mouse knees, thus enabling the determination of cartilage 
biochemical and biomechanical properties without the need for joint disarticulation. 
 As demonstrated herein for mouse cartilage and previously for cartilage from 
other species, CECT correlates with GAG content [29, 184-187, 189, 190, 193], 
compressive modulus [29, 34], and coefficient of friction [34]. Hence, CECT is a 
valuable tool for assessing cartilage composition and function. Additionally, CECT is 
more rapid, easier to perform, more flexible, and non-destructive compared to common 
mechanical testing and histological methods for evaluating cartilage biochemical and 
biomechanical properties. With a contrast agent sensitive to GAG, CECT can expedite 
the study of OA pathophysiology for mouse models, thus enabling more experiments for 
evaluating the disease and efficacy of treatments. Furthermore, modern, high-resolution, 
CT scanners enable in vivo CECT of mice knees. If combined with an appropriate 
contrast agent, in vivo CECT provides an opportunity for longitudinal assessment of 




Figure 5.1: Diffusion-in data for CA4+ into the cartilage of three mouse tibial plateaus. Data is 
plotted as the mean CECT attenuation of both the medial and lateral tibial plateau cartilage 
normalized by the mean baseline (not contrast-enhanced) attenuations (lines are for visualization 
purposes only). By fitting the data for each sample with an equation of the form CECT 
Atten.=a*e
-b(time)
 + c, tau values (calculated as 1/b) can be computed for each sample, and the 
mean tau value was found to be 6.17 ± 0.19 min (mean ± SD). 
 
 
Figure 5.2: Standard curve correlating mean Ip Value (a measure of the red intensity from 
Safranin-O stained histology sections) to GAG content determined via the DMMB assay for 42 
depth-wise layers obtained from six neighboring bovine cartilage plug pairs. The correlation was 
strong (R
2
 = 0.93) and statistically significant (p < 0.05), indicating that quantifying the red 





Figure 5.3: Correlations for mouse medial (♦) and lateral (■) tibial plateau surfaces between: a) 
mean CECT attenuation and GAG content, b) indentation equilibrium modulus (E) and GAG 
content, and c) mean CECT attenuation and E. All correlations were strong (R
2
 > 0.6) and 
statistically significant (p < 0.05) for both surfaces. 
 
 
Figure 5.4: Correlations between a) pendulum coefficient of friction (µ) and average tibial 
plateau GAG content and b) mean tibial plateau cartilage CECT attenuation and µ for mouse 
knees. Both correlations were strong (coefficients of variation greater than or equal to 0.59) and 





Figure 5.5: Using contrast-enhanced CT, color maps can be generated in any orientation for 
visualization of depth-wise cartilage attenuation with the underlying bone morphology and 
attenuation also visible. For example, traditional sagittal CECT color maps (analogous to 
Safranin-O stained histological sections) can be generated for the medial tibial plateau samples 
with a) the highest GAG content and b) the lowest GAG content found in this study. CECT also 
enables 3D color map generation that can be visually sectioned in any view independently or up 
to three planes simultaneously, as demonstrated by the 3D color maps for the same c) highest 
GAG and d) lowest GAG samples. By zooming into the regions encompassed in the red squares, 
it is easier to distinguish the difference in depth-wise attenuation patterns for the same e) high 
GAG and f) low GAG samples. The color scale bar indicates the corresponding CECT 
attenuation in Hounsfield Units (HU) for all CECT color maps. The distribution of the CA4+ 
contrast agent matches the typical distribution of Safranin-O stain in histological sections, with a 
greater attenuation in the middle and deep zone for the sample with high GAG and a fairly 




CHAPTER 6: Longitudinal Assessment of Mouse Tibial Plateau Cartilage using In Vivo 
Contrast-Enhanced CT following Destabilization of the Medial Meniscus and 
Relationships between Ex Vivo Imaging and Compressive Modulus 
 
Introduction 
 Osteoarthritis (OA) is a widespread disease affecting both cartilage and bone in 
synovial joints. It is typically characterized by the progressive degradation of articular 
cartilage, resulting in eventual bone-on-bone contact during joint articulation. As a result 
of the bone-bone contact, patients suffering from OA often experience debilitating pain, 
which negatively impacts their activity level and quality of life. Healthy articular 
cartilage can withstand high loads while providing low friction during the joint 
articulation of many common activities. Unfortunately, cartilage breaks down as OA 
progresses, beginning with a reduction in glycosaminoglycan (GAG) content, followed 
by a decrease in compressive stiffness and lubricating ability, and finally, cartilage 
erosion. Mouse models are routinely employed to study cartilage degeneration 
mechanisms in OA. In this species, the disease is inducible via genetic knockouts (e.g., 
collagen IX [49, 275, 276], osteopontin [277], ADAMTS4 [278], or ADAMTS5 [279] 
deficiencies) or surgically (e.g., anterior cruciate ligament transection (ACLt) [280] or 
destabilization of the medial meniscus (DMM) [280-282]), or the disease can 
spontaneously develop in some murine strains (e.g, STR/ort) [283-285].  
 The progression of OA in mouse models is typically assessed by histological 
scoring of the articular cartilage (e.g., Osteoarthritis Research Society International 
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(OARSI) or International Cartilage Research Society (ICRS) scores) [279, 295]. For 
semi-quantitative measures of cartilage biochemical content, Safranin-O staining is 
frequently used [49, 288], because the cationic dye is attracted to the anionic GAGs in 
cartilage. However, histology is challenging and limited, because it is time-consuming, 
destructive, requires advanced skill, cannot be performed on intact joints, and cannot 
quickly provide a 3D map of the biochemical properties of the cartilage. Furthermore, 
using histological methods to assess cartilage properties in OA studies requires large 
sample sizes, because temporal monitoring of the cartilage as the disease progresses is 
not possible, so animals must be euthanized at specific time points for the articular 
cartilage to be excised and examined ex vivo. With a goal of generating more global 
measures of murine joint pathology, whole joint and mixed modality imaging [279, 282, 
285], fluorescence-assisted carbohydrate electrophoresis [279], and phase-contrast 
computed tomography (CT) [172] are being utilized to examine cartilage. However, like 
histology, these techniques are limited in their in vivo applicability. 
 In order to characterize cartilage tissue and its degradation in live animals, 
researchers perform in vivo imaging of knee joints using different animal models, 
including rats, guinea pigs, rabbits, pigs, goats and dogs [154, 155, 158, 163, 195, 196, 
199, 296-307]. However, most of these studies examine morphological features of 
cartilage (e.g., thickness and volume), yet determining the biochemical and mechanical 
properties of cartilage tissue in vivo would provide greater information on tissue health. 
Predicated on Donnan Equilibrium Theory, contrast-enhanced CT (CECT) uses contrast 
agents that partition throughout the cartilage extracellular matrix (ECM) in proportion to 
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the negative fixed charge density (FCD) arising from the GAGs [185, 191]. Using 
anionic contrast agents, ex vivo CECT strongly correlates with both GAG concentration 
and compressive stiffness [29]. To date, there are two published studies of in vivo 
quantitative CECT imaging of an animal knee joint, and both experiments used rats [195, 
196]. Although rat models were used for these imaging studies, likely because of the 
limited resolution of the in vivo scanner available, mouse models are more frequently 
used to study OA. Thus, CECT provides new opportunities for serial in vivo assessment 
of the mechanical and biochemical properties of mouse articular cartilage, while 
drastically reducing the necessary sample sizes.  
 Although previous in vivo CECT studies utilized the commercially available 
anionic contrast agent Ioxaglate, a new, cationic, iodinated contrast agent (CA4+) [192] 
partitions throughout cartilage in direct proportion to GAG content [185, 191]. Using 
CA4+, resulting CECT attenuations strongly correlate with bovine and mouse cartilage 
GAG content [34, 185, 191] (Chapters 2 & 5), equilibrium compressive modulus (E) [34] 
(Chapters 2 & 5) and coefficient of friction (µ) [34] (Chapters 2 & 5). Furthermore, 
CA4+ enhanced CT attenuations more strongly correlate with GAG content [185] 
(Chapter 4) and compressive modulus (Chapter 4) than Ioxaglate-enhanced attenuations 
from the same samples. Building on this ex vivo data and recent in vivo diffusion kinetics 
data in a rabbit model [199], the aims of this study were to 1) develop high-resolution in 
vivo CECT with Ioxaglate and CA4+ to longitudinally measure murine cartilage quality 
(CECT attenuation as a surrogate for GAG) following a destabilization of the medial 
meniscus (DMM) procedure; and 2) compare the ex vivo CECT attenuations to 
  
124 
compressive modulus (E). Herein, the longitudinal in vivo imaging results and the 




Contrast Agent and Saline Preparation 
 Ioxaglate at 80, 160 and 320 mgI/mL was prepared by diluting native Ioxaglate 
(Hexabrix320, Mallinckrodt, St. Louis, MO) with deionized water. The cationic contrast 
agent CA4+ was synthesized as previously reported [192], and CA4+ contrast agent 
solutions were prepared at 6, 12, 24 and 48 mgI/mL by dissolving the dry compound in 
deionized water and balancing the pH to 7.4 using concentrated 4.0M NaOH. All 
Ioxaglate and CA4+ solutions were also adjusted to 400 mOsm/kg using sodium chloride 
to match the in situ osmolality of articular cartilage (350-450 mOsm/kg [217]). For the in 
vivo imaging, all contrast agent solutions were sterilized by filtering through a 0.22-µm 
syringe filter and autoclaving in aliquots. For the ex vivo experiments, GIBCO Anti-Anti 
stock solution (Invitrogen, Grand Island, NY), 5mM of EDTA (Sigma, St. Louis, MO), 
and benzamidine HCl (Sigma B6506, St. Louis, MO) were included in all the contrast 
agent and saline solutions that were exposed to the cartilage to prevent further 




Destabilization of the Medial Meniscus (DMM) Animal Model 
 All in vivo animal procedures were approved by the Swiss Cantonal Authorities. 
After induction of isoflurane anesthesia, one random knee from each of eight C57BL/6, 
female, 12-week-old, mice was shaved and sterilely prepared. Through a medial 
parapatellar incision, the anterior horn of the medial meniscus was sharply detached from 
the tibia, thereby destabilizing the medial meniscus (DMM), which induced medial 
femoral-tibial joint instability [280]. The joint capsule was then closed with a continuous 
8-0 tapered Vicryl suture with single stitches. The surgeries were performed aseptically, 
and animals were placed in heated cages until they were completely awake. The non-
operated knee served as an untouched, internal control. After surgery, the animals were 
allowed free cage activity, imaged in vivo at the time points specified below, and were 
euthanized at 6 weeks. The endpoint of 6 weeks was chosen, as this duration has been 
well documented in this model to establish early- to mid-stage OA [280]. 
 
In Vivo Contrast-Enhanced CT (CECT) Imaging 
 Beginning 1 week after DMM surgery, each mouse was anesthetized as 
previously described, and both hind knees were shaved and sterilely prepared. Since this 
was a pilot in vivo experiment, and the optimal contrast agent concentrations were 
unknown, both knees of each mouse were intra-articularly injected with 20 µL of one of 
the Ioxaglate concentrations containing 10% epinephrine (to retard the diffusion of the 
contrast agent from the joint capsule [199]) using a 27 gauge needle and CT scanned as 
described below. One to two days later, after the Ioxaglate had time to clear the joint 
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[199], the knees were injected with one of the CA4+ concentrations and CT scanned 
again. Table 6.1 provides a summary of the contrast agent concentrations used for each 
mouse at each time point. All injections were performed aseptically. Following injection 
and while the mice were still under anesthesia, both knees were flexed and extended 
thirty times to distribute the contrast agent throughout the joint [199].  
 After flexing the limbs, the animals were individually placed in a specially 
designed holder for CT imaging. While still anesthetized, both legs were fully extended 
in parallel for easier imaging of both knee joints simultaneously and taped to avoid 
movement artifacts. A scout view (X-ray image) was taken to position the scanned area 
exactly. Based on pilot ex vivo diffusion data (Chapter 5) and known diffusion kinetics in 
live animals [199], the injected contrast agents were allowed to diffuse into the cartilage 
for a total of fifteen minutes post-injection. Once this time was reached, both knee joints 
were simultaneously scanned in vivo using a VivaCT40 scanner (Scanco Medical AG, 
Brüttisellen, Switzerland). Since this was a pilot study, a few different scan settings were 
tested throughout the experiment and are summarized in Table 6.1. Each CECT scan 
lasted 15-20 min. After scanning, the animals were transferred to a heated wake-up box 
until they were completely awake. The injection and CECT imaging sequences for both 
Ioxaglate and CA4+ were repeated on weeks 3, 4, 5, and 6 post-surgery. The in vivo µCT 
data were converted to DICOM format using the proprietary software from Scanco 
Medical before being imported for post-processing using Analyze™ (AnalyzeDirect, 
Overland Park, KS). For each in vivo scan, the cartilage was manually segmented from 
the subchondral bone using a spline tool in the Volume Edit module by three trained 
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users. The mean contrast-enhanced CT (CECT) attenuation value for each medial and 
lateral surface was then obtained by averaging the X-ray attenuation over all transaxial 
µCT slices corresponding to cartilage tissue and converted to Hounsfield Units (HU) 
using dI water attenuation data obtained at the same scan settings and the scanner 
calibration data. The attenuation values for each surface at each time point were then 
normalized by the joint space attenuation to determine a partition coefficient. 
 
Indentation Compressive Modulus (E) Testing 
 After the mice were euthanized, the knee joints were disarticulated, all 
surrounding soft tissue was removed, and the tibias were rinsed three times in excess 
saline to desorb any residual synovial fluid or contrast agent. To facilitate easier gripping 
during ex vivo imaging and mechanical testing, the distal tibia of all knees were 
embedded in polymethylmethacrylate (PMMA) bone cement. The tibial samples were 
then individually positioned in a µCT imaging system (µCT50, Scanco Medical AG, 
Brüttisellen, Switzerland) using a custom, airtight holder that maintained a humid 
environment. The samples were scanned at an isotropic voxel resolution of 2 µm, 70-kVp 
tube voltage, 114-µAmp current, 500-ms integration time, and 3x frame averaging. These 
baseline µCT data were converted to DICOM format as previously described and 
imported for post-processing in Analyze. The mean cartilage thickness of the medial and 
lateral cartilage surfaces was then determined using the Line Profile module in Analyze.  
 The medial and lateral surfaces of each sample were then evaluated using a 
standard indentation testing procedure [271]. Briefly, the tibial diaphysis was secured in a 
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fixture and positioned such that the central, weight-bearing region of the cartilage surface 
was aligned perpendicular to a 0.3-mm diameter, plane-ended, glass indenter tip. After 
submerging the cartilage in saline, a 3mN pre-load was applied. Each sample was then 
compressed using a 4-step indentation stress-relaxation regimen consisting of four 5% 
strain steps at a displacement rate of 60 µm/min (Zwick Z005, Zwick/Roell GmbH, 
Kennesaw, GA), each followed by a 200-sec relaxation period. The compressive modulus 
(E) was then computed by fitting a linear regression line to the resulting equilibrium 
stress-strain data. 
 
Ex Vivo Contrast-Enhanced CT (CECT) Imaging 
 Following mechanical testing, the samples recovered in saline for at least 1 hr at 
room temperature before being immersed in 0.25 mL of CA4+ solution for 2 hrs at room 
temperature. Each sample was then gently blotted to remove excess contrast agent and 
scanned again using the same µCT50 scanner and settings. After scanning, each sample 
was rinsed in 1 mL of saline at 4° C overnight and then frozen. The CECT data were 
converted to DICOM format, imported into Analyze, and the cartilage was segmented 
from the subchondral bone using a region-growing algorithm in the ROI module. The 
mean CECT attenuation value for each cartilage surface was obtained and is reported as 





 Relationships between E and ex vivo CECT attenuation were examined using 
univariate linear regression analysis (SPSS 17.0, Chicago, IL), with the coefficient of 
determination (R
2
) used to assess the strength of the correlations. Furthermore, 
differences in partition coefficient between Ioxaglate and CA4+ for the medial and lateral 
surfaces for each time point were compared using Student’s t-test. Significance was set as 
two-tailed P-value < 0.05. 
 
Results 
Relationship between Ex vivo CECT Attenuation and Compressive Modulus 
The CA4+ enhanced CT attenuation was strongly and significantly correlated 




Contrast-enhanced CT (CECT) Patterns in Cartilage Tissue 
 The sagittal CECT color maps generated for lateral tibial plateau samples with 
high (Figure 6.2a) and low (Figure 6.2d) compressive moduli (E) from Ioxaglate in vivo 
CECT scans do not reflect the differences in moduli. Instead, both the joint space and 
cartilage tissue appear uniformly bright. However, the CA4+ in vivo CECT scans of 
these two surfaces have noticeable differences in tissue attenuation, with more blue-green 
color (high CECT attenuation and [CA4+]) distinguishable in the cartilage tissue for the 
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sample with high E (Figure 6.2b) than for the sample with low E (Figure 6.2e). The 
differences in cartilage attenuation patterns between the two surfaces are most clearly 
visible in the CA4+ ex vivo CECT color maps (Figures 6.2c&f). Furthermore, the 
distribution of the CA4+ contrast agent matches the typical distribution of Safranin-O 
stain in histological sections, with a greater attenuation in the middle and deep zone for 
samples with high E and a fairly uniform distribution for samples with low E (Chapter 4). 
 The same cartilage attenuation patterns for the lateral surfaces are also noticeable 
in three-dimensional (3D) color maps generated from both the Ioxaglate and CA4+ in 
vivo CECT scans, as well as the CA4+ ex vivo CECT scans (Figure 6.3). As with the 
sagittal color maps, the Ioxaglate CECT scans have a highly attenuating joint space with 
similarly attenuating cartilage. However, for the CA4+ in vivo scans, more green-blue 
color is detectable in the cartilage of the sample with high E (Figure 6.3b) than for the 
sample with low E (Figure 6.3h). This difference is more noticeable when enlarging the 
region of interest encompassed by the red square for each sample (Figure 6.3e&k). 
Again, the differences in attenuation between the two samples is most clear for the 3D 
color maps from the CA4+ ex vivo scans (Figure 6.3c&i) and more noticeable for the 
zoomed-in color maps from those scans (Figure 6.3f&l). 
 
Longitudinal Trends in Cartilage Partition Coefficient 
 Figure 6.4 displays the trends in cartilage partition coefficient following DMM 
surgery for both the medial and lateral surfaces in the operated (Figure 6.4a) and non-
operated (untouched control, Figure 6.4b) knees. For Ioxaglate, the partition coefficient 
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remained low (mean of 1.25) and essentially constant for both surfaces in both knees 
throughout all 5 weeks of imaging. However, the partition coefficient of CA4+ was 
significantly greater than that of Ioxaglate for both surfaces in both knees for all time 
points, and the coefficient for all surfaces gradually decreased over time, albeit not 
significantly, compared to Week 1. 
 
Discussion 
 Since cartilage GAG content directly affects its mechanical properties and 
decreases early in the pathogenesis of OA, a technique that is sensitive to changes in 
GAG content for cartilage is of significant interest. Performing CECT with a contrast 
agent that is highly attracted to GAG enables both in vivo and ex vivo assessment of 
murine cartilage GAG content and mechanical properties, thus providing a minimally-
invasive assessment of cartilage function and health. Figure 6.1 displays the strong, 
significant correlations between ex vivo CA4+ enhanced CT attenuation and indentation, 
equilibrium compressive modulus (E) for both the medial and lateral cartilage surfaces. 
These data agree with previous reports for murine, bovine, and human cartilage. 
Specifically, using the same CA4+ concentration, the mean ex vivo CECT attenuation 
strongly and positively correlated with E for both medial (R
2
= 0.78) and lateral (R
2
 = 
0.63) mouse tibial plateau cartilage surfaces when using healthy and artificially degraded 
samples (Chapter 5). The strong correlations between CECT and E also agree with results 
from bovine (R
2
=0.90) (Chapter 2) [29, 34] and human (R
2
=0.88) (Chapter 4) cartilage. 
With CA4+, the electrostatic attraction between the contrast agent and the negatively 
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charged GAGs results in high contrast agent uptake in mouse cartilage and positive linear 
correlations between CECT attenuation and E. 
 As discussed previously (Chapter 5), CECT is advantageous compared to 
indentation testing. Specifically, to measure the compressive stiffness across a cartilage 
surface using indentation testing, multiple locations must be tested, which requires many 
hours. Furthermore, the sample thickness at each testing site must be measured to 
compute a compressive modulus from such tests, and the thickness is often measured 
with a destructive, needle-puncture method [50]. On the other hand, one CECT scan (~15 
min for the in vivo scans or ~2 hrs for the ex vivo scans) following contrast agent 
injection/immersion yields an estimate of the same stiffness information in a rapid, 
reliable and non-destructive manner.  
 Additionally, there are several considerable challenges associated with using 
histology to obtain information about cartilage biochemical content, all of which CECT 
avoids. These include irreversible sample loss or damage due to: processing glitches; 
sectioning in the incorrect orientation; and tears, folds or dislodging during sectioning, 
washing or mounting. Furthermore, once stained, a different staining cannot be 
performed. If optical density measures [128] are desired from histological sections, these 
results can be substantially affected by debris on slides and day-to-day variability in both 
microscope lighting and staining batches (even with the same settings or recipes). On the 
other hand, one rapid, facile CECT scan post-contrast agent exposure generates related 
information more quickly, non-destructively, and without the risk of sample damage/loss. 
If the CECT scan fails to capture the region of interest or does not finish, the sample can 
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simply be re-scanned, whereas with histology, if the sectioning or staining is faulty, there 
is no possibility to salvage the sections. Unlike with histology, in which only one stain 
can be applied per slide, contrast agents can either be desorbed from samples during ex 
vivo experiments or allowed to efflux from the joint space (typically occurs within 24 hrs 
[199]) during in vivo experiments, thus enabling the same cartilage surfaces to be 
exposed to multiple contrast agents as demonstrated herein. Finally, whereas histology 
permits only 2D sectioning and analysis, CECT enables the same 2D visualizations 
(Figure 6.2), but it also generates 3D reconstructions of samples, which can be virtually 
sectioned in real-time along one to three planes (Figure 6.3). Hence, the CECT 
attenuations that quantitatively agreed with compressive modulus in Figure 6.1 can 
easily be viewed in any arbitrary plane or as a whole 3D structure. 
 The in vivo qualitative color maps as well as the longitudinal partition coefficients 
(Figure 6.4a&b) are the first reported in vivo CECT data from a mouse OA model. To 
date, there are two published studies of in vivo quantitative CECT imaging of knee 
cartilage, and both employed rat models [195, 196]. Piscaer et al. [195] used mono-
iodoacetate (MIA) to induce the arthritis, and the mean Ioxaglate-enhanced CT 
attenuation of the cartilage increased by 15% four days after MIA injection, 10% after 16 
days, and 19% after 44 days in different groups of animals, indicating some variability in 
either the disease development or scanning/imaging processing techniques. However, the 
authors report a shift in the cumulative histograms with each respective time point, 
indicating over time that the MIA treated cartilage surfaces contained more pixels of 
higher attenuation values. This signifies more Ioxaglate and thus fewer GAGs in the MIA 
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treated cartilage. Using the same in vivo imaging protocol and rat strain, Siebelt et al. 
[196] also report an increasing trend in CECT attenuation relative to baseline and/or the 
contra-lateral control knee following induction of OA using MIA injection, creation of 
cartilage defects (grooves), or treadmill running over the course of the time points of 0 
(baseline), 1, 3, 6, 12, 18, and 24 weeks. Although there are no reports of longitudinal 
CECT scans of mouse cartilage, destabilization of the medical meniscus (DMM) is a 
well-established method for inducing OA in a mouse model [280-282, 308] and is known 
to create mild to moderate OA at 4 weeks and moderate OA at 8 weeks, with lesions 
focused on the central weight-bearing region [280]. 
 Based on the previous rat in vivo imaging studies and mouse histological 
evidence, this author expects the Ioxaglate partition coefficients to increase over time as 
the disease developed and the GAG concentration presumably decreases. However, as 
shown in Figures 6.4a&b, this trend does not occur. Instead, the Ioxaglate partition 
coefficients remain essentially constant over the course of the study for both the operated 
and control knees. There are a few possible explanations for this unexpected result. Since 
this study was a pilot in vivo study, different CT settings were used throughout the 
experiment. However, differences in CT settings were corrected by converting all gray 
scale values to HU using the scanner calibration information and a reference deionized 
water scan. A second likely reason is that the joint spaces had different concentrations of 
Ioxaglate. This is expected, because: different concentrations were injected, mice knees 
have different volumes, and some contrast agent can reflux from the joint immediately 
post-injection. All of these factors cause varied joint space concentrations. Hence, this 
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variability was accounted for by computing partition coefficients (defined as 
concentration of contrast agent in cartilage tissue normalized by concentration in the joint 
space), thus joint space concentration variability does not affect the trends reported 
herein. The most likely cause of the unexpected Ioxaglate trends is the difficulty of 
contouring Ioxaglate-enhanced CT images. The cartilage-bone boundary is easily and 
reproducibly distinguishable in these scans, while the cartilage-joint space interface is not 
as discernable, particularly when a low joint space concentration is present. Thus, the 
Ioxaglate CECT contouring is questionable, which is an inherent limitation to using 
Ioxaglate as a cartilage contrast agent and likely explains why some of Ioxaglate partition 
coefficients are greater than 1 (typical Ioxaglate partition coefficient is ~0.6 [199]). 
 For CA4+, the in vivo partition coefficients decrease over time for both the 
medial and lateral surfaces in the operated knee (Figure 6.4a), but the values also 
decrease for the control knee (Figure 6.4b), which was unexpected. As with Ioxaglate, 
the same plausible reasons for inaccurate CECT data are also controlled for CA4+ (e.g., 
different CT settings and joint space concentrations are both accounted for). Additionally, 
unlike for the Ioxaglate images, the cartilage-joint space boundary was clearly visible on 
the majority of the CA4+ CECT slices, thus enabling reliable cartilage segmentation. 
However, the CA4+ partition coefficients must be revisited, as the uptake of CA4+ into 
articular cartilage is dependent on the concentration to which the cartilage is exposed. 
Current work is investigating an appropriate correction factor for normalizing these 
CA4+ partition coefficient data to enable comparisons between scans. Furthermore, it is 
possible that the anterior regions of these scans are influencing the results, as the 
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meniscus sits tightly over the cartilage in this area, therefore contrast agent penetration 
into the cartilage could have been reduced. This possibility is currently being investigated 
for both Ioxaglate and CA4+. Finally, the CA4+ partition coefficient decrease over time 
for the control knee could reflect a change in mobility or gait of the animals following 
destabilization of the operated knee, potentially resulting in increased use of the 
contralateral limb and hence more rapid cartilage degeneration. Future studies using a 
group of animals with sham-control operations would elicit this effect. 
 Unlike the aforementioned rat studies, a 0-wk (true baseline) time point was not 
captured in this experiment. This resulted from a combination of factors: 1) minimizing 
anesthesia events for the animals; 2) concern that intra-articular injection of contrast 
agent with epinephrine prior to joint surgery could lead to wound healing complications; 
and 3) imaging immediately after surgery was not feasible, as the contrast media would 
leak from the recent arthrotomy. However, a 1-week baseline time point is appropriate, 
given the time course reported for OA development in this model [280] and that the 
contra-lateral knee served as an internal control. The tibial plateaus were chosen for 
image analyses and mechanical testing, as their cartilage surfaces are thicker than the 
opposing femoral surfaces, which enabled more reliable contouring and thickness 
measuring. Furthermore, these cartilage surfaces resemble simple, 3D geometric shapes, 
namely a convex, yet relatively flat dome, which enabled both easier and appropriate 
indentation testing, as adequate tissue surrounded the testing site [274], while the femoral 
cartilage surfaces did not have appropriate surface shapes or thicknesses. To increase 
statistical power, future studies could use more mice and euthanize groups of them at 
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different time points throughout the progression of OA, thus enabling both longitudinal 
cartilage monitoring and direct comparisons to ex vivo measures throughout the study. 
 In this study, both in vivo and ex vivo contrast-enhanced CT (CECT) evaluated 
tibial plateau cartilage for mice that had undergone destabilization of the medial meniscus 
(DMM) surgery. Additionally, in vivo CECT attenuation was tracked over time following 
the DMM procedure. Since CECT enables both in vivo longitudinal monitoring of 
cartilage and ex vivo assessment of GAG content [29, 184-187, 189-191] (Chapters 2, 4, 
5, and shown here), compressive modulus [29, 34] (Chapters 2, 4, 5 and shown here), 
coefficient of friction [34] (Chapters 2 and 5), and bone properties [282, 285], CECT is a 
valuable tool for determining information about two of the most crucially affected tissues 
during OA: cartilage and bone. Additionally, the technique is more rapid, easier to use, 
and non-destructive compared to common mechanical testing and histological methods 
for evaluating cartilage health, thereby preventing the need for large sample sizes in OA 
animal studies. With CECT as a tool to study cartilage and bone, CECT facilitates further 
investigations into the real-time interrelationships between cartilage and bone properties 





Table 6.1: Ioxaglate (Iox) and CA4+ contrast agent concentrations and control (ctrl) files used 
for each mouse at each in vivo imaging time point. 
 
 
Figure 6.1: Correlations for mouse medial (♦) and lateral (■) tibial plateau surfaces between 
mean CECT attenuation and indentation equilibrium modulus (E). Both correlations were strong 
(R
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Figure 6.2: Using contrast-enhanced CT, color maps can be generated in any view for 
visualization of depth-wise cartilage attenuation with the underlying bone morphology and 
attenuation also visible. For example, sagittal CECT color maps (analogous to Safranin-O stained 
histological sections) can be generated for a lateral tibial plateau sample with a high compressive 
modulus (E) from either an Ioxaglate in vivo CECT scan (a), a CA4+ in vivo CECT scan (b) or a 
CA4+ ex vivo, disarticulated (air background) CECT scan (c). Similar color maps can be 
generated for a lateral sample with a low E (d-f). The differences in depth-wise attenuation are 
most clearly visible in the CA4+ ex vivo CECT color maps, are visible in the CA4+ in vivo 
CECT color maps, but are not well differentiable in the Ioxaglate in vivo CECT color maps. The 
distribution of the CA4+ contrast agent matches the typical distribution of Safranin-O stain in 
histological sections, with a greater attenuation in the middle and deep zone for the sample with 
high E and a fairly uniform distribution for the sample with low E, while this pattern is not 





Figure 6.3: Unlike histology, which only permits 2D sectioning in one plane, CECT enables 3D 
color map generation that can be visually sectioned in any view independently or up to three 
planes simultaneously, as demonstrated by the 3D color maps for the sample with high E (a-f) 
and low E (g-l) for Ioxaglate in vivo CECT scans (a, d, g, j), CA4+ in vivo CECT scans (b, e, h, 
k) and CA4+ ex vivo CECT scans (c, f, I, l). By zooming into the regions encompassed in the red 
squares, it is easier to distinguish the difference in depth-wise attenuation patterns for each scan 
of these samples. The color scale bar indicates the corresponding CECT attenuation in Hounsfield 
Units (HU) for all CECT color maps. The distribution of the CA4+ contrast agent in the ex vivo 
scans is most distinguishable and matches the typical distribution of Safranin-O stain in 
histological sections, with a greater attenuation in the middle and deep zone for the sample with 
high GAG and a fairly uniform distribution for the sample with low GAG. This distribution is 
also discernable in the CA4+ in vivo CECT scans, but the opposite distribution (since Ioxaglate is 





Figure 6.4: Trends from in vivo contrast-enhanced CT scans using both Ioxaglate (Iox) and 
CA4+ for mean partition coefficients (defined as concentration of contrast agent in the cartilage 
tissue divided by concentration in the joint space) over time post-DMM surgery for mouse tibial 
plateau surfaces from operated (a) and non-operated (untouched control) (b) knees. Med = 
medial, lat = lateral. NOTES: 1) The Ioxaglate partition coefficients should not be greater than 1, 
as this agent is electrostatically repelled from cartilage tissue. This issue is still being 
investigated, but the CECT data was extremely difficult to contour for these scans (cartilage was 
not easily discernable on most scans). 2) Simply normalizing by joint space concentration is not 
appropriate for CA4+, as the contrast agent uptake is dependent on the concentration to which the 
cartilage is exposed. Therefore, current work is investigating an appropriate correction factor for 
normalizing these CA4+ partition coefficient data to enable comparisons between scans. 3) 
Finally, for both contrast agents, it is possible that the anterior regions of these scans are 
influencing the results, as the meniscus sits tightly over the cartilage in this area, therefore 






CHAPTER 7: A Synthetic mini-Comb Polymer Biolubricant Reduces Cartilage Wear by 
Minimizing the Coefficient of Friction During Long-Duration Torsional Testing of Intact 
and Previously Worn Cartilage 
 
Introduction 
 In healthy diarthrodial joints, articular cartilage and synovial fluid maintain a near 
frictionless surface that supports and dissipates applied loads. Of the various lubrication 
mechanisms [68], boundary lubrication is the harshest, as it generates the most friction. 
This lubrication mode dominates once the cartilage interstitial fluid pressure subsides, 
and the fluid film between the cartilage surfaces diminishes, resulting in cartilage-
cartilage contact. In this lubrication regime, the cartilage surface properties, as opposed to 
interstitial-fluid or fluid-film properties, dictate the lubrication between the surfaces. 
Effective boundary lubrication is important for the protection and maintenance of 
articular surfaces, since the opposing cartilage layers within the joint make contact over 
~10% of the total area, where much of the friction may occur [309]. Furthermore, this 
lubrication mode dominates during many daily activities that involve the start-up of 
motion following extended compression of the tissue (e.g., standing after prolonged 
sitting or walking after sustained standing) [310].  
 Several biomacromolecules in healthy synovial fluid (SF), including hyaluronic 
acid (HA) and lubricin [1, 311-313], reduce friction during boundary lubrication. With a 
molecular weight of 3-10 MDa [314] and at a concentration of ~2 mg/mL in SF, HA is 
linear polymer of repeating disaccharides composed of D-glucuronic acid and D-N-
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acetylglucosamine [315] that is an effective hydrodynamic lubricant at low shear rates 
but not at high loads [316], and can be an effective boundary lubricant [64]. Lubricin, at a 
concentration of ~ 250 μg/mL, plays an important role in lubrication at high loads [311]. 
It has a molecular weight of 225 kDa, contains ~ 800 amino acids [313], and is an 
elongated, flexible molecule that binds to the outer surface of cartilage and acts as a 
boundary lubricant. 
 In healthy joints, HA and lubricin maintain low friction during boundary 
lubrication by preventing direct contact between the opposing cartilage surfaces. 
However, during early osteoarthritis (OA), cartilage loses glycosaminoglycans (GAGs) 
[11, 12, 317], which increases the hydraulic permeability of the tissue. The increase in 
fluid flow distributes more of the joint loads to the collagen-proteoglycan matrix, 
resulting increased boundary lubrication. During OA, this increased matrix loading 
occurs simultaneously with a decreased concentration of lubricin [318] and HA [64], 
resulting in early surface damage to the collagen network. This damage decreases 
cartilage tensile stiffness initially at the surface, but eventually, the weakening progresses 
to the deeper layers, leading to reduced cartilage mechanical integrity [21, 28, 29]. 
Eventually, cartilage lesions and thinning arise from the weakened collagen network 
being subjected to higher frictional loading [9], and the arthritic cartilage can severely 
wear [319]. This author hypothesizes that supplementing SF with a polymer that reduces 
the coefficient of friction (µ) will minimize cartilage wear (i.e., tissue thinning and 
lesions), and ultimately delay or mitigate the need for a partial or total joint arthroplasty.  
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 Towards this goal, this author’s research group is investigating large molecular 
weight polyanions as viscous biolubricants for cartilage tissue. From a tribological design 
perspective, a viscous lubricant will create a thin film between the cartilage surfaces, as it 
enhances interfacial pressurization so that a pressurized fluid film can more easily form. 
This thin film will reduce the prevalence of boundary lubrication, thus avoiding harsh 
frictional loads. Additionally, a polyanion will maintain the polymer at the cartilage 
surface as cartilage possesses an overall fixed negative charge due to the GAGs, and a 
molecular weight greater than 1 MDa will retard its diffusion through the synovial 
membrane, thus increasing its joint space residence time. The synthesis of a 2.5 MDa 
poly(7-oxanorbornene-2-carboxylate) [320] as an effective biolubricant in cartilage-on-
cartilage, torsional, single-rotation friction tests was recently reported [223]. As each 
monomer possesses a formal negative charge, this polymer is highly anionic. To more 
easily match the osmolality of healthy SF (400 mOsm, [217]) when the polymer is 
dissolved in aqueous salt solution, to reduce the overall negative charge of the polymer, 
and to examine the effect of altering the polymer architecture, a mini-comb polymer of 
poly(7-oxanorbornene-2-carboxylate) containing pendent tetraethyleneglycol (TEG) 
chains was synthesized. The viscous lubricating and wear-prevention abilities of this new 
polymer were then evaluated using an ex vivo cartilage-on-cartilage model, and the 
polymer’s acute biocompatibility was examined in vivo. Specifically, the polymer’s 
effects on gait using a rat model and on synovitis compared to a saline control using a 





Specimen Preparation and Study Design 
 Twenty-six mated, osteochondral plug pairs were cored from the femoral groove 
(12mm diameter) and patella (7mm diameter) of seven freshly slaughtered, skeletally 
mature cows. All the samples were then frozen at -20 °C in 400 mOsm/kg saline 
containing GIBCO Anti-Anti stock solution (5x; Invitrogen, Grand Island, NY), 
ethylenediaminetetraacetic acid (5mM; Sigma, St. Louis, MO), and benzamidine HCl 
(5mM; Sigma B6506, St. Louis, MO). These same additives were included in all the 
solutions that were exposed to the samples to prevent nonspecific degradation of the 
cartilage during the experiments. Prior to testing, all samples were thawed overnight at 4 
°C. Twelve plug pairs were used to evaluate the frictional properties and wear prevention 
of saline, bovine synovial fluid (BSF), and 2M TEG during a long-duration torsional test 
(Study 1). In Study 2, three plug pairs were used to evaluate the reversibility of the 
improved frictional properties when testing the pairs in 2M TEG following testing in 
BSF. Finally, eleven plug pairs were used to evaluate the ability of BSF, Synvisc-One, 
and 2M TEG to improve the frictional properties of previously worn cartilage (Study 3). 
Group bias was controlled in Studies 1 and 3 by using neighboring plug pairs from the 




Contrast Agent (CA4+) and Biolubricant (2M TEG) Preparation 
 The computed tomography (CT) contrast agent CA4+ was synthesized as 
previously reported [192]. The contrast agent solution was prepared by dissolving the dry 
compound in deionized water, balancing the pH to 7.4 using NaOH and adjusting the 
osmolality to 400 mOsm/kg using sodium chloride to match the in situ osmolality of 
articular cartilage (350-450 mOsm/kg [217]).  
 The 2MDa poly(7-oxanorbornene-2-carboxylate) polymer was synthesized as 
previously reported [223, 320]. Briefly, the 7-oxanorbornene-2-carboxylate monomer 
was dissolved in benzene and polymerized using a ruthenium [1,3-bis(2,4,6-
trimethylphenyl)-2-imidazolidinylidene]dichloro (phenylmethylene) 
(tricyclohexylphosphine)] catalyst to afford the polymer of molecular weight (Mn) 
2,000,000Da (PDI=1.2). The polymer was subsequently saponified and dialyzed against a 
3,400Da cut off at pH=7.4 to afford the acid product as the sodium salt. The 
tetraethyleneglycol (TEG) chains were added using carbodiimide coupling in phosphate 
buffer at pH=6. After dialyzing against a 3,400Da cut off at pH=7.4 and freeze drying, 
the final product was obtained as a white powder. The polymer was dissolved in 
deionized water at 2% by weight to create the 2M TEG biolubricant (Figure 7.1 inset). 
 
Baseline Surface Photographing and µCT Imaging 
 For all studies, the congruent cartilage surfaces of the osteochondral plugs were 
photographed (1x and 2.25x magnification) using a microscope camera (PL-B681CU, 
PixeLINK, Ottawa, ON) to ensure all the plugs had comparably smooth surfaces prior to 
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torsional testing. For Study 1, the plugs were immersed in the CA4+ contrast agent at 12 
mgI/mL (patella plugs: 1 mL, groove plugs: 3 mL) for 24 hrs at room temperature. 
Following immersion in the CA4+ contrast agent, each sample was gently blotted to 
remove excess contrast agent, and the plugs were positioned in a µCT imaging system 
(µCT40, Scanco Medical AG, Brüttisellen, Switzerland) using a custom, airtight holder 
that maintained a humid environment to prevent drying of the cartilage. Sequential 
transaxial µCT images of the cartilage and subchondral bone were acquired at an 
isotropic voxel resolution of 36 µm, 70-kVp tube voltage, 113-µAmp current, and 300-
ms integration time for all samples. The µCT data were converted to DICOM format 
using the proprietary software from Scanco before being imported for post-processing 
using Analyze™ (Analyze Direct, Overland Park, KS). The cartilage was segmented 
from the subchondral bone using a region-growing algorithm. The thicknesses of the 
segmented cartilage object maps were then measured at 5 points across the width of the 
tissue for all coronal slices. Following contrast-enhanced CT (CECT) imaging, each 
sample was washed in excess saline for 24 hrs. Since sample surface roughness from 
Studies 2 & 3 was not compared, the cartilage thicknesses for Studies 2 & 3 were 
measured using the same procedure as for Study 1, except the thicknesses were measured 
from non-contrast-enhanced µCT scans. 
 
Baseline Coefficient of Friction (µ) Testing 
 The baseline frictional properties of all plug pairs were evaluated using saline as 
the test solution and the same mechanical testing procedure [63]. Briefly, each 
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osteochondral plug pair was aligned collinearly using custom fixtures, and a pre-load was 
applied to establish complete contact between the patellar and femoral groove surfaces. 
While immersed in saline, each plug pair was compressed to 18% of the total cartilage 
thickness (for the pair) at a displacement rate of 0.005 mm/sec (Enduratec 3230, BOSE, 
Eden Prairie, MN). Following compression, the samples relaxed for 70 min, and then the 
femoral groove plug was rotated against the patellar plug for 720° at 5°/sec (effective 
velocity of 0.3 mm/sec) [63]. The compressive force, torque, displacement, and rotational 
data were collected at 10 Hz, and the fixtures and chambers were cleaned following each 
test. Three torsional coefficients of friction (µ) were computed, representing the baseline 
performance of articular cartilage [63] using the equation µ = T/(RN), where T is the 
torque, N is the normal force, and R is radius of the sample. Specifically, we calculated: 
µstatic: the maximum value of µ for the first 10° of rotation.  
µstatic_eq: computed using the maximum value of T from the first 10° of rotation 
and the normal force as the force at the end of the relaxation period.  
µkinetic: the average value of µ from 360° to 720°. 
 
Long-Duration Frictional Testing 
 After recovering in saline overnight, the plug pairs from Study 1 were randomly 
immersed in either the 2M TEG biolubricant, BSF, or saline (n=4 for each) for >4 hrs 
prior to long-duration testing. For the long-duration torsional test, the plugs from the 
femoral groove were rotated against the plugs from the patella at 360°/sec (22 mm/sec) 
for 1260 wear cycles, while subjected to 0.78 MPa compressive stress. One cycle 
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consisted of 720° of clockwise (CW) rotations, 1440° of counter-clockwise rotations and 
720° of CW rotations. Every 20 cycles, the plugs were separated for 1 cycle to allow the 
lubricant to be reintroduced between the cartilage surfaces. The average µ (µmean) was 
calculated for wear cycles between successive “lift-offs.” For Study 1 only, the rotations 
were paused every hour for extraction of a 100-µL lubricant aliquot for later wear 
analysis. After each test, the fixtures and chambers were cleaned, and the plug pairs were 
allowed to recover for >16 hrs in saline. 
 For the reversibility study (Study 2), the plug pairs were subjected to the 
previously described long-duration torsional test on four sequential days. Using BSF as 
the lubricant, the first regimen was used to pre-condition the samples. The lubricants for 
each of the following wear regimens (Wear1-3) were BSF, 2M TEG, and BSF, 
respectively. Each plug pair was immersed in the respective lubricant for >4 hrs prior to 
testing and then rinsed overnight in saline on a rocker table after testing. 
 For Study 3, all the plug pairs were subjected to a wear regimen on three 
sequential days: the first two regimens (Wear1 and 2) were intended to progressively 
“wear” the cartilage, and the third cycle was to test the efficacy of each lubricant on 
“worn” cartilage. For Wear1 and 2, saline was used as the lubricant, and the plugs were 
recovered in saline overnight on a rocker table between subsequent wear cycles before 
initiating the third wear regimen (Wear3) in which the mated plugs were lubricated with 




Analysis of Surface Roughness 
 For all studies, the cartilage surfaces of each plug were photographed again 
following each long-duration torsional test. The samples from Study 1 were then 
immersed again in CA4+ at 12 mgI/mL for 24 hrs at room temperature, scanned again on 
the µCT imaging system, and the µCT data were evaluated using Analyze™. After the 
long-duration torsional tests, circular wear grooves (rings) developed on some of the 
samples, indicating surface wear. Two blinded observers counted the number of rings on 
both the baseline (no rings present for any samples) and wear-tested cartilage surface 
photographs for the samples from Study 1 to evaluate the ability of the different 
lubricants to prevent cartilage surface wear. The average number of rings for each 
lubricant group was then computed.  
 Additionally, five sequential coronal and five sequential sagittal CECT images 
pre- and post-long-duration testing were evaluated to measure the change in each plug’s 
cartilage surface roughness [321]. Using Analyze, each of the ten CECT slices were 
contoured and sampled to acquire spatial data points of the entire cartilage boundary. A 
trained user then selected the data corresponding to the articular surface, and a third 
degree polynomial function was then fit to the data. To measure the surface roughness, 
the cross product of head-to-tail vectors of each point was calculated and then multiplied 
by the vertical distance between a given surface data point and its corresponding value on 
the fitted curve, resulting in a “roughness product value.” For each CECT slice, the root 
mean square (RMS) of all roughness product values was computed, and the average RMS 
was then calculated for all slices for the baseline and worn articular surface for each 
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sample. The percent increases in the average worn RMS values with respect to those of 
the same sample at baseline were then compared between the different lubricants 
(MATLAB 11a, The MathWorks, Natick, MA). 
 
Analysis of Wear Solutions 
 Following the long-duration tests for Study 1, the remaining lubricant solutions 
were collected. Highly concentrated papain solution (in a buffer solution of 50 mM 
sodium phosphate, 5 mM EDTA, 2 mM dithiothreitol, pH 6.8) was added to each 
remaining lubricant solution and each 1-hr aliquot, resulting in a final papain 
concentration of 1 mg/mL and minimal dilution of the lubricants. The solutions were then 
digested at 60 °C for 24 hrs. The GAG content of each digested solution was determined 
using the 1,9-dimethylmethylene blue (DMMB) colorimetric assay [218]. To convert 
from absorbance to GAG content, a linear calibration curve was generated for each 
lubricant using chondroitin-4-sulfate (Sigma 27042, St. Louis, MO) at concentrations 
ranging from 0-50 µg/mL, dissolved in the respective lubricant, and then digested with 
papain as previously described. Ten microliters of each chondroitin-4-sulfate calibration 
solution and each digestion solution were separately combined with 100 µL of DMMB 
dye solution in a 96-well plate. The absorbance of each resulting solution at 520 nm was 
measured in triplicate using a plate reader (Beckman Coulter AD340, Fullerton, CA). The 
total GAG mass in each lubricant solution was calculated using the appropriate 
calibration curve and the volume of lubricant used during the long-duration testing. 
 Unfortunately, the DMMB assay could not be used to determine the amount of 
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GAG in the BSF solutions, as the background signal from BSF was too great relative to 
that of the wear debris. For 2M TEG, the background signal was not greater than its 
standard curve, but no GAG was detectable in these wear solutions. The small amount of 
GAG detected in the saline wear solutions relative to the mass of GAG in a 7-mm 
cartilage disk (~1.5 mg) explains why no significant changes were observed in CECT 
attenuations between pre- and post-wear CECT scans. It seems that the long-duration 
torsional test does not release enough GAG to be detectable via CECT, although future 
studies will need to investigate if differences could be detected between samples before 
and after harsher regimens. 
 
In Vivo Studies 
 Male Lewis rats (n=4, Charles River#380380), weighing approximately 260-285 
grams at start were injected with 2% 2M TEG (40 µL) in the right knee after being 
anesthetized with isoflurane. Animals were observed daily for local swelling or any other 
adverse reaction to the injections. Gait analysis was performed 3 days post-injection to 
determine any inflammation associated pain to injection using the following process. 
 The rear feet of the rats were placed in colored ink and black ink is applied to the 
dorsal side of the foot on the suspected painful leg. Rats were placed on paper and 
allowed to walk the full length then removed. 
 Gait scores: 
 0 = Normal, equal ink staining on both feet 
 1 = Slight limp, toe staining evident and some heel staining for all steps, no 
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 carrying or dragging. If left has very little heel staining (rat walks mainly on toes) 
 then slightly less toe staining in right leg for most steps. (or approximately 25% 
 less staining on right vs. left) 
 2 = Limping, toes only staining for all steps, no carrying or dragging. If left has 
 very little heel staining (rat walks mainly on toes) then slightly less toe staining in 
 right leg for most steps. (or approximately 50% less staining on right vs. left) 
 3 = Dragging and carrying leg, black drag marks from dorsal side of foot present 
 or some attempt to use right as evidenced by minimal toe staining in at least one 
 print, may pause and place right foot down for a single step. (or approximately 
 75% less staining on right vs. left) 
4 = Carrying leg entire time, no staining from painful leg or only minor black 
drag marks, no toe staining in any print. (100% less staining on right vs. left) 
 
 In Study 5, ten female beagle dogs were injected with 2M TEG (n=5) or saline 
(n=5) into one knee joint at Bolder BioPATH. On day 4, animals were euthanized, and 
the synovium was sectioned and stained with H&E. All sections were examined by a 
board-certified veterinary pathologist (Dr. Alison Bendele). 
 
Statistics 
 One-way ANOVA was used to evaluate differences between: 1) baseline µ values 
for all lubricant groups within each study, 2) µmean for each lubricant group in Study 1, 3) 
number of “wear rings” on adjacent cartilage surfaces for each lubricant group in Study 
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1, 4) percent increase in surface roughness after long-duration testing for each lubricant 
in Study 1, 5) mass of GAG in lubricant solutions from Study 1, 6) differences in µmean 
for Wear2 and Wear3 each normalized to Wear1 in Study 2, and 7) the percent change in 
µmean for Wear3 relative to Wear2 for all time points and lubricants in Study 3. 




 The poly(7-oxanorbornene-2-carboxylate) polymer was synthesized with a Mn of 
2,000,000 g/mol (PDI=1.2) as measured via size exclusion chromatography (SEC), and 
the TEG chains were successfully added to 30% of the polymer’s carboxylate groups as 
determined by NMR. Reaction yields for the two steps ranged between 80-95% (n=3), 
and the final 2M TEG polymer (Figure 7.1 inset) was completely soluble in water at 2% 
by weight. 
 
Long-Duration Torsional Friction Properties (Study 1)  
 There were no significant differences in the initial baseline coefficient of friction 
(µ) values among the plug pairs assigned to saline, BSF or 2M TEG test groups for µstatic, 
µstatic_eq, or µkinetic. Long-duration torsional testing of plug pairs lubricated with 2M TEG 
exhibited the lowest µmean values, being significantly lower for all time points after 5280 
sec compared to plugs lubricated with saline, which had the greatest µmean results (Figure 
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7.1). The plug pairs lubricated with BSF exhibited µmean values greater than those of 2M 
TEG and less than those of saline, being significantly lower than saline for 8 time points 
after 6240 sec of testing. 
 
Wear Properties (Study 1) 
 Cartilage plug pairs lubricated with 2M TEG had fewer circular wear grooves 
(“rings,” see Figure 7.2 inset) on their surface compared to samples lubricated in saline 
(p = 0.06, Figure 7.2). Additionally, the samples lubricated with 2M TEG (Figure 7.3a-
3) had noticeably less rough surfaces following wear testing than those tested in saline 
(Figure 7.3a-1) and BSF (Figure 7.3a-2). Comparing each femoral groove plug’s post-
wear surface roughness to its baseline surface roughness, the percent change in surface 
roughness after wear testing was significantly lower for samples tested in 2M TEG 
compared to samples lubricated with saline (Figure 7.3b). The average mass of GAG (a 
known wear debris product [322, 323]) in the 2M TEG wear test solutions was 
undetectable, while the mass of GAG found in the saline wear solutions was substantial 
at 121.1 ± 33.1 µg (mean ± SD). 
 
Reversibility of 2M TEG’s Lubricating Effect (Study 2)  
 For Study 2, the reversibility of 2M TEG’s lubricating effect was evident when 
the mean was computed of each wear regimen’s µ-values normalized to the µ-values of 
Wear1 (Figure 7.4). The mean coefficient of friction of Wear2 (2M TEG) reduced by 
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20.9 ± 10.5% relative to that of Wear1 (BSF), while the mean coefficient of friction of 
Wear3 (BSF) increased by 2.0 ± 7.1% relative to Wear1. The normalized Wear2 mean µ-
value was significantly less than the normalized Wear3 µ-value (p<0.05). 
 
Effectiveness of 2M TEG on Previously Worn Cartilage Surfaces (Study 3) 
 In Study 3, there were no significant differences in baseline µ values among the 
three paired-plug groups assigned in Wear3 to BSF, Synvisc or 2M TEG: µstatic (p = 
0.415), µstatic_eq (p = 0.210), and µkinetic (p = 0.986). The percent reduction in µmean for 
Wear3 relative to Wear2 was the greatest for 2M TEG, followed by Synvisc, then BSF 
(Figure 7.5); being significantly greater for 2M TEG than for BSF for all time points 
except 800, 6080, 6240, 6400, 6560, 6720, 6880, 7040 and 84080 sec (p<0.05). 
 
Rat and Dog Pilot Studies  
 Rats injected with 2% 2M TEG gained approximately 7-8 grams over the course 
of the study and had no observed clinical abnormalities. The rats had gait scores of 0 on 
day 3 after injection, with mean gait deficiency percentages of 8-10%. Dog knees 
injected with saline had normal synovia, but one had minimal papillary proliferation 
(Figure 7.6a). Knees injected with 2% 2M TEG were comparable to saline-injected 






 The typical treatments for OA include weight loss, exercise, activity modification, 
assistive devices (e.g., canes), non-steroidal anti-inflammatory drugs, and intra-articular 
injections of corticosteroids. When these methods are unsuccessful or the disease 
becomes severe, partial or total joint arthroplasty is required. In an effort to delay joint 
replacement, viscosupplementation has emerged as a treatment where hyaluronic acid 
(HA) solutions are injected intra-articularly [324, 325]. Yet, there is significant 
controversy surrounding the use of intra-articular injections of HA (e.g., Synvisc, 
Orthovisc, Hyalgan, and Supartz) due to its limited clinical efficacy, susceptibility to 
hyaluronidase enzymatic degradation, and short residence time (t1/2 = 1-3 days) in the 
synovial joint [326, 327]. Moreover, no studies have documented the short- or long-term 
efficacy of such viscosupplements ex vivo under any lubrication mode to reduce wear. 
Hence, there is a need for new treatments that reduce cartilage friction and wear to 
provide chondroprotection. 
 A novel, 2 MDa synthetic polyanion based on poly(7-oxanorbornene-2-
carboxylate) and possessing TEG chains on 30% of its monomer units (2M TEG, Figure 
7.1 inset) was evaluated as a lubricant for cartilage surfaces. Figure 7.1 shows the 
significant reduction in coefficient of friction (µmean) for plug pairs lubricated with 2M 
TEG compared to samples tested in saline and BSF. Plateau formation in the coefficient 
of friction curve is observed and indicates the cartilage interstitial fluid pressure has 
subsided (a plateau also formed at the same time in the saline creep curves, further 
indicating the fluid pressure has subsided). Using Stribec curves for cartilage, the plateau 
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indicates a transition from hydrodynamic/elastohydrodynamic lubrication to viscous 
lubrication (for a lubricant with a high viscosity, e.g., BSF and 2M TEG) or boundary 
lubrication (for a lubricant with low viscosity, e.g., saline) [68]. The equilibrium values 
of µmean (defined as the mean value of µmean from 8000 to 10080 sec, as the curves were 
fully plateaued in this range), for saline, BSF, and 2M TEG are 0.0626 ± 0.0015 (mean ± 
SD), 0.0448 ± 0.0016, and 0.0316 ± 0.0005, respectively. The 2M TEG biolubricant 
provided superior lubrication even after the interstitial fluid pressure had subsided, 
indicating the viscous lubricant is superior to saline in our operating conditions. 
Additionally, fitting an exponential of the form µmean = a*e
-b*time
 + c (MATLAB 2011a, 
MATLAB, Natick, MA) to the curves, the tau values (1/b), which represent the time at 
which 63.2% of the plateau µmean value is reached [184, 185], are determined to be 4527 
± 2321 sec (mean ± SD), 3253 ± 4112, and 1070 ± 281 for saline, BSF, and 2M TEG 
respectively. Although the samples were harvested from neighboring locations on the 
same surfaces of three knees, the differences in µ curves and tau values for each lubricant 
are explained using Stribec curves. Since the viscosity of 2M TEG is substantially greater 
than that of saline, and the mechanical testing parameters are the same for both saline and 
2M TEG, samples tested in the biolubricant maintain mixed-mode lubrication as their 
interstitial-fluid pressure subsides, while samples tested in saline transition to boundary 
lubrication. During mixed-mode lubrication, a thin film between the cartilage surfaces 
reduces interfacial friction below that of boundary lubrication, hence the µ values for 2M 
TEG plateau lower than those of saline. 
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 Several studies have reported cartilage friction performance using continuous 
rotation [57, 67] and cyclic sliding [6, 7, 56, 68, 219, 220, 322, 328, 329]. However, only 
two studies have documented coefficients of friction using a cartilage-on-cartilage setup 
[322, 329], and they used continuous cyclic sliding. Although it is difficult to compare µ 
values directly, as the experimental conditions between torsional and linearly oscillating 
configurations differ, Katta et al. also found that µ vs. time followed an exponential trend 
for bovine femoral groove cartilage samples reciprocally sliding with one cartilage 
surface against another while lubricated with saline [322]. Using 0.5 MPa compressive 
stress, 4 mm/sec sliding velocity, and 4-mm stroke length, this study reported µ values of 
~0.015 after 3 hrs of testing (10,800 strokes), which is the same order of magnitude as the 
equilibrium µmean values [0.0626 ± 0.0015 (mean ± SD)] obtained in the present study 
after 10,080 rotations using bovine patella and femoral groove cartilage, saline as the 
lubricant, 0.78 MPa compressive stress, and an effective sliding speed of 22 mm/sec. The 
reason the equilibrium µmean values reported herein were ~4x greater than those of Katta 
et al. is likely due to the limited opportunity for lubricant reintroduction between the two 
rotating surfaces in the torsional regimen, which likely creates harsher boundary 
conditions than the alternative sliding regimen that permits continuous re-coating of one 
cartilage surface.  
 To our knowledge, no continuous torsional regimens have been reported using 
cartilage-on-cartilage testing. Hence, we will compare our findings to those from 
cartilage-on-steel [67] and cartilage-on-glass [57] configurations. Wang and Ateshian 
used bovine glenoid cartilage in a cartilage-on-steel configuration with saline as the 
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lubricant and reported equilibrium µ values ranging from 0.4 to 1.2 after a compressive 
stress relaxation period following 4.5% strain and using rotational speeds of 0.23 to 1146 
°/sec (effective sliding speeds of 0.0075 to 37.5 mm/sec) [67]. Despite fewer total 
rotations, these µ values are an order of magnitude higher than those reported herein, 
indicating the superior lubricity of an opposing cartilage surface compared to one of steel. 
Also using saline as the lubricant, Kumar et al. reported µ = ~0.007 after 10 minutes 
(23.9 rotations) of torsional cartilage-on-glass testing using porcine patella cartilage with 
a 0.54 MPa compressive stress at 14.3°/sec (1 mm/sec) [57], which is an order of 
magnitude lower than the average saline µmean value reported herein (0.0173) at 640 sec 
(10m40sec). However, our mean µ (0.0075) after our first wear cycle (160 rotations) was 
comparable to the final µ value in this study, even though they tested cartilage-on-glass 
and their rotational speed was slower and non-alternating. This agrees with the notion 
that surface interactions are less dominant during the fluid-dependent lubrication regime.  
 Unlike other reported testing methods, our protocol included lift offs every 20 
cycles (160 rotations) to reintroduce lubricant between the two articular surfaces. Such 
separations are unnecessary in a cyclic sliding configuration, as the lubricant is 
reintroduced to the exposed static cartilage surface once the oscillating cartilage surface 
slides to the end of its stroke. The other reported torsional tests for cartilage did not 
include lift offs, likely because the torsional loading was shorter and/or at slower speeds 
[57, 67]. By allowing lubricant to be reintroduced during lift off periods in a long-
duration torsional testing regimen, the protocol becomes more mimetic of physiological 
lubrication during joint motion, as new lubricant is continuously exposed to the 
  
161 
articulating surfaces. The lift-off periods were limited to 8 rotations to prevent substantial 
recovery of the interstitial pressure in the cartilage tissue when the surfaces were 
separated. Although greater sliding speeds can cause hydrodynamic lubrication [68], 
quick rotations were chosen to reduce the testing duration at room temperature. The 
super-physiologic, effective sliding speeds chosen were used to evaluate the lubricating 
ability of 2M TEG in harsher conditions than those encountered in the joint, analogous to 
common, accelerated wear regimens performed on machine bearings.   
 As shown in Figures 7.2 & 7.3, the biolubricant’s presence resulted in 
significantly less cartilage surface wear than when saline was used as the lubricant. The 
circular grooves or rings that formed on the cartilage surfaces post-wear testing (Figure 
7.2 inset) likely developed as slightly thicker regions of the cartilage tissues sheared 
against each other during the rotations. This author hypothesizes that when saline is used 
as the treatment group and after the intra-tissue fluid pressure has subsided, the 
macroscopically smooth cartilage will wear at these harsh conditions as any remaining 
HA or lubricin molecules on the cartilage surfaces are driven out of the interface. 
However, when BSF is used as the lubricant, hyaluronic acid (HA) and lubricin 
molecules can re-deposit between the cartilage surfaces during liftoffs, thus preventing 
direct matrix-matrix contact, resulting in less surface roughening. When 2M TEG is used 
as the lubricant, these large polymers reside between the cartilage surfaces, affording 
fewer wear rings and less surface roughening.  
 Only a few groups have examined ex vivo cartilage wear following long-duration 
friction testing [322, 323]. Katta et al. used a stylus profilometer and found that normal 
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stress had little effect on surface roughness after 7 hrs of cyclic sliding in saline, whereas 
pre-treatment with Chond. ABC resulted in smoother surfaces after testing [322]. 
Verberne et al. measured the surface roughness of their samples using an optical 
profilometer after 450,000 cycles of sliding cartilage-on-cartilage in saline at 66.7 
mm/sec under 2.4 or 4.8 MPa of compressive stress and reported a slight smoothing of 
the cartilage post-testing [323]. Instead of using a profilometer, this experiment extended 
a surface roughness assessment technique developed for analyzing Safranin-O stained 
histology slices [321] to our CECT data. As shown in Figure 7.3, the samples tested in 
saline experienced ~7.22x increase in surface roughness compared to baseline, while 
samples tested in BSF and 2M TEG show a 2.62x and 1.05x increase, respectively. 
Hence, use of the 2M TEG biolubricant minimizes surface wear. Moreover, the 
advantages of using CT imaging to determine surface roughness, unlike histology, are 
that the measurements are quick, 3D images can be collected, and if developed as an in 
vivo technique, a pre-treatment (surgery only) scan could be performed without 
damaging the tissue so that a percent change in roughness after treatment can be 
calculated for a given cartilage surface. This would enable a minimally-invasive OA 
assessment tool for studying OA progression and treatment efficacy in small and large 
animal models. 
 The cartilage surface roughness results agree with the amount of GAG released 
into the lubricant solutions when testing. More GAG is lost from the cartilage samples 
tested for 3 hrs in saline (121.1 ± 33.1 µg) than those tested in 2M TEG (not detectable). 
This result is consistent with the earlier observations of fewer surface rings (Figure 7.2) 
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and the lower percent increase in surface roughness (Figure 7.3) with the 2M TEG group 
compared to the saline group. The GAG content observed in the saline wear solutions is 
consistent with literature reports. Katta et al. found 0.75 mg of GAG in saline solutions 
after testing bovine femoral groove cartilage (9-mm diameter) in a cartilage-on-cartilage 
setup for 25,200 sliding strokes (4-mm length) at 0.5 MPa compressive stress and 4 
mm/sec sliding speed [322]. Additionally, Verberne et al. detected 0.75 mg of GAG in 
saline solutions after testing human femoral head cartilage (4-mm diameter) in a 
cartilage-on-cartilage configuration for 300,000 sliding strokes (1-mm length) at 2.4 MPa 
compressive stress and 66.7 mm/sec sliding speed [323]. These testing protocols utilized 
more sliding strokes than our protocol, hence, our finding of 0.121 mg of GAG in the 
saline wear solutions is comparable to these results. 
 In Study 2, a direct comparison between BSF and 2M TEG is explored by using 
repeat testing on the same cartilage samples to determine if 2M TEG can reduce µ below 
that imparted by BSF. Pilot studies using BSF as the lubricant confirmed that after the 
first pre-conditioning wear regimen, the next three regimens (Wear1-3) had comparable 
µmean values (not shown). Since the percent reduction from Wear1 to Wear2 was 20.9 ± 
10.5% (Figure 7.4), 2M TEG can reduce µ below that imparted by BSF for cartilage 
samples. The percent increase from Wear1 to Wear3 was 2.0 ± 7.1%, indicating that 2M 
TEG does not bind articular cartilage, consistent with the electrostatic repulsion between 
the polymer and the fixed negative charge density present in cartilage. Instead, the 
polymer behaves as a viscous lubricant and forms a layer interposed between the two 
cartilage surfaces during testing. Although 2M TEG can be rinsed away from cartilage 
  
164 
surfaces in excess saline, loss of the lubricant would be retarded in an intact joint, as its 
molecular weight is greater than the largest pores of the joint capsule (~750 kDa, [330]).  
 In addition to a direct comparison between BSF and 2M TEG, in Study 3, the 
ability of BSF, Synvisc-One, and 2M TEG to improve the frictional performance of 
previously worn cartilage was compared. Figure 7.5 shows the percent reduction in µmean 
over time for these three lubricants following the second pre-conditioning wear regimen 
with saline. Since it is known from Study 1 that samples tested in saline are significantly 
rougher than samples tested in BSF or 2M TEG, substantial surface roughening was 
induced during the first two pre-conditioning regimens of Study 3. Despite the increased 
roughness, 2M TEG was still able to reduce the coefficient of friction by ~60%, 
compared to ~35% for Synvisc-One and ~15% for BSF, being significantly greater than 
BSF for most of the time points. These studies demonstrate 2M TEG can ameliorate 
subsequent wear for already roughened ex vivo cartilage surfaces. 
 To examine acute in vivo biocompatibility, rat gait patterns were monitored after 
intra-articular injection into their knees (n=4), and there was no effect on gait or clinical 
signs of abnormalities. Finally, injection of 2M TEG had comparable effects to saline 
control injections into knee joints of beagle dogs. For both injections, histological H&E 
stain revealed normal pathology with one instance of synovial papillary proliferation for 
saline and two such instances for 2M TEG. However, neither proliferation was more than 
mild (Figure 7.6). These preliminary gait and inflammation data indicate minimal acute 
safety concerns, thus enabling eventual in vivo efficacy testing.  
 In osteoarthritis, cartilage progressively breaks down, resulting in a loss of 
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proteoglycans, leading to increased hydration and a predominance of boundary 
lubrication, and eventually fibrillation of the extracellular matrix [27]. As a consequence 
of these compositional alterations, the lubricating ability of osteoarthritic cartilage 
reduces, affecting the functionality of the tissue. Additionally, the synovial fluid also 
degenerates and becomes a less effective lubricant. The 2M TEG biolubricant reduces 
cartilage wear by lowering the coefficient of friction during long-duration torsional 
testing of intact and previously worn cartilage. Its performance is superior to BSF and 
Synvisc (a currently used HA-based viscosupplement). Future studies using healthy and 
osteoarthritic human cartilage are planned to validate our findings and further challenge 
this biolubricant as a potential treatment for early-stage OA. The present studies 
demonstrate 2M TEG’s enhanced lubrication for both healthy and worn cartilage in 
loading conditions that are far more abrasive than those experienced in vivo. 
Furthermore, the biolubricant exhibited minimal in vivo inflammation that was 
comparable to a saline control. By minimizing further cartilage wear with no 
inflammatory effects, biolubricants like 2M TEG provide opportunities for minimally-





Figure 7.1: Coefficients of friction (µmean) for bovine cartilage plug pairs (patella against femoral 
groove) tested in three lubricants during the long-duration torsional friction regimen (>10,000 
rotations) of Study 1. *2M TEG (structure shown in inset) < Saline (p<0.05), #BSF < Saline 
(p<0.05), ↑ indicates pause for lubricant extraction (plugs held apart for ~30 sec). 
 
 
Figure 7.2: Total number of rings on cartilage plug surfaces from each pair tested (example 
photo shown in inset) following long-duration torsional friction testing in three lubricants in 





Figure 7.3: a) Representative CECT color maps of femoral groove plugs subjected to long-
duration torsional friction testing in Study 1 using (1) saline, (2) BSF, and (3) 2M TEG. b) 
Percent increase in cartilage surface roughness following long-duration torsional friction testing 
in three lubricants during Study 1. *2M TEG < Saline (p<0.05). 
 
 
Figure 7.4: Mean of each wear regimen’s µ-values normalized to the µ-values of Wear1. The 
mean coefficient of friction of Wear2 (2M TEG) reduced by 20.9 ± 10.5% relative to that of 
Wear1 (BSF), while the mean coefficient of friction of Wear3 (BSF) increased by 2.0 ± 7.1% 
relative to Wear1. *The normalized Wear2 mean µ-value was significantly less than the 





Figure 7.5: Percent change in µmean from Wear2 to Wear3 for samples tested in BSF, Synvisc and 
2M TEG during Study 3. The percent change in µmean values for 2M TEG were significantly 
lower than those for BSF for all time points except 800, 6080, 6240, 6400, 6560, 6720, 6880, 
7040 and 8480 sec.  *2M TEG < BSF (p<0.05), except for the two time points indicated with # 
(800 and 8480 sec). 
 
Figure 7.6: Representative H&E histological sections (50x) of synovium from Beagle knees 




CHAPTER 8: Conclusion 
 Many methods are available for measuring cartilage mechanical properties and 
biochemical content directly. Some common mechanical testing techniques are confined, 
unconfined and indentation testing for determining cartilage compressive modulus (E); 
and torsional, linear or pendulum tests for obtaining cartilage coefficient of friction (µ). 
To quantify glycosaminoglycan (GAG) content, the 1,9-dimethylmethylene blue 
(DMMB) colorimetric assay or Safranin-O histological staining are frequently used. 
Nevertheless, research and clinical needs exist for non-destructive measures of these 
cartilage properties. Various arthroscopic techniques are explored in Chapter 1, some of 
which generate results that agree with reference measures of cartilage stiffness and GAG 
content. However, these techniques are limited by their risks to the patient (chance of 
anesthesia complications or infection), cost (for the devices, surgeons, and operating 
room time), and the time required to perform the measurements (several minutes to 
hours, including patient prep) and for the patient to recover. On the other hand, external 
imaging modalities (MRI and CT) can examine articular cartilage minimally-invasively 
both with and without contrast agents. Indeed, previous MRI and CT imaging data 
correlate with direct measures of cartilage biochemical content and compressive stiffness. 
However, most experiments utilize ideal cartilage models (cartilage discs or 
osteochondral plugs), but rarely use intact pre-clinical animal or human models. 
 To advance contrast-enhanced CT (CECT) imaging for articular cartilage, this 
work presents further development of a new cationic contrast agent (CA4+) for 
minimally-invasive assessment of cartilage GAG, E and µ. Specifically, the ability of 
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CA4+ enhanced CT to measure these three cartilage properties is initially established 
using an ideal bovine osteochondral plug model (Chapter 2), then the technique is 
developed for measuring the same properties in human finger joints (Chapter 4) and 
mouse knees (Chapters 5 & 6). Furthermore, contrast-enhanced CT (CECT) with CA4+ 
is effective at determining bovine meniscal GAG content, indicating the technique’s 
ability to evaluate multiple tissues involved in osteoarthritis (OA). CECT’s sensitivity for 
critical cartilage biochemical and biomechanical properties indicates its utility as both a 
non-destructive research tool as well as a method for diagnosing and monitoring early-
stage OA. In addition to being a diagnostic, CECT is also effective at evaluating the 
efficacy of a new biolubricant (2M TEG) for early-stage treatment of OA. In particular, 
CECT can detect differences in cartilage surface roughness between samples tested in 
saline (a negative control) and 2M TEG. Hence, CECT, particularly with a contrast agent 
that is highly sensitive to cartilage GAG content and mechanical properties, such as 
CA4+, stands as a valuable research tool for subsequent in vivo animal and clinical use. 
 The findings presented herein generate opportunities for further development of 
both CA4+ and 2M TEG. Due to the sensitivity of CA4+ to cartilage properties and CT 
to bone properties, CA4+ enhanced CT enables new comparative studies for examining 
relationships between cartilage and bone for both human (e.g., metacarpophalangeal 
joint) and animal (e.g., mouse OA models) joints. Such studies could greatly improve the 
current understanding of OA pathogenesis and progression. Since CECT can minimally-
invasively assess cartilage health, more thorough in vivo experiments are warranted to 
fully establish the technique as an alternative to histology. Although the benefits of 
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longitudinal monitoring are significant (e.g., fewer animals and less cost are required), a 
larger in vivo mouse study, that includes groups of animals euthanized at specific time 
points, is necessary to demonstrate the CECT can accurately measure cartilage properties 
as OA develops in an animal model. Furthermore, since CECT generates rapid, 3D 
reconstructions that are analogous to Safranin-O stained histology, the technique should 
be expanded for high throughput, including automated sample immersion into contrast 
agents and subsequent CT scanning. Regarding the 2M TEG biolubricant, joint space 
residence time studies are necessary to validate the long-term presence and efficacy of 
2M TEG using in vivo OA animal models. 
 Although there are opportunities for further development of CA4+ enhanced CT, 
both CT and MRI imaging have opportunities for improvement as well. Both modalities 
will benefit from faster computer processing speeds, as the images will be acquired, 
reconstructed and transferred more rapidly. Additionally, increased computer memory 
and improved detectors will enable higher resolution scanning, which will facilitate 
greater sensitivity to GAG and mechanical properties and permit studying more aspects 
of the cartilage ECM. For MRI, new scan sequences are being reported regularly that 
could drastically reduce scan time, improve signal to noise ratio, and better detect subtle 
changes in cartilage biochemical composition, and hence mechanical properties [331, 
332]. Similarly for CT, new cone-beam, extremity CT scanners are being developed that 
enable imaging at much higher resolutions (0.100 to 0.200 mm isotropic), and new 
detectors enable lower radiation doses [205]. However, scanner upgrades are only one 
end of the spectrum for improving the assessment of articular cartilage. Although Gd-
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DTPA and the anionic CECT contrast agents (e.g., ioxaglate, iothalmate) are 
commercially available, these contrast agents are not formulated for articular cartilage. 
Hence, opportunities exist for the synthesis of new contrast agents that are specifically 
designed to measure cartilage properties. One such new CECT contrast agent presented 
herein, CA4+, utilizes electrostatic interactions to accurately measure cartilage GAG 
content and mechanical properties. However, additional contrast agents are being 
synthetized with different architectures [270] or for different imaging modalities (e.g., 
MRI) [333], but such agents could also be engineered to target and detect specific 
macromolecules crucial to cartilage function. By coupling improved resolution and scan 
times with an optimal contrast agent (or combination of agents), MRI or CECT would be 
an essential tool for diagnosing early-stage OA and monitoring the efficacy of treatments. 
 Once an ideal tool is available for clinically assessing cartilage mechanical 
properties, patient care will drastically improve. For example, in a motor vehicle 
accident, a young adult may break his/her leg and tear an ACL. Once repaired, the bone 
and ACL will heal. However, the cartilage in the patient’s knee was also damaged and 
will eventually develop OA, which if not treated early, will necessitate a joint 
replacement at a fairly young age. Unfortunately, prosthetic joints typically last 15-20 
years, thus the patient will likely undergo a more morbid operation for a subsequent 
replacement. Therefore, instead of waiting for the disease to fully progress and manifest 
as pain or limited mobility, the patient could be screened regularly (maybe once every 1-
2 years) for the presence of early OA. Once detected, an orthopedic surgeon could 
recommend lifestyle changes (e.g., weight loss or activity modification) and/or proscribe 
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a therapeutic (e.g., HA supplementation or other novel therapies [223]) to delay OA 
progression. If the disease further progressed, the focal cartilage defects could be 
localized via a 3D scan and potentially replaced with tissue engineered cartilage [334] or 
reinforced with a polymer network [335]. These early-stage treatment options currently 
are not fully utilized, because the disease can only be detected in its late stages when joint 
arthroplasty is warranted. Furthermore, with an optimal imaging technique for assessing 
cartilage health, the efficacy of new treatments could be evaluated in both pre-clinical 
animal models and clinical trials, obviating the need for large sample sizes in animal 
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